0001493152-19-017372.txt : 20191114 0001493152-19-017372.hdr.sgml : 20191114 20191114150137 ACCESSION NUMBER: 0001493152-19-017372 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 74 CONFORMED PERIOD OF REPORT: 20190930 FILED AS OF DATE: 20191114 DATE AS OF CHANGE: 20191114 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Synergy CHC Corp. CENTRAL INDEX KEY: 0001562733 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 990379440 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-55098 FILM NUMBER: 191219257 BUSINESS ADDRESS: STREET 1: 865 SPRING STREET CITY: WESTBROOK STATE: ME ZIP: 04092 BUSINESS PHONE: 615-939-9004 MAIL ADDRESS: STREET 1: 865 SPRING STREET CITY: WESTBROOK STATE: ME ZIP: 04092 FORMER COMPANY: FORMER CONFORMED NAME: Synergy Strips Corp. DATE OF NAME CHANGE: 20140429 FORMER COMPANY: FORMER CONFORMED NAME: Oro Capital Corporation, Inc. DATE OF NAME CHANGE: 20121121 10-Q 1 form10-q.htm

 

 

 

U. S. SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 10-Q

 

[X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 2019

 

[  ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ____________ to ____________

 

Synergy CHC Corp.

 

Nevada   000-55098   99-0379440
(State or other jurisdiction   (Commission   (IRS Employer
of Incorporation)   File Number)   Identification Number)

 

865 Spring Street

Westbrook, Maine 04092

(Address of principal executive offices)

 

(615) 939-9004

(Issuer’s Telephone Number)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common stock, $0.00001 par value   SNYR   OTCQB

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes [X] No [  ]

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (Sec.232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes [X] No [  ]

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule12b-2 of the Exchange Act.

 

Large accelerated filer [  ] Accelerated filer [  ] Non-accelerated filer [  ] Smaller reporting company [X]
   
Emerging Growth Company [  ]    

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [  ]

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes [  ] No [X]

 

As of November 12, 2019, 89,889,074 shares of our common stock were issued and outstanding.

 

 

 

 
 

 

SYNERGY CHC CORP.

 

INDEX

 

Table of Contents

 

PART I FINANCIAL INFORMATION  
     
Item 1. Condensed consolidated financial statements 3
     
  Condensed consolidated balance sheets as of September 30, 2019 (unaudited) and December 31, 2018 3
     
  Condensed consolidated statements of operations and comprehensive (loss) income for the three and nine months ended September 30, 2019 and 2018 (unaudited) 4
     
  Condensed consolidated statements of changes in stockholders’ equity for the three and nine months ended September 30, 2019 and 2018 (unaudited) 5
     
  Condensed consolidated statements of cash flows for the nine months ended September 30, 2019 and 2018 (unaudited) 6
     
  Notes to unaudited condensed consolidated financial statements 7
     
Item 2. Management’s discussion and analysis of financial condition and results of operations 24
     
Item 3. Quantitative and qualitative disclosures about market risk 30
     
Item 4. Controls and procedures 30
     
PART II OTHER INFORMATION  
     
Item 1. Legal proceedings 31
     
Item 1A. Risk factors 31
     
Item 2. Unregistered sales of equity securities and use of proceeds 31
     
Item 3. Defaults upon senior securities 31
     
Item 4. Mine Safety Disclosures 31
     
Item 5. Other information 31
     
Item 6. Exhibits 31
     
Signatures 32

 

2
 

 

PART I – FINANCIAL INFORMATION

 

ITEM 1. FINANCIAL STATEMENTS

 

Synergy CHC Corp.

Condensed Consolidated Balance Sheets

 

   September 30, 2019   December 31, 2018 
   (Unaudited)     
Assets          
Current Assets:          
Cash and cash equivalents  $1,389,311   $459,736 
Restricted cash   100,000    136,180 
Accounts receivable, net   1,902,130    4,458,225 
Prepaid expenses and other current assets   435,165    828,847 
Income taxes receivable   404,391    386,686 
Inventory, net   2,233,152    2,670,305 
Total Current Assets   6,464,149    8,939,979 
           
Fixed assets, net   166,282    269,771 
Goodwill   7,793,240    7,793,240 
Intangible assets, net   2,199,751    3,007,521 
Total Assets  $16,623,422   $20,010,511 
           
Liabilities and Stockholders’ Equity          
Current Liabilities:          
Accounts payable and accrued liabilities  $4,497,616   $8,397,220 
Deferred revenue   9,947    49,709 
Current portion of long-term debt, net of debt discount and debt issuance cost, related party   5,937,576    1,963,887 
Total Current Liabilities   10,445,139    10,410,816 
           
Long-term Liabilities:          
Note payable, net of debt discount and debt issuance cost, related party   250,491    5,629,002 
Total Long-term Liabilities   250,491    5,629,002 
Total Liabilities   10,695,630    16,039,818 
           
Commitments and contingencies          
           
Stockholders’ Equity:          
Common stock, $0.00001 par value; 300,000,000 shares authorized; 89,889,074 and 89,862,683 shares issued and outstanding, respectively   899    899 
Additional paid in capital   18,980,276    18,817,800 
Accumulated other comprehensive income   80,126    179,116 
Accumulated deficit   (13,133,509)   (15,027,122)
Total stockholders’ equity   5,927,792    3,970,693 
Total Liabilities and Stockholders’ Equity  $16,623,422   $20,010,511 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements

 

3
 

 

Synergy CHC Corp.

Unaudited Condensed Consolidated Statements of Operations and Comprehensive (Loss) Income

 

   For the three months ended   For the nine months ended 
   September 30, 2019   September 30, 2018   September 30, 2019   September 30, 2018 
Revenue  $7,364,546   $9,190,377   $23,170,222   $28,619,950 
Cost of sales   2,490,444    2,945,389    6,638,481    8,500,057 
Gross profit   4,874,102    6,244,988    16,531,741    20,119,893 
                     
Operating expenses                    
Selling and marketing   2,771,884    3,960,131    8,731,129    13,361,490 
General and administrative   1,437,624    1,189,681    3,997,437    4,425,826 
Depreciation and amortization   301,388    455,579    911,259    1,363,016 
Total operating expenses   4,510,896    5,605,391    13,639,825    19,150,332 
                     
Income from operations   363,206    639,597    2,891,916    969,561 
                     
Other (income) expenses                    
Interest income   (105)   (50)   (329)   (121)
Interest expense   180,759    288,479    805,172    864,342 
Other income   -    (27,674)   -    (27,674)
Remeasurement loss on translation of foreign subsidiary   101,289    66,353    112,551    197,674 
Amortization of debt issuance cost   30,820    93,089    103,782    171,824 
                     
Total other expenses   312,763    420,197    1,021,176    1,206,045 
                     
Net income (loss) before income taxes   50,443    219,400    1,870,740    (236,484)
Income tax (benefit) expense   (57,421)   (126,190)   (22,873)   256,812 
Net income (loss) after tax  $107,864   $345,590   $1,893,613   $(493,296)
                     
Net income (loss) per share – basic  $0.00   $0.00   $0.02   $(0.01)
Net income (loss) per share – diluted  $0.00   $0.00   $0.02   $(0.01)
                     
Weighted average common shares outstanding                    
Basic   89,889,044    89,862,683    89,881,223    89,862,683 
Diluted   89,889,044    89,862,683    89,881,223    89,862,683 
                     
Comprehensive (loss) income:                    
Net income (loss)   107,864    345,590    1,893,613    (493,296)
Foreign currency translation adjustment   47,011    (17,578)   (98,990)   85,826 
Comprehensive income (loss)  $154,875   $328,012   $1,794,623   $(407,470)

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements

 

4
 

 

Synergy CHC Corp.

Unaudited Condensed Consolidated Statements of Changes in Stockholders’ Equity

 

   Common stock   Additional Paid in   Accumulated Other Comprehensive   Accumulated   Total Stockholders’ 
   Shares   Amount   Capital   Income (Loss)   Deficit   Equity 
Balance as of December 31, 2017   89,862,683   $899   $18,376,801   $(77,989)  $(8,866,432)  $9,433,279 
                               
Fair value of vested stock options             119,617              119,617 
Foreign currency translation gain                  60,513         60,513 
                               
Net loss                       (55,493)   (55,493)
Balance as of March 31, 2018   89,862,683   $899   $18,496,418   $(17,476)  $(8,921,928)  $9,557,913 
Fair value of vested stock options             119,769              119,769 
Foreign currency translation gain                  42,891         42,891 
                               
Net loss                       (783,393)   (783,393)
Balance as of June 30, 2018   89,862,683   $899   $18,616,187   $25,415   $(9,705,322)  $8,937,179 
Fair value of vested stock options             (90,396)             (90,396)
Foreign currency translation gain                  (17,577)        (17,577)
                               
Net income                       345,590    345,590 
Balance as of September 30, 2018   89,862,683   $899   $18,525,791   $7,838   $(9,359,732)  $9,174,796 

 

   Common stock   Additional Paid in   Accumulated Other Comprehensive   Accumulated   Total Stockholders’ 
   Shares   Amount   Capital   Income   Deficit   Equity 
Balance as of December 31, 2018   89,862,683   $899   $18,817,800   $179,116   $(15,027,122)  $3,970,693 
                               
Fair value of vested stock options             45,534              45,534 
Foreign currency translation loss                  (70,940)        (70,940)
Common stock issued for Per-fekt settlement   26,391         39,585              39,585 
Net income                       1,467,287    1,467,287 
Balance as of March 31, 2019   89,889,074   $899   $18,902,919   $108,176   $(13,559,835)  $5,452,159 
                               
Fair value of vested stock options             38,679              38,679 
Foreign currency translation loss                  (75,061)        (75,061)
Net income                       318,462    318,462 
Balance as of June 30, 2019   89,889,074   $899   $18,941,597   $33,115   $(13,241,373)  $5,734,238 
Fair value of vested stock options             38,679              38,679 
Foreign currency translation gain                  47,011         47,011 
Net income                       107,864    107,864 
Balance as of September 30, 2019   89,889,074   $899   $18,980,276   $80,126   $(13,133,509)  $5,927,792 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements

 

5
 

 

Synergy CHC Corp.

Unaudited Condensed Consolidated Statements of Cash Flows

 

   For the nine months ended 
   September 30, 2019   September 30, 2018 
Cash Flows from Operating Activities          
Net income (loss)  $1,893,613   $(493,296)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:          
Depreciation and amortization   911,259    1,363,016 
Amortization of debt issuance cost   103,782    171,824 
Stock based compensation expense   162,476    148,990 
Remeasurement loss on translation of foreign subsidiary   112,551    197,674 
Foreign currency transaction gain   (4,878)   (47,887)
Non cash implied interest   28,895    58,014 
Changes in operating assets and liabilities:          
Accounts receivable   2,556,095    2,309,350 
Inventory   437,155    (539,438)
Other current assets   393,683    375,795 
Accounts payable and accrued liabilities   (4,024,983)   (1,545,260)
Deferred revenue   (39,763)   44,983 
Net cash provided by operating activities   2,529,885    2,043,765 
           
Cash Flows from Investing Activities          
Payments for acquisition of fixed assets   -    (129,087)
Payment for acquisition of domain name   -    (15,213)
Purchase of intangible assets   -    (50,000)
Net cash used in investing activities   -    (194,300)
           
Cash Flows from Financing Activities          
Repayment of notes payable   (1,537,500)   (2,287,500)
Net cash used in financing activities   (1,537,500)   (2,287,500)
           
Effect of exchange rate on cash, cash equivalents and restricted cash   (98,990)   85,827 
           
Net increase (decrease) in cash, cash equivalents and restricted cash   893,395    (352,208)
           
Cash, Cash Equivalents and restricted cash, beginning of period   595,916    2,094,685 
           
Cash, Cash Equivalents and restricted cash, end of period  $1,489,311   $1,742,477 
           
Supplemental Disclosure of Cash Flow Information:          
Cash paid during the period for:          
Interest  $723,892   $983,130 
Income taxes  $38,919   $224,114 
Supplemental Disclosure of Non-cash Investing and Financing Activities:  $-   $- 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements

 

6
 

 

Synergy CHC Corp.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

Note 1 – Nature of the Business

 

Synergy CHC Corp. (“Synergy”, “we”, “us”, “our” or the “Company”) (formerly Synergy Strips Corp.) was incorporated on December 29, 2010 in Nevada under the name “Oro Capital Corporation.” On April 21, 2014, the Company changed its fiscal year end from July 31 to December 31. On April 28, 2014, the Company changed its name to “Synergy Strips Corp.”. On August 5, 2015, the Company changed its name to “Synergy CHC Corp.”

 

The Company is a consumer health care company that is in the process of building a portfolio of best-in-class consumer product brands. Synergy’s strategy is to grow its portfolio both organically and by further acquisition.

 

Effective January 1, 2019 the Company has merged its U.S. subsidiaries (Neuragen Corp., Breakthrough Products, Inc., Sneaky Vaunt Corp., and The Queen Pegasus Corp.) into the parent company.

 

Synergy is the sole owner of two subsidiaries: NomadChoice Pty Ltd., and Synergy CHC Inc. and the results have been consolidated in these statements.

 

Note 2 – Summary of Significant Accounting Policies

 

General

 

The accompanying condensed consolidated financial statements as of September 30, 2019 and December 31, 2018 and for the three and nine months ended September 30, 2019 and 2018 are unaudited. These unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information and are presented in accordance with the requirements of Rule S-X of the Securities and Exchange Commission (the “SEC”) and with the instructions to Form 10-Q. Accordingly, they do not include all the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three and nine months ended September 30, 2019 are not necessarily indicative of the results that may be expected for the fiscal year ending December 31, 2019. The unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements as of and for the year ended December 31, 2018 and footnotes thereto included in the Company’s Annual Report on Form 10-K filed with the SEC on March 29, 2019.

 

Basis of Presentation

 

The unaudited condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.

 

Use of Estimates

 

The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosure of contingent liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates. Significant estimates are assumptions about collection of accounts receivable, useful life of fixed and intangible assets, goodwill and assumptions used in Black-Scholes-Merton, or BSM, valuation methods, such as expected volatility, risk-free interest rate, and expected dividend rate.

 

Cash and Cash Equivalents

 

The Company considers all cash on hand and in banks, including accounts in book overdraft positions, certificates of deposit and other highly-liquid investments with maturities of three months or less, when purchased, to be cash and cash equivalents. As of September 30, 2019, the Company had no cash equivalents. The Company maintains its cash and cash equivalents in banks insured by the Federal Deposit Insurance Corporation (FDIC) in accounts that at times may be in excess of the federally insured limit of $250,000 per bank. The Company minimizes this risk by placing its cash deposits with major financial institutions. At September 30, 2019, the uninsured balance amounted to $981,699.

 

7
 

 

Restricted Cash

 

The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the statement of financial position that sum to the total of the same such amounts shown in the statement of cash flows.

 

   September 30, 2019   December 31, 2018   September 30, 2018 
             
Cash and cash equivalents  $1,389,311   $459,736   $1,605,381 
Restricted cash   100,000    136,180    137,096 
Total cash, cash equivalents, and restricted cash shown in the statement of cash flows  $1,489,311   $595,916   $1,742,477 

 

Amounts included in restricted cash represent amounts held for credit card collateral.

 

Capitalization of Fixed Assets

 

The Company capitalizes expenditures related to property and equipment, subject to a minimum rule, that have a useful life greater than one year for: (1) assets purchased; (2) existing assets that are replaced, improved or the useful lives have been extended; or (3) all land, regardless of cost. Acquisitions of new assets, additions, replacements and improvements (other than land) costing less than the minimum rule in addition to maintenance and repair costs, including any planned major maintenance activities, are expensed as incurred.

 

Intangible Assets

 

We evaluate the recoverability of intangible assets periodically and take into account events or circumstances that warrant revised estimates of useful lives or that indicate that impairment exists. All of our intangible assets are subject to amortization except intellectual property of $1,450,000 acquired as part of an Asset Purchase Agreement entered into with Factor Nutrition Labs LLC on January 22, 2015, $10,000 acquired as part of an Asset Purchase Agreement entered into with Perfekt Beauty Holdings LLC and CDG Holdings, LLC on June 21, 2017 and $50,000 acquired as part of an Asset Purchase Agreement entered into with Cocowhite on May 22, 2018. Intangible assets are amortized on a straight line basis over the useful lives. During the year ended December 31, 2018, the Company fully impaired intangible assets related to Perfekt and Cocowhite and charged to operations impairment loss of $60,000. As of September 30, 2019, our qualitative analysis of intangible assets with indefinite lives did not indicate any impairment.

 

Long-lived Assets

 

Long-lived assets include equipment and intangible assets other than those with indefinite lives. We assess the carrying value of our long-lived asset groups when indicators of impairment exist and recognize an impairment loss when the carrying amount of a long-lived asset is not recoverable when compared to undiscounted cash flows expected to result from the use and eventual disposition of the asset.

 

Indicators of impairment include significant underperformance relative to historical or projected future operating results, significant changes in our use of the assets or in our business strategy, loss of or changes in customer relationships and significant negative industry or economic trends. When indications of impairment arise for a particular asset or group of assets, we assess the future recoverability of the carrying value of the asset (or asset group) based on an undiscounted cash flow analysis. If carrying value exceeds projected, net, undiscounted cash flows, an additional analysis is performed to determine the fair value of the asset (or asset group), typically a discounted cash flow analysis, and an impairment charge is recorded for the excess of carrying value over fair value. However, as of December 31, 2018 our review of intangible assets related to two of our subsidiaries did indicate that the carrying amount of the asset may not be recoverable. During the year ended December 31, 2018, the Company fully impaired related intangible assets and charged to operations impairment loss of $864,067. As of September 30, 2019, our qualitative analysis of long-lived assets did not indicate any impairment.

 

Goodwill

 

An asset purchase is accounted for under the purchase method of accounting. Under that method, assets and liabilities of the business acquired are recorded at their estimated fair values as of the date of the acquisition, with any excess of the cost of the acquisition over the estimated fair value of the net tangible and intangible assets acquired recorded as goodwill. As of September 30, 2019, our qualitative analysis of goodwill did not indicate any impairment.

 

Revenue Recognition

 

The Company recognizes revenue in accordance with the Financial Accounting Standards Board’s (“FASB”), Accounting Standards Codification (“ASC”) ASC 606, Revenue from Contracts with Customers (“ASC 606”). Revenues are recognized when control is transferred to customers in amounts that reflect the consideration the Company expects to be entitled to receive in exchange for those goods. Revenue recognition is evaluated through the following five steps: (i) identification of the contract, or contracts, with a customer; (ii) identification of the performance obligations in the contract; (iii) determination of the transaction price; (iv) allocation of the transaction price to the performance obligations in the contract; and (v) recognition of revenue when or as a performance obligation is satisfied.

 

8
 

 

The Company recognizes revenue upon shipment from its fulfillment centers. Certain of our distributors may also perform a separate function as a co-packer on our behalf. In such cases, ownership of and title to our products that are co-packed on our behalf by those co-packers who are also distributors, passes to such distributors when we are notified by them that they have taken transfer or possession of the relevant portion of our finished goods. Freight billed to customers is presented as revenues, and the related freight costs are presented as cost of goods sold. Cancelled orders are refunded if not already dispatched, refunds are only paid if stock is damaged in transit, discounts are only offered with specific promotions and orders will be refilled if lost in transit.

 

Contract Assets

 

The Company does not have any contract assets such as work-in-process. All trade receivables on the Company’s condensed consolidated balance sheet are from contracts with customers.

 

Contract Costs

 

Costs incurred to obtain a contract are capitalized unless short term in nature. As a practical expedient, costs to obtain a contract that are short term in nature are expensed as incurred. The Company does not have any contract costs capitalized as of September 30, 2019.

 

Contract Liabilities - Deferred Revenue

 

The Company’s contract liabilities consist of advance customer payments and deferred revenue. Deferred revenue results from transactions in which the Company has been paid for products by customers, but for which all revenue recognition criteria have not yet been met. Once all revenue recognition criteria have been met, the deferred revenues are recognized.

 

Accounts receivable

 

Accounts receivable are generally unsecured. The Company establishes an allowance for doubtful accounts receivable based on the age of outstanding invoices and management’s evaluation of collectability. Accounts are written off after all reasonable collection efforts have been exhausted and management concludes that likelihood of collection is remote. Any future recoveries are applied against the allowance for doubtful accounts. As of both September 30, 2019 and December 31, 2018, allowance for doubtful accounts was $0.

 

Advertising Expense

 

The Company expenses marketing, promotions and advertising costs as incurred. Such costs are included in selling expense in the accompanying unaudited condensed consolidated statements of operations.

 

Research and Development

 

Costs incurred in connection with the development of new products and processing methods are charged to general and administrative expenses as incurred.

 

Income Taxes

 

The Company utilizes FASB ASC 740, “Income Taxes,” which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns. Under this method, deferred tax assets and liabilities are determined based on the difference between the tax basis of assets and liabilities and their financial reporting amounts based on enacted tax laws and statutory tax rates applicable to the periods in which the differences are expected to affect taxable income. A valuation allowance is recorded when it is “more likely-than-not” that a deferred tax asset will not be realized.

 

9
 

 

The Company generated a deferred tax asset through net operating loss carry-forward. However, a valuation allowance of 100% has been established due to the uncertainty of the Company’s realization of the net operating loss carry forward prior to its expiration.

 

NomadChoice Pty Ltd, the Company’s wholly-owned foreign subsidiary, is subject to income taxes in the jurisdictions in which it operates. Significant judgment is required in determining the provision for income tax. There are many transactions and calculations undertaken during the ordinary course of business for which the ultimate tax determination is uncertain. The company recognizes liabilities for anticipated tax audit issues based on the Company’s current understanding of the tax law. Where the final tax outcome of these matters is different from the carrying amounts, such differences will impact the current and deferred tax provisions in the period in which such determination is made.

 

Synergy CHC Inc. is a wholly-owned foreign subsidiary, is subject to income taxes in the jurisdictions in which it operates. Significant judgment is required in determining the provision for income tax. There are many transactions and calculations undertaken during the ordinary course of business for which the ultimate tax determination is uncertain. The company recognizes liabilities for anticipated tax audit issues based on the Company’s current understanding of the tax law. Where the final tax outcome of these matters is different from the carrying amounts, such differences will impact the current and deferred tax provisions in the period in which such determination is made.

 

Net Earnings (Loss) Per Common Share

 

The Company computes earnings per share under ASC subtopic 260-10, Earnings Per Share. Basic earnings (loss) per share is computed by dividing the net income (loss) attributable to the common stockholders (the numerator) by the weighted average number of shares of common stock outstanding (the denominator) during the reporting periods. Diluted earnings per share is computed by increasing the denominator by the weighted average number of additional shares that could have been outstanding from securities convertible into common stock (using the “treasury stock” method), unless their effect on net loss per share is anti-dilutive. As of September 30, 2019, and 2018, options to purchase 6,166,667 and 7,166,667 shares of common stock, respectively, were outstanding. As of September 30, 2018, warrants to purchase 1,000,000 shares of common stock were outstanding.

 

The following is a reconciliation of the number of shares used in the calculation of basic earnings per share and diluted earnings per share for the three and nine months ended September 30, 2019, and 2018:

 

   For the three months ended   For the nine months ended 
   September 30, 2019   September 30, 2018   September 30, 2019   September 30, 2018 
                 
Net income (loss) after tax  $107,864   $345,590   $1,893,613   $(493,296)
                     
Weighted average common shares outstanding   89,889,044    89,862,683    89,881,223    89,862,683 
Incremental shares from the assumed exercise of dilutive stock options   -    -    -    - 
Incremental shares from the assumed exercise of dilutive stock warrants   -    -    -    - 
Dilutive potential common shares   89,889,044    89,862,683    89,881,223    89,862,683 
                     
Net earnings (loss) per share:                    
Basic  $0.00   $0.00   $0.02   $(0.01)
Diluted  $0.00   $0.00   $0.02   $(0.01)

 

The following securities were not included in the computation of diluted net earnings per share as their effect would have been antidilutive:

 

   2019   2018 
         
Options to purchase common stock   6,166,667    7,166,667 
Warrants to purchase common stock   -    1,000,000 
    6,166,667    8,166,667 

 

Fair Value Measurements

 

The Company measures and discloses the fair value of assets and liabilities required to be carried at fair value in accordance with ASC 820, Fair Value Measurements and Disclosures. ASC 820 defines fair value, establishes a framework for measuring fair value, and enhances fair value measurement disclosure.

 

10
 

 

ASC 825 defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required or permitted to be recorded at fair value, the Company considers the principal or most advantageous market in which it would transact and considers assumptions that market participants would use when pricing the asset or liability, such as inherent risk, transfer restrictions, and risk of nonperformance. ASC 825 establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 825 establishes three levels of inputs that may be used to measure fair value:

 

Level 1 - Quoted prices for identical assets or liabilities in active markets to which we have access at the measurement date.

 

Level 2 - Inputs other than quoted prices within Level 1 that are observable for the asset or liability, either directly or indirectly.

 

Level 3 - Unobservable inputs for the asset or liability.

 

The determination of where assets and liabilities fall within this hierarchy is based upon the lowest level of input that is significant to the fair value measurement.

 

As of September 30, 2019, the Company has determined that there were no assets or liabilities measured at fair value.

 

Inventory

 

Inventory consists of raw materials, components and finished goods. The Company’s inventory is stated at the lower of cost (FIFO cost basis) or net realizable value. Finished goods include the cost of labor to assemble the items.

 

Stock-Based Compensation

 

ASC 718, “Compensation – Stock Compensation,” prescribes accounting and reporting standards for all share-based payment transactions in which employee services are acquired. Transactions include incurring liabilities, or issuing or offering to issue shares, options, and other equity instruments such as employee stock ownership plans and stock appreciation rights. Share-based payments to employees, including grants of employee stock options, are recognized as compensation expense in the financial statements based on their fair values. That expense is recognized over the period during which an employee is required to provide services in exchange for the award, known as the requisite service period (usually the vesting period).

 

The Company accounts for stock-based compensation issued to non-employees and consultants in accordance with the provisions of ASC 505-50, “Equity – Based Payments to Non-Employees.” Measurement of share-based payment transactions with non-employees is based on the fair value of whichever is more reliably measurable: (a) the goods or services received; or (b) the equity instruments issued. The fair value of the share-based payment transaction is determined at the earlier of performance commitment date or performance completion date.

 

Foreign Currency Translation

 

The functional currency of one of the Company’s foreign subsidiaries (Nomadchoice Pty Ltd.) is the U.S. Dollar. The Company’s foreign subsidiary maintains its records using local currency (Australian Dollar). All monetary assets and liabilities of the foreign subsidiary were translated into U.S. Dollars at quarter end exchange rates, non-monetary assets and liabilities of the foreign subsidiary were translated into U.S. Dollars at transaction day exchange rates. Income and expense items related to non-monetary items were translated at exchange rates prevailing during the transaction date and other incomes and expenses were translated using average exchange rate for the period. The resulting translation adjustments, net of income taxes, were recorded in statements of operations as Remeasurement gain or loss on translation of foreign subsidiary.

 

The functional currency of the Company’s other foreign subsidiary (Synergy CHC Inc.) is the Canadian Dollar (CAD). The Company’s foreign subsidiary maintains its records using local currency (CAD). All assets and liabilities of the foreign subsidiary were translated into U.S. Dollars at period end exchange rates and stockholders’ equity is translated at the historical rates. Income and expense items were translated using average exchange rate for the period. The resulting translation adjustments, net of income taxes, are reported as other comprehensive income and accumulated other comprehensive income in the stockholder’s equity in accordance with ASC 220 – Comprehensive Income.

 

11
 

 

The exchange rates used to translate amounts in AUD and CAD into USD for the purposes of preparing the consolidated financial statements were as follows:

 

Balance sheet:

 

   September 30, 2019   December 31, 2018 
Period-end AUD: USD exchange rate  $0.6746   $0.7046 
Period-end CAD: USD exchange rate  $0.7551   $0.7330 

 

Income statement:

 

   September 30, 2019   September 30, 2018 
Average Quarterly AUD: USD exchange rate  $0.6994   $0.7579 
Average Quarterly CAD: USD exchange rate  $0.7524   $0.7768 

 

Translation gains and losses that arise from exchange rate fluctuations from transactions denominated in a currency other than the functional currency are translated into either Australian Dollars or Canadian Dollars, as the case may be, at the rate on the date of the transaction and included in the results of operations as incurred.

 

Concentrations of Credit Risk

 

In the normal course of business, the Company provides credit terms to its customers; however, collateral is not required. Accordingly, the Company performs credit evaluations of its customers and maintains allowances for possible losses which, when realized, were within the range of management’s expectations. From time to time, a higher concentration of credit risk exists on outstanding accounts receivable for a select number of customers due to individual buying patterns.

 

Warehousing costs

 

Warehouse costs include all third party warehouse rent fees and are charged to selling and marketing expenses as incurred. Any additional costs relating to assembly or special pack-outs of the Company’s products are charged to cost of sales.

 

Product display costs

 

All displays manufactured and purchased by the Company are for placement of product in retail stores. This also includes all costs for display execution and setup and retail services are charged to cost of sales and expensed as incurred.

 

Cost of Sales

 

Cost of sales includes the purchase cost of products sold and all costs associated with getting the products into the retail stores including buying and transportation costs.

 

Debt Issuance Costs

 

Debt issuance costs consist primarily of arrangement fees, professional fees and legal fees. These costs are netted off with the related loan and are being amortized to interest expense over the term of the related debt facilities.

 

Shipping Costs

 

Shipping and handling costs billed to customers are recorded in sales. Shipping costs incurred by the company are recorded in selling and marketing expenses.

 

Related parties

 

Parties are considered to be related to the Company if the parties, directly or indirectly, through one or more intermediaries, control, are controlled by, or are under common control with the Company. Related parties also include principal owners of the Company, its management, members of the immediate families of principal owners of the Company and its management and other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests. All transactions with related parties are recorded at fair value of the goods or services exchanged.

 

12
 

 

Segment Reporting

 

Segment identification and selection is consistent with the management structure used by the Company’s chief operating decision maker to evaluate performance and make decisions regarding resource allocation, as well as the materiality of financial results consistent with that structure. Based on the Company’s management structure and method of internal reporting, the Company has one operating segment. The Company’s chief operating decision maker does not review operating results on a disaggregated basis; rather, the chief operating decision maker reviews operating results on an aggregate basis.

 

Presentation of Financial Statements – Going Concern

 

Going Concern Evaluation

 

In connection with preparing unaudited condensed consolidated financial statements for the three and nine months ended September 30, 2019, management evaluated whether there were conditions and events, considered in the aggregate, that raised substantial doubt about the Company’s ability to continue as a going concern within one year from the date that the financial statements are issued.

 

The Company considered the following:

 

● At September 30, 2019, the Company had an accumulated deficit of $13,133,509.

● At September 30, 2019, the Company had working capital deficit of $3,980,990.

● Revenue decline in 2019 as compared to 2018 of $5,449,728.

 

Ordinarily, conditions or events that raise substantial doubt about an entity’s ability to continue as a going concern relate to the entity’s ability to meet its obligations as they become due.

 

The Company evaluated its ability to meet its obligations as they become due within one year from the date that the financial statements are issued by considering the following:

 

● The Company raised $10.0 million via debt financing during the year ended December 31, 2017.

● In 2019, the Company repaid $1,537,500 of loans.

● The Company generated net income of $107,864 for the three months ended September 30, 2019 and $1,893,613 for the nine months ended September 30, 2019.

● In 2019, the Company has generated $2,529,885 of cash from operating activities.

● Working capital deficit of $3,980,990 at September 30, 2019, includes loans payable to related party of $5,937,576, payables to related party of $370,939 and deferred revenue of $9,947.

● The Company has line of credit facility of $20 million available from its current lender for future mergers and acquisition.

 

Management concluded that above factors alleviate doubts about the Company’s ability to generate enough cash from operations and other available sources to satisfy its obligations for the next twelve months from the issuance date.

 

The Company will take the following actions if it starts to trend unfavorably to its internal profitability and cash flow projections, in order to mitigate conditions or events that would raise substantial doubt about its ability to continue as a going concern:

 

● Raise additional capital through line of credit and/or loan financing for future mergers and acquisition.

● Implement additional restructuring and cost reductions.

● Raise additional capital through a private placement.

 

As of November 14, 2019 and September 30, 2019, the Company had $684,916 and $1,489,311, respectively, in cash and cash equivalents.

 

13
 

 

Recent Accounting Pronouncements

 

ASU 2018-13

 

In August 2018, the FASB issued ASU 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework – Changes in Disclosure Requirements for Fair Value Measurement, which removes, modifies and adds certain disclosure requirements in Topic 820 “Fair Value Measurement”. ASU 2018-13 is effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. Early adoption is permitted. The adoption of ASU 2018-13 is not expected to have any impact on the Company’s unaudited condensed consolidated financial statements.

 

ASU 2018-07

 

In June 2018, the FASB issued ASU 2018-07, Compensation – Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting, which simplifies the accounting for share-based payments to nonemployees by aligning it with the accounting for share-based payments to employees, with certain exceptions. ASU 2018-07 is effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. Early adoption is permitted. The adoption of ASU 2018-07 did not have any impact on the Company’s unaudited condensed consolidated financial statements.

 

ASU 2018-05

 

This Accounting Standards Update adds SEC paragraphs pursuant to the SEC Staff Accounting Bulletin No. 118, which expresses the view of the staff regarding application of Topic 740, Income Taxes, in the reporting period that includes December 22, 2017 - the date on which the Tax Cuts and Jobs Act (H.R.1, An Act to Provide for Reconciliation Pursuant to Titles II and V of the Concurrent Resolution on the Budget for Fiscal Year 2018) was signed into law. We are currently evaluating the impact of adopting ASU 2017-13 on our consolidated financial statements.

 

ASU 2018-02

 

On December 22, 2017, the U.S. federal government enacted a tax bill, H.R.1, An Act to Provide for Reconciliation Pursuant to Titles II and V of the Concurrent Resolution on the Budget for Fiscal Year 2018 (Tax Cuts and Jobs Act of 2017). Stakeholders raised a narrow-scope financial reporting issue that arose as a consequence of the Tax Cuts and Jobs Act of 2017. The amendments in this Update allow a reclassification from accumulated other comprehensive income to retained earnings for stranded tax effects resulting from the Tax Cuts and Jobs Act of 2017. The amendments in this Update affect any entity that is required to apply the provisions of Topic 220, Income Statement-Reporting Comprehensive Income, and has items of other comprehensive income for which the related tax effects are presented in other comprehensive income as required by GAAP. The amendments in this update is effective for all entities for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. Early adoption of the amendments in this Update is permitted, including adoption in any interim period, (1) for public business entities for reporting periods for which financial statements have not yet been issued and (2) for all other entities for reporting periods for which financial statements have not yet been made available for issuance. The amendments in this Update should be applied either in the period of adoption or retrospectively to each period (or periods) in which the effect of the change in the U.S. federal corporate income tax rate in the Tax Cuts and Jobs Act is recognized.

 

This Accounting Standards Update is the final version of Proposed Accounting Standards Update 2018-210—Income Statement—Reporting Comprehensive Income (Topic 220), which has been deleted. We are currently evaluating the impact of adopting ASU 2017-13 on our consolidated financial statements.

 

ASU 2018-01

 

The amendments in this Update provide an optional transition practical expedient to not evaluate under Topic 842 existing or expired land easements that were not previously accounted for as leases under Topic 840, Leases. An entity that elects this practical expedient should evaluate new or modified land easements under Topic 842 beginning at the date that the entity adopts Topic 842. An entity that does not elect this practical expedient should evaluate all existing or expired land easements in connection with the adoption of the new lease requirements in Topic 842 to assess whether they meet the definition of a lease. We are currently evaluating the impact of adopting ASU 2017-13 on our consolidated financial statements.

 

14
 

 

Note 3 – Inventory

 

Inventory consists of finished goods, components and raw materials. The Company’s inventory is stated at the lower of cost (FIFO cost basis) or net realizable value.

 

The carrying value of inventory consisted of the following:

 

   September 30, 2019   December 31, 2018 
Finished goods  $1,825,086   $1,956,942 
Components   290,056    441,282 
Inventory in transit   101,980    256,051 
Raw materials   16,030    16,030 
Total inventory  $2,233,152   $2,670,305 

 

On January 22, 2015, inventory was pledged to Knight Therapeutics under the Loan Agreement (see note 10).

 

Note 4 – Accounts Receivable

 

Accounts receivable, net of allowances for sales returns and doubtful accounts, consisted of the following:

 

   September 30, 2019   December 31, 2018 
Trade accounts receivable  $1,902,130   $4,458,225 
Less allowances   -    - 
Total accounts receivable, net  $1,902,130   $4,458,225 

 

Note 5 – Prepaid Expenses and Other Current Assets

 

Prepaid expenses and other current assets consisted of the following:

 

   September 30, 2019   December 31, 2018 
Advances for inventory  $14,571   $25,170 
Media production   -    20,791 
Insurance   29,183    13,302 
Deposits   10,257    45,144 
Trademarks   19,707    78,826 
Rent   86,354    103,912 
Promotion   114,018    342,220 
License agreement   -    58,333 
Software subscriptions   48,962    34,440 
Rebranding   7,415    40,783 
Clinical research   23,745    35,617 
Miscellaneous   33,286    30,309 
Related party receivables   9,467    - 
Capital asset deposit   38,200    - 
Total  $435,165   $828,847 

 

Note 6 – Concentration of Credit Risk

 

Cash and cash equivalents

 

The Company maintains its cash and cash equivalents in banks insured by the Federal Deposit Insurance Corporation (FDIC) in accounts that at times may be in excess of the federally insured limit of $250,000 per bank. The Company minimizes this risk by placing its cash deposits with major financial institutions. At September 30, 2019 and December 31, 2018, the uninsured balances amounted to $981,699 and $162,729, respectively.

 

Accounts receivable

 

As of September 30, 2019, three customers accounted for 57% of the Company’s accounts receivable. As of December 31, 2018, three customers accounted for 83% of the Company’s accounts receivable.

 

15
 

 

Major customers

 

For the nine months ended September 30, 2019, two customers accounted for approximately 47% of the Company’s net revenue. For the three months ended September 30, 2019, two customers accounted for approximately 58% of the Company’s net revenue. For the nine months ended September 30, 2018, three customers accounted for approximately 50% of the Company’s net revenue. For the three months ended September 30, 2018, two customers accounted for approximately 58% of the Company’s net revenue. For the year ended December 31, 2018, two customers accounted for approximately 41% of the Company’s net revenues. Substantially all of the Company’s business is with companies in the United States.

 

Accounts payable

 

As of September 30, 2019 and December 31, 2018, two vendors accounted for 73% and 77%, respectively, of the Company’s accounts payable.

 

Major suppliers

 

For the nine months ended September 30, 2019, two suppliers accounted for approximately 39% of the Company’s purchases. For the nine months ended September 30, 2018, three suppliers accounted for approximately 49% of the Company’s purchases. For the three months ended September 30, 2019, two suppliers accounted for approximately 46% of the Company’s purchases. For the three months ended September 30, 2018, two suppliers accounted for approximately 48% of the Company’s purchases. Substantially all of the Company’s business is with suppliers in the United States.

 

Note 7 – Fixed Assets and Intangible Assets

 

As of September 30, 2019, and December 31, 2018, fixed assets and intangible assets consisted of the following:

 

   September 30, 2019   December 31, 2018 
         
Property and equipment  $566,445   $566,445 
Less accumulated depreciation   (400,163)   (296,674)
Fixed assets, net  $166,282   $269,771 

 

Depreciation expense for the three months ended September 30, 2019 and 2018 was $31,166 and $38,299, respectively. Depreciation expense for the nine months ended September 30, 2019 and 2018 was $103,489 and $114,461, respectively.

 

   September 30, 2019   December 31, 2018 
         
FOCUS factor intellectual property  $1,450,000   $1,450,000 
Perfekt intellectual property   -    10,000 
Cocowhite intellectual property   -    50,000 
Intangible assets subject to amortization   5,388,230    7,150,165 
Less accumulated amortization   (4,638,479)   (4,728,576)
Less accumulated impairment   -    (924,068)
Intangible assets, net  $2,199,751   $3,007,521 

 

Amortization expense for the three months ended September 30, 2019 and 2018 was $270,222 and $417,280, respectively. Amortization expense for the nine months ended September 30, 2019 and 2018 was $807,770 and $1,248,555, respectively. These intangible assets were acquired through an Asset Purchase Agreement and Stock Purchase Agreements.

 

Note 8 – Related Party Transactions

 

The Company accrued and paid consulting fees of $57,917 per month and management fees of $129,478 to a company owned by Mr. Jack Ross, Chief Executive Officer of the Company. The Company expensed $226,515 during the three months ended September 30, 2019 and $650,728 during the nine months ended September 30, 2019. As of September 30, 2019, the total outstanding balance was $0 for consulting fees and reimbursements.

 

On June 26, 2015, the Company entered into a Security Agreement with Knight Therapeutics, Inc., through its wholly owned subsidiary Neuragen Corp., for the purchase of Knight Therapeutics, Inc.’s assets. At September 30, 2019, the Company owed Knight $487,500 in relation to this agreement (see Note 10). The Company recorded present value of future payments of $263,546 and $272,151 as of September 30, 2019 and December 31, 2018, respectively.

 

On August 18, 2015, the Company entered into a Consulting Agreement with Kara Harshbarger, the co-founder of Hand MD, LLC, pursuant to which she will provide marketing and sales related service. The Company pays Ms. Harshbarger $10,000 a month for one year unless the Consulting Agreement is terminated earlier by either party. The Company has extended this agreement on a month to month basis. Hand MD, LLC is a 50% owner in Hand MD Corp. The Company expensed $30,000 through payroll for the three months ended September 30, 2019 and $90,000 for the nine months ended September 30, 2019. As of September 30, 2019, the total outstanding balance was $0.

 

16
 

 

On August 9, 2017, the Company entered into a Loan Agreement with Knight Therapeutics (Barbados) Inc., a related party, for a working capital loan. At September 30, 2019, the Company owed Knight $5,924,522 on this loan, net of debt issuance cost (see Note 10).

 

On December 23, 2016, we entered into an agreement with Knight Therapeutics for the distribution rights of FOCUSFactor in Canada. In conjunction with this agreement, we are required to pay Knight a distribution fee equal to 30% of gross sales for sales achieved through a direct sales channel and 5% of gross sales for sales achieved through retail sales. The minimum due to Knight under this agreement is $100,000 Canadian dollars. As of September 30, 2019, the total outstanding balance was $200,000 Canadian dollars (approximately $152,834 USD).

 

On December 23, 2016, we entered into an agreement with Knight Therapeutics for the distribution rights of Hand MD into Canada. In conjunction with this agreement, we are required to pay Knight a distribution fee equal to 60% of gross sales for sales achieved through a direct sales channel until the sales in the calendar year equal the threshold amount and then 40% of all such gross sales in such calendar year in excess of the threshold amount and 5% of gross sales for sales achieved through retail sales. The minimum due to Knight under this agreement is $25,000 Canadian dollars. As of September 30, 2019, the total outstanding balance was $25,000 Canadian dollars (approximately $18,325 USD).

 

The Company expensed royalty of $36,082 during the three months ended September 30, 2019 and $175,391 during the nine months ended September 30, 2019. At September 30, 2019 NomadChoice Pty Ltd., a subsidiary of the Company, owed Knight Therapeutics $36,082 in connection with a royalty distribution agreement.

 

The Company expensed royalty of $1,067 during the three months ended September 30, 2019 and $4,252 for the nine months ended September 30, 2019. At September 30, 2019 the Company owed Knight Therapeutics $1,067 in connection with a royalty distribution agreement for Sneaky Vaunt.

 

The Company expensed commissions of $0 during the three months ended September 30, 2019 and $9,065 for the nine months ended September 30, 2019. At September 30, 2019, the Company owed Founded Ventures, owned by a shareholder in the Company, $0 in connection with a commission agreement for Sneaky Vaunt.

 

The Company expensed commissions of $0 during the three months ended September 30, 2019 and $644 for the nine months ended September 30, 2019. At September 30, 2019, the Company owed Founded Ventures $0 in connection with a commission agreement for The Queen Pegasus.

 

The Company paid $6,180 during the three months ended September 30, 2019 and $14,801 for the nine months ended September 30, 2019 to Hand MD, Corp, related to a royalty agreement. At September 30, 2019, the Company owed Hand MD Corp. $0 in minimum future royalties.

 

17
 

 

Note 9 – Accounts Payable and Accrued Liabilities

 

As of September 30, 2019, and December 31, 2018, accounts payable and accrued liabilities consisted of the following:

 

   September 30, 2019   December 31, 2018 
Accrued payroll  $243,730   $217,069 
Legal fees   116,769    71,236 
Commissions   255,170    134,784 
Manufacturers   2,529,037    3,898,896 
Promotions   140,359    1,262,503 
Returns allowance   -    850,627 
Accounting fees   97,714    104,198 
Rent   -    61,738 
Customers   1,800    76,617 
Interest   49,306    - 
Royalties, related party   191,211    304,434 
Warehousing   11,106    64,289 
Sales taxes   302,870    180,222 
Taxes   -    178,069 
Severance Accrual   270,333    506,250 
Related Party Reimbursements   131,650    178,825 
Others   156,561    307,463 
Total  $4,497,616   $8,397,220 

 

Note 10 – Notes Payable

 

The Company’s loans payable at September 30, 2019 and December 31, 2018 are as follows:

 

   September 30, 2019   December 31, 2018 
         
Loans payable  $6,263,545   $7,772,150 
Unamortized debt issuance cost   (75,478)   (179,261)
Total   6,188,067    7,592,889 
Less: Current portion   (5,937,576)   (1,963,887)
Long-term portion  $250,491   $5,629,002 

 

18
 

 

$950,000 June 26, 2015 Security Agreement:

 

On June 26, 2015, the Company issued a 0% promissory note in a principal amount of $950,000 in connection with an Asset Purchase Agreement. The note requires $250,000 to be paid on or before June 30, 2016, and $700,000 to be paid in quarterly installments (beginning with the quarter ended September 30, 2015) equal to the greater of $12,500 or 5% of U.S. net sales, and 2% of U.S. net sales of Neuragen for 60 months thereafter. The payment of such amounts is secured by a security interest in certain assets, undertakings and property (“Collateral”) pursuant to the Security Agreement, which will be released upon receipt of total payments of $1.2 million.

 

The Company recorded present value of future payments of $263,546 and $272,151 as of September 30, 2019 and December 31, 2018, respectively. The Company recorded imputed interest expense of $9,526 for the three months ended September 30, 2019 and $28,896 for the nine months ended September 30, 2019.

 

During the three and nine months ended September 30, 2019, the Company made payments of $12,500 and $37,500, respectively, in connection with this Security Agreement.

 

$10,000,000 August 9, 2017 Loan:

 

On August 9, 2017, we entered into a Second Amendment to Loan Agreement (“Second Amendment”) with Knight, pursuant to which Knight agreed to loan us an additional $10 million, and an ongoing credit facility of up to $20 million, and which amount was borrowed at closing (the “Financing”) for working capital purposes. At closing, we paid Knight an origination fee of $200,000 and a work fee of $100,000 and also paid $100,000 of Knight’s expenses associated with the Loan.

 

Additional Tranches under the Loan Agreement are available to the Company until August 9, 2022 provided that no event of default exists. Each Additional Tranche must be for a minimum amount of $1.0 million, may only be used to finance qualified acquisitions (as defined in the Loan Agreement), and can be denied in Knight’s absolute discretion. If an Additional Tranche is denied, the Company can effect a qualified acquisition through a special purpose entity with such special purpose entity being entitled to obtain financing from third parties so long as such financing does not adversely affect Knight or Knight’s rights under the Loan Agreement. Upon the closing of any Additional Tranche, the Company will pay Knight an origination fee equal to 2% of the Additional Tranche, a work fee equal to 1% of the amount of the Additional Tranche, and reimburse Knight for its expenses incurred in connection with its consideration of any Additional Tranche (whether or not advanced).

 

The Loan bears interest at 10.5% per annum. The amended Loan Agreement matures on August 8, 2020 and (b) the date that Knight, in its discretion, accelerates the Company’s obligations due to an event of default.

 

On the Maturity Date of the Third Tranche and every Additional Tranche (or upon the acceleration of each such loan), the Company must pay Knight a success fee (the “Success Fee”) of that number of Company common shares equal to 10% of the loan, divided by the lesser of (a) $1.50, (b) the lowest price at which any common shares were issued by the Company in any offering or equity financing or other transaction between the Closing Date and the date the Success Fee is due, and (c) the current market price on the date the Success Fee is due. The Company may also pay the Success Fee in cash pursuant to the terms of the Loan Agreement.

 

The Loan Agreement includes customary representations, warranties, and affirmative and restrictive covenants, including covenants to attain and maintain certain financial metrics, and to not merge or dispose of assets, acquire other businesses (except for businesses substantially similar or complementary to the Company’s business, and provided that the aggregate consideration to be paid does not exceed $100,000 and the acquired business guarantees the Company’s obligations under the Loan Agreement) or make capital expenditures in excess of $500,000. The Loan Agreement also includes customary events of default, including payment defaults, breaches of covenants, change of control and material adverse effect defaults. Upon the occurrence of an event of default and during the continuation thereof, the principal amount of all loans under the Loan Agreement will bear a default interest rate of an additional 5%.

 

The Company’s obligations and liabilities under the Loan Agreement are secured and unconditionally guaranteed by certain of the Company’s wholly owned subsidiaries as provided in the Loan Agreement.

 

We have met all the covenants except for the TTM EBITDA of $5 million during the period ending March 31, 2018. Default Interest rate of 5% (from 10.5% to 15.5%) applies in accordance to our current agreement and will be in effect starting April 1, 2018 and will be in effect until the $5 million TTM EDITDA covenant is achieved. When we entered into Loan Amendment Agreement on May 14, 2018, the interest rate was reduced to 13% due to reducing payroll expenses. Also, Synergy will maintain Focus Factor Net Sales as measured on a year-end basis of at least USD $15 million for each fiscal year starting with December 31, 2017.

 

19
 

 

We have amended our covenants under our loan agreement on March 27, 2019 and are currently in compliance with all covenants. The new covenants are as follows: we will maintain a minimum EBITDA of $1,900,000 for the twelve months ending on December 31, 2018, $2,500,000 for the twelve months ending March 31, 2019, $3,500,000 for the twelve months ending September 30, 2019 and $5,000,000 for the twelve months period ending on last day of each fiscal quarters thereafter. We shall maintain a net debt to TTM EBITDA ratio of no more than 8:1 for the twelve month period ending on December 31, 2018 until March 31, 2019 and shall maintain a net debt to TTM EBITDA ratio of no more than 6:1 thereafter. We shall maintain at all times a positive cash balance of $575,000 for the three month period ending December 31, 2018, $750,000 for the three month period ending March 31, 2019 and $1,000,000 thereafter. The default interest rate of 2.5% applies (from 13% to 15.5%) in accordance to our current agreement and will be in effect from October 1, 2018 to June 30, 2019. Effective June 30, 2019 the interest rate referred back to 10.5%.

 

The Company also recorded deferred financing costs of $452,869 with respect to the above loan. The Company recognized amortization of deferred financing costs of $30,820 and $103,782 during the three and nine months ended September 30, 2019, respectively. Unamortized debt issuance cost as of September 30, 2019 amounted to $75,478.

 

The Company recognized interest expense of $166,833 and paid $166,833 during the three months ended September 30, 2019 and $759,069 and paid $709,763 during the nine months ended September 30, 2019. Accrued interest was $49,306 as of September 30, 2019. The loan balance at September 30, 2019 was $6,000,000.

 

Note 11 – Stockholders’ Equity

 

The total number of shares of all classes of capital stock which the Company is authorized to issue is 300,000,000 shares of common stock with $0.00001 par value.

 

During the nine months ended September 30, 2019, the Company issued 26,391 shares of its common stock valued at $39,585 in full and final settlement on the Perfekt transaction.

 

As of September 30, 2019 and December 31, 2018, there were 89,889,074 and 89,862,683, respectively, shares of the Company’s common stock issued and outstanding.

 

Note 12 – Commitments & Contingencies

 

Litigation:

 

From time to time the Company may become a party to litigation in the normal course of business. Management believes that there are no current legal matters that would have a material effect on the Company’s financial position or results of operations.

 

Employee Commitments

 

The Company and Mr. McCullough entered into an employment agreement on October 17, 2017 (the “Employment Agreement”) with an initial term of 3 years. In exchange for his service as President, Mr. McCullough will receive an annual base salary of $340,000. He received a cash signing bonus of $37,500 paid on January 1, 2018, and an additional cash signing bonus of $37,500 paid on July 1, 2018. Mr. McCullough will be eligible for an annual bonus of up to twenty-five percent (25%) of his base salary. The annual bonus will be determined at the discretion of our Board or compensation committee based upon the achievement of financial goals established by the Company’s Chief Executive Officer. Mr. McCullough will also be eligible for additional bonus compensation based on the Company’s achievement of certain annual earnings and retail sales goals established each year by the Company’s Chief Executive Officer. Subject to the Company’s achievement of an annual overall earnings goal and certain adjustments in the event of future acquisitions by the Company, Mr. McCullough will be eligible to receive five percent (5%) of all retail sales by the Company in excess of the annual retail sales goal set by the Chief Executive Officer.

 

The Company granted Mr. McCullough an option to purchase 1,000,000 shares of the Company’s common stock (the “Option Grant”). The Option Grant vests in three (3) equal annual installments on the first three anniversaries of Mr. McCullough’s start date with the Company, provided that Mr. McCullough remains employed by the Company on each such date. The Option Grant was granted under the Company’s 2014 Stock Incentive Plan pursuant to a stock grant agreement between the Company and Mr. McCullough.

 

Other Commitments

 

During the nine months ended September 30, 2019 the Company received a 60 day Proposition 65 letter that one of its products did not have California’s Proposition 65 label. The Company has settled the matter and made a one-time payment of $85,000 in full satisfaction of the matter.

 

20
 

 

Note 13 – Stock Options

 

The following table summarizes the options outstanding, option exercisability and the related prices for the shares of the Company’s common stock issued to employees and consultants under the Plan at September 30, 2019:

 

    Options Outstanding   Options Exercisable 
Exercise
Prices ($)		   Number
Outstanding		   Weighted
Average
Remaining
Contractual
Life
(Years)		   Weighted
Average
Exercise
Price ($)		   Number
Exercisable		   Weighted
Average
Exercise
Price ($)		 
$ 0.25 - $0.70    6,166,667    5.8   $0.54    5,750,000   $0.53 

 

The stock option activity for the nine months ended September 30, 2019 is as follows:

 

   Options
Outstanding		   Weighted
Average
Exercise Price		 
Outstanding at December 31, 2018   7,166,667   $0.50 
Granted   -    - 
Exercised   -    - 
Expired or canceled   (1,000,000)   0.25 
Outstanding at September 30, 2019   6,166,667   $0.54 

 

Stock-based compensation expense related to vested options was $38,679 and $122,891 during the three and nine months ended September 30, 2019, respectively, which is a component of general and administrative expense in the statement of income. The Company determined the value of share-based compensation for options vesting during the period using the Black-Scholes fair value option-pricing model with the following weighted average assumptions: estimated fair value of Company’s common stock of $0.48-0.50, risk-free interest rate of 1.95-1.99%, volatility of 116-117%, expected lives of 10 years, and dividend yield of 0%. Stock options outstanding as of September 30, 2019, as disclosed in the above table, have an intrinsic value of $0. As of September 30, 2019, unamortized stock-based compensation costs related to options was $167,608, and will be recognized over a period of 1 year.

 

Note 14 – Segments

 

Segment identification and selection is consistent with the management structure used by the Company’s chief operating decision maker to evaluate performance and make decisions regarding resource allocation, as well as the materiality of financial results consistent with that structure. Based on the Company’s management structure and method of internal reporting, the Company has one operating segment. The Company’s chief operating decision maker does not review operating results on a disaggregated basis; rather, the chief operating decision maker reviews operating results on an aggregate basis.

 

Net sales attributed to customers in the United States and foreign countries for the three months ended September 30, 2019 and 2018 were as follows:

 

   September 30, 2019   September 30, 2018 
United States  $6,785,123   $8,944,970 
Foreign countries   579,423    245,407 
   $7,364,546   $9,190,377 

 

Foreign countries primarily consist of Australia and Canada.

 

The Company’s net sales by product group for the three months ended September 30, 2019 and 2018 were as follows:

 

   September 30, 2019   September 30, 2018 
Nutraceuticals  $7,094,211   $8,540,044 
Over the Counter (OTC)   9,055    125,878 
Consumer Goods   224,724    260,027 
Cosmeceuticals   36,556    264,428 
   $7,364,546   $9,190,377 

 

(1) Net sales for any other product group of similar products are less than 10% of consolidated net sales.

 

21
 

 

The Company’s net sales by major sales channel for the three months ended September 30, 2019 and 2018 were as follows:

 

   September 30, 2019   September 30, 2018 
Online  $2,318,455   $4,902,161 
Retail   5,046,091    4,288,216 
   $7,364,546   $9,190,377 

 

Net sales attributed to customers in the United States and foreign countries for the nine months ended September 30, 2019 and 2018 were as follows:

 

   September 30, 2019   September 30, 2018 
United States  $21,377,182   $27,215,818 
Foreign countries   1,793,040    1,404,132 
   $23,170,222   $28,619,950 

 

The Company’s net sales by product group for the nine months ended September 30, 2019 and 2018 were as follows:

 

   September 30, 2019   September 30, 2018 
Nutraceuticals  $22,151,047   $26,450,312 
Over the Counter (OTC)   38,121    459,980 
Consumer Goods   576,754    822,959 
Cosmeceuticals   404,300    886,699 
   $23,170,222   $28,619,950 

 

(1) Net sales for any other product group of similar products are less than 10% of consolidated net sales.

 

The Company’s net sales by major sales channel for the nine months ended September 30, 2019 and 2018 were as follows:

 

   September 30, 2019   September 30, 2018 
Online  $8,841,272   $13,926,758 
Retail   14,328,950    14,693,192 
   $23,170,222   $28,619,950 

 

Long-lived assets (net) attributable to operations in the United States and foreign countries as of September 30, 2019 and December 31, 2018 were as follows:

 

   September 30, 2019   December 31, 2018 
United States  $10,150,670   $11,058,528 
Foreign countries   8,603    12,004 
   $10,159,273   $11,070,532 

 

22
 

 

Note 15 – Income Taxes

 

Income tax (benefit) expense was ($57,421) and ($22,873) for the three and nine months ended September 30, 2019, respectively, compared to ($126,190) and $256,812, respectively, for the same periods in 2018. The current provision is attributable to Australian operations and the current tax rate in effect in that country.

 

On December 22, 2017, the Tax Cuts and Jobs Act (the TCJA), which significantly modified U.S. corporate income tax law, was signed into law by President Trump. The TCJA contains significant changes to corporate income taxation, including but not limited to the reduction of the corporate income tax rate from a top marginal rate of 35% to a flat rate of 21%, limitation of the tax deduction for interest expense to 30% of earnings (except for certain small businesses), limitation of the deduction for net operating losses to 80% of current year taxable income and generally eliminating net operating loss carrybacks, allowing net operating losses to carryforward without expiration, one-time taxation of offshore earnings at reduced rates regardless of whether they are repatriated, elimination of U.S. tax on foreign earnings (subject to certain important exceptions), immediate deductions for certain new investments instead of deductions for depreciation expense over time, and modifying or repealing many business deductions and credits (including changes to the orphan drug tax credit and changes to the deductibility of research and experimental expenditures that will be effective in the future). Notwithstanding the reduction in the corporate income tax rate, the overall impact of the new federal tax law is uncertain, including to what extent various states will conform to the newly enacted federal tax law.

 

The Company has not recorded the necessary provisional adjustments in the financial statements in accordance with its current understanding of the TCJA and guidance currently available as of this filing. The Company is reviewing the TCJA’s potential ramifications.

 

The total deferred tax asset is calculated by multiplying a domestic (US) 21% marginal tax rate by the cumulative net operating loss carryforwards (“NOL”). The domestic marginal tax rate does not include any state & local marginal tax rate attributable to the Company. The Company currently has estimated NOLs, which expire through 2035. Management has determined based on all the available information that a 100% valuation reserve is required.

 

For U.S. purposes, the Company has not completed its evaluation of NOL utilization limitations under Internal Revenue Code, as amended (the “Code”) Section 382/383, change of ownership rules. If the Company has had a change in ownership, the NOL’s would be limited or eliminated, as to the amount that could be utilized each year, based on the Code. NOL’s attributable to Breakthrough Products, Inc., which are the majority of the Company’s domestic NOL’s are Separate Return Limitation Year (SRLY) NOL’s. Such losses may generally not be available for use (limited or eliminated).

 

The Company has not filed its State & Local Income/Franchise tax returns in States it is required to file for the last few years, so such returns and liability remain open, but the Company does not believe such amounts are material

 

Note 16 – Subsequent Events

 

Management evaluated all activities of the Company through the issuance date of the Company’s unaudited condensed consolidated financial statements and concluded that no subsequent events have occurred that would require adjustments or disclosure into the unaudited condensed consolidated financial statements.

 

23
 

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

The following discussion and analysis of the results of operations and financial condition of Synergy for the three and nine months ended September 30, 2019 and 2018, should be read in conjunction with the unaudited condensed consolidated financial statements of Synergy, and the notes to those unaudited condensed consolidated financial statements that are included elsewhere in this Form 10-Q. Our discussion includes forward-looking statements based upon current expectations that involve risks and uncertainties, such as our plans, objectives, expectations and intentions. Actual results and the timing of events could differ materially from those anticipated in these forward-looking statements as a result of a number of factors, including those set forth under the caption, “Cautionary Notice Regarding Forward-Looking Statements” and the “Business” section in our Form 10-K filed on March 29, 2019. We use words such as “anticipate,” “estimate,” “plan,” “project,” “continuing,” “ongoing,” “expect,” “believe,” “intend,” “may,” “will,” “should,” “could,” and similar expressions to identify forward-looking statements.

 

Overview

 

The Company is in the business of marketing and distributing consumer branded products through various distribution channels primarily in the health and wellness industry. The Company’s strategy is to grow both organically and by future acquisition.

 

Our management’s discussion and analysis of our financial condition and results of operations are only based on our current business and should be read in conjunction with our condensed consolidated financial statements. Key factors affecting our results of operations include revenues, cost of revenues, operating expenses and income and taxation.

 

Non-GAAP Financial Measures

 

We currently focus on Adjusted EBITDA to evaluate our business relationships and our resulting operating performance and financial position. Adjusted EBITDA is defined as EBITDA (net income plus interest expense, income tax expense, depreciation and amortization), further adjusted to exclude certain non-cash expenses and other adjustments as set forth below. We present Adjusted EBITDA because we consider it an important measure of our performance and it is a meaningful financial metric in assessing our operating performance from period to period by excluding certain items that we believe are not representative of our core business, such as certain non-cash items and other adjustments.

 

We believe that Adjusted EBITDA, viewed in addition to, and not in lieu of, our reported results in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”), provides useful information to investors.

 

   For the three
months ended
September 30, 2019		 
Net income after tax  $107,864 
Interest income   (105)
Interest expense   180,759 
Taxes   (57,421)
Depreciation   31,166 
Amortization   301,042 
EBITDA  $563,305 
Stock-based compensation   38,679 
One-time expenses   116,194 
Loss on foreign currency translation and transaction   69,097 
Adjusted EBITDA  $

787,275

 

 

24
 

 

   For the nine
months ended
September 30, 2019		 
Net income after taxes  $1,893,613 
Interest income   (329)
Interest expense   805,172 
Taxes   (22,873)
Depreciation   103,489 
Amortization   911,552 
EBITDA  $3,690,624 
Stock-based compensation   162,476 
One-time expenses   325,189 
Loss on foreign currency translation and transaction   107,673 
Adjusted EBITDA  $4,285,962 

 

EBITDA and Adjusted EBITDA are considered non-GAAP financial measures. EBITDA represents earnings before interest, taxes, depreciation and amortization. Adjusted EBITDA represents EBITDA, further adjusted to exclude the impact of certain expenses and transactions that we believe are not representative of our core operating results, including stock-based compensation; one-time expenses; and the gain on foreign currency translation and transaction. The Company’s definitions of EBITDA and adjusted EBITDA might not be comparable to similarly titled measures reported by other companies.

 

Results of Operations for the Three months Ended September 30, 2019 and 2018

 

Revenue

 

For the three months ended September 30, 2019, we had revenue of $7,364,546 from sales of our products, as compared to revenue of $9,190,377 for the same period in 2018. We had a decrease in Nutraceuticals in 2019 as compared to 2018 due to not overspending on marketing. We had a decrease in Over the Counter in 2019 as compared to 2018 due to an out of stock product. We had a decrease in Consumer Goods in 2019 as compared to 2018 due to a shift in business focus. We had a decrease in Cosmeceuticals in 2019 as compared to 2018 due to a shift in business focus. The revenue is comprised of the following categories:

 

   September 30, 2019   September 30, 2018 
Nutraceuticals  $7,094,211   $8,540,044 
Over the Counter (OTC)   9,055    125,878 
Consumer Goods   224,724    260,027 
Cosmeceuticals   36,556    264,428 
   $7,364,546   $9,190,377 

 

Cost of Revenue

 

For the three months ended September 30, 2019, our cost of revenue was $2,490,444. Our cost of revenue for the three months ended September 30, 2018, was $2,945,389. We had a decrease in Nutraceuticals in 2019 as compared to 2018 due to lower sales and a different mix of products being sold. We had a decrease in Over the Counter in 2019 as compared to 2018 due to an out of stock product. We had a decrease in Consumer Goods in 2019 as compared to 2018 due to a decrease in revenue. We had a decrease in Cosmeceuticals in 2019 as compared to 2018 due to a decrease in revenue. The cost of revenue is comprised of the following categories:

 

   September 30, 2019   September 30, 2018 
Nutraceuticals  $2,469,205   $2,850,628 
Over the Counter (OTC)   -    23,906 
Consumer Goods   12,040    33,481 
Cosmeceuticals   9,199    37,374 
   $2,490,444   $2,945,389 

 

25
 

 

Gross Profit

 

Gross profit was $4,874,102, or 66% for the three months ended September 30, 2019, as compared to gross profit of $6,244,988, or 68% for the same period in 2018, a decrease of $1,370,886, or 22%. The decrease in gross profit margin is directly related to the mix of products being sold.

 

Operating Expenses

 

Selling and Marketing Expenses

 

For the three months ended September 30, 2019, our selling and marketing expenses were $2,771,884 as compared to $3,960,131 for the same period in 2018, which is primarily due to decreased personnel in our advertising and marketing departments and decreased advertising.

 

General and Administrative Expenses

 

For the three months ended September 30, 2019, our general and administrative expenses were $1,437,624. For the three months ended September 30, 2018, our general and administrative expenses were $1,189,681. The increase is primarily due to one-time expenses and listing fees.

 

Depreciation and Amortization Expenses

 

For the three months ended September 30, 2019, our depreciation and amortization expenses were $301,388 as compared to $455,579 for the same period in 2018. The decrease is due to the impairment of assets owned at the end of 2018.

 

Other Income and Expenses

 

For the three months ended September 30, 2019 and 2018 we had other (income) and expense items of the following:

 

   Three months
ended
September 30, 2019		   Three months
ended
September 30, 2018		 
Interest income  $(105)  $(50)
Interest expense   180,759    288,479 
Other income   -    (27,674)
Remeasurement loss on translation of foreign subsidiary   101,289    66,353 
Amortization of debt issuance cost   30,820    93,089 
Total other expense  $312,763   $420,197 

 

For the three months ended September 30, 2019, we had interest expense of $180,759 as compared to $288,479 for the same period in 2018. The decrease was due to decrease in the interest rate of one of the loans from 13% to 10.5% offset by repayment of certain other indebtedness.

 

Net Income

 

For the three months ended September 30, 2019, our net income was $107,864 as compared to a net income of $345,590 for the same period in 2018.

 

26
 

 

Results of Operations for the Nine months Ended September 30, 2019 and 2018

 

Revenue

 

For the nine months ended September 30, 2019, we had revenue of $23,170,222 from sales of our products, as compared to revenue of $28,619,950 for the same period in 2018. We had a decrease in Nutraceuticals in 2019 as compared to 2018 due to not overspending on marketing. We had a decrease in Over the Counter in 2019 as compared to 2018 due to an out of stock product. We had a decrease in Consumer Goods in 2019 as compared to 2018 due to a shift in business focus. We had an decrease in Cosmeceuticals in 2019 as compared to 2018 due to a shift in business focus. The revenue is comprised of the following categories:

 

   September 30, 2019   September 30, 2018 
Nutraceuticals  $22,151,047   $26,450,312 
Over the Counter (OTC)   38,121    459,980 
Consumer Goods   576,754    822,959 
Cosmeceuticals   404,300    886,699 
   $23,170,222   $28,619,950 

 

Cost of Revenue

 

For the nine months ended September 30, 2019, our cost of revenue was $6,638,481. Our cost of revenue for the nine months ended September 30, 2018, was $8,500,057. We had a decrease in Nutraceuticals in 2019 as compared to 2018 due to lower sales and a different mix of products being sold. We had a decrease in Over the Counter in 2019 as compared to 2018 due to an out of stock product. We had a decrease in Consumer Goods in 2019 as compared to 2018 due to a decrease in revenue. We had a decrease in Cosmeceuticals in 2019 as compared to 2018 due to decreased revenue. The cost of revenue is comprised of the following categories:

 

   September 30, 2019   September 30, 2018 
Nutraceuticals  $6,512,546   $8,178,988 
Over the Counter (OTC)   -    71,076 
Consumer Goods   44,063    91,479 
Cosmeceuticals   81,872    158,514 
   $6,638,481   $8,500,057 

 

Gross Profit

 

Gross profit was $16,531,741, or 71% for the nine months ended September 30, 2019, as compared to gross profit of $20,119,893, or 70% for the same period in 2018, a decrease of $3,588,152, or 18%. The increase in gross profit margin is directly related to the mix of products being sold.

 

Operating Expenses

 

Selling and Marketing Expenses

 

For the nine months ended September 30, 2019, our selling and marketing expenses were $8,731,129 as compared to $13,361,490 for the same period in 2018, which is primarily due to decreased personnel in our advertising and marketing departments and decreased advertising.

 

27
 

 

General and Administrative Expenses

 

For the nine months ended September 30, 2019, our general and administrative expenses were $3,997,437. For the nine months ended September 30, 2018, our general and administrative expenses were $4,425,826. The decrease is primarily due to better management of operating costs.

 

Depreciation and Amortization Expenses

 

For the nine months ended September 30, 2019, our depreciation and amortization expenses were $911,259 as compared to $1,363,016 for the same period in 2018. The decrease is due to the impairment of intangible assets in 2018.

 

Other Income and Expenses

 

For the nine months ended September 30, 2019 and 2018 we had other (income) and expense items of the following:

 

   Nine months
ended
September 30, 2019		   Nine months
ended
September 30, 2018		 
Interest income  $(329)  $(121)
Interest expense   805,172    864,342 
Other income   -    (27,674)
Remeasurement loss on translation of foreign subsidiary   112,551    197,674 
Amortization of debt issuance cost   103,782    171,824 
Total other expense  $1,021,176   $1,206,045 

 

For the nine months ended September 30, 2019, we had interest expense of $805,172 as compared to $864,342 for the same period in 2018. The decrease was due to decrease in the interest rate of one of our loans from 13% to 10% offset by repayment of certain other indebtedness.

 

Net Income (Loss)

 

For the nine months ended September 30, 2019, our net income was $1,893,613 as compared to a net loss of $(493,296) for the same period in 2018.

 

Liquidity and Capital Resources

 

Overview

 

As of September 30, 2019, we had $1,389,311 cash on hand and a $3,980,990 working capital deficit, which includes a balloon payment on our loan of $4,500,000. In addition, we also had restricted cash of $100,000 which is held for credit card collateral.

 

28
 

 

Nine months ended September 30, 2019 and 2018

 

Net Cash Provided by Operating Activities

 

Net cash provided by operating activities for the nine months ended September 30, 2019 was $2,529,885, compared to $2,043,765 for the same period in 2018. This increase in net cash provided by operating activities for the nine months ended September 30, 2019 was primarily attributable to having net income, a decrease in accounts payable and accrued expenses and fewer inventory purchases.

 

The $2,529,885 consists of our net income of $1,893,613 adjusted by:

 

Amortization of debt issuance cost  $103,782 
Depreciation and amortization   911,259 
Stock based compensation   162,476 
Non cash implied interest   28,895 
Remeasurement loss on translation of foreign subsidiary   112,551 
Foreign currency transaction gain   (4,878)
Decrease in accounts receivable   2,556,095 
Decrease in inventory   437,155 
Decrease in other current assets   393,683 
Decrease in deferred revenue   (39,763)
Decrease in accounts payable and accrued expenses   (4,024,983)

 

Net Cash Used in Investing Activities

 

Net cash used in investing activities for the nine months ended September 30, 2019 was $0, compared to net cash used of $194,300 for the same period in 2018. The decrease in cash used in investing activities during 2019 is attributable to the purchase of assets in 2018.

 

Net Cash Used in Financing Activities

 

Net cash used in financing activities for the nine months ended September 30, 2019 was $1,537,500, compared to net cash used of $2,287,500 for the same period in 2018. This is attributable to the payoff of a loan in 2018.

 

Repayment of notes payable  $(1,537,500)

 

Key 2019 Initiatives

 

During 2019, we have plans for organic growth within our current product lines by developing and launching new products. Our technology center in Halifax, Nova Scotia is in full operation providing marketing services to all of our brands. We have new marketing campaigns in process and intend to expand our online presence for each product. While we intend to grow further through additional acquisitions, we feel it is important to also develop our existing products.

 

29
 

 

Contractual Obligations and Off-Balance Sheet Arrangements

 

Contractual Obligations

 

None.

 

Off-Balance Sheet Arrangements

 

None.

 

Inflation

 

The effect of inflation on the Company’s operating results was not significant.

 

Summary of Significant Accounting Policies

 

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities, the disclosure of contingent assets and liabilities and the reported amounts of revenue and expenses during the reported periods. The more critical accounting estimates include estimates related to revenue recognition and accounts receivable allowances. We also have other key accounting policies, which involve the use of estimates, judgments and assumptions that are significant to understanding our results, which are described in Note 2 to our unaudited condensed consolidated financial statements appearing elsewhere in this report.

 

Recent Accounting Pronouncements

 

Note 2 to our unaudited condensed consolidated financial statements appearing elsewhere in this report includes Recent Accounting Pronouncements.

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

As a “smaller reporting company” as defined by Item 10 of Regulation S-K, we are not required to provide the information required by this item.

 

ITEM 4. CONTROLS AND PROCEDURES

 

Evaluation of Disclosure Controls and Procedures

 

Our Chief Executive Officer (principal executive officer), who is also our Chief Financial Officer (principal financial officer), reviewed the effectiveness of our disclosure controls and procedures as of the end of the period covered by this report and concluded that as of September 30, 2019, (i) the Company’s disclosure controls and procedures were not effective to ensure that material information relating to the Company is recorded, processed, summarized, and reported within the time periods specified in the rules and forms of the Securities and Exchange Commission (the “Commission”), and (ii) the Company’s controls and procedures have not been designed to ensure that information required to be disclosed by the Company in the reports that it files or submits under the Securities Exchange Act of 1934, as amended, is accumulated and communicated to the Company’s management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

 

Changes in Internal Controls Over Financial Reporting

 

There were no changes in our internal control over financial reporting that occurred during the fiscal quarter covered by this report that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

 

Inherent Limitations on Effectiveness of Controls

 

The Company’s management does not expect that its disclosure controls or its internal control over financial reporting, when and if effective, will prevent or detect all error and all fraud. A control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the control system’s objectives will be met. The design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Further, because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that misstatements due to error or fraud will not occur or that all control issues and instances of fraud, if any, within the Company have been detected. These inherent limitations include the realities that judgments in decision making can be faulty and that breakdowns can occur because of simple error or mistake. Controls can also be circumvented by the individual acts of some persons, by collusion of two or more people, or management override of the controls. The design of any system of controls is based in part on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Over time, controls may become inadequate because of changes in conditions or deterioration in the degree of compliance with policies or procedures.

 

30
 

 

PART II – OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS

 

From time to time, we may become involved in various lawsuits and legal proceedings, which arise, in the ordinary course of business. However, litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm our business. We are currently not aware of any such legal proceedings or claims that we believe will have a material adverse effect on our business, financial condition or operating results.

 

ITEM 1A. RISK FACTORS

 

As a “smaller reporting company” as defined by Item 10 of Regulation S-K, we are not required to provide information required by this Item.

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

None.

 

ITEM 3. DEFAULT UPON SENIOR SECURITIES

 

None.

 

ITEM 4. MINE SAFETY DISCLOSURES

 

Not Applicable.

 

ITEM 5. OTHER INFORMATION

 

None.

 

ITEM 6. EXHIBITS

 

Exhibit

Number

   Description
     
31.1   Section 302 Certification by the Corporation’s Chief Executive Officer *
     
31.2   Section 302 Certification by the Corporation’s Chief Financial Officer *
     
32.1   Section 906 Certification by the Corporation’s Chief Executive Officer *
     
32.2   Section 906 Certification by the Corporation’s Chief Financial Officer *
     
101.INS   XBRL Instance Document* **
     
101.SCH   XBRL Taxonomy Extension Schema Document* **
     
101.CAL   XBRL Taxonomy Extension Calculation Linkbase Document* **
     
101.DEF   XBRL Taxonomy Extension Definition Linkbase Document* **
     
101.LAB   XBRL Taxonomy Extension Label Linkbase Document* **
     
101.PRE   XBRL Taxonomy Extension Presentation Linkbase Document* **

 

  * Filed herewith
     
  ** Pursuant to Rule 406T of Regulation S-T, the Interactive Data Files on Exhibit 101 hereto are deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, are deemed not filed for purposes of Section 18 of the Securities and Exchange Act of 1934, as amended, and otherwise are not subject to liability under those sections.

 

31
 

 

Signatures

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Signatures   Title   Date
         
/s/ Jack Ross   Chief Executive Officer   November 14, 2019
Jack Ross   Chief Financial Officer    

 

32
 

 

 EX-31.1 2 ex31-1.htm

 

Exhibit 31.1

 

CERTIFICATION

 

I, Jack Ross, certify that:

 

1. I have reviewed this Quarterly Report on Form 10-Q of Synergy CHC Corp.;
   
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
   
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
   
4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
   
  a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
     
  b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
     
  c. Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
     
  d. Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
     
5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
   
  a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
     
  b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: November 14, 2019 By:  /s/ Jack Ross
    Jack Ross
    Chief Executive Officer
    (Principal Executive Officer)

 

 
 

 

 EX-31.2 3 ex31-2.htm

 

Exhibit 31.2

 

CERTIFICATION

 

I, Jack Ross, certify that:

 

1. I have reviewed this Quarterly Report on Form 10-Q of Synergy CHC Corp.;
   
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
   
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
   
4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
   
  a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
     
  b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
     
  c. Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
     
  d. Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
     
5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
   
  a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
     
  b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.

 

Date: November 14, 2019 By:  /s/ Jack Ross
    Jack Ross
    Chief Financial Officer
(Principal Financial and Accounting Officer)

 

 
 

 EX-32.1 4 ex32-1.htm

 

Exhibit 32.1

 

CERTIFICATION

 

In connection with the quarterly report of Synergy CHC Corp. (the “Company”) on Form 10-Q for the quarter ended September 30, 2019, as filed with the Securities and Exchange Commission (the “Report”), I, Jack Ross, Chief Executive Officer (Principal Executive Officer) of the Company, hereby certify as of the date hereof, solely for purposes of Title 18, Chapter 63, Section 1350 of the United States Code, that to the best of my knowledge:

 

  (1) The Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, and
     
  (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated.

 

Date: November 14, 2019 By:  /s/ Jack Ross
    Jack Ross
    Chief Executive Officer
    (Principal Executive Officer)

 

 
 

 EX-32.2 5 ex32-2.htm

 

Exhibit 32.2

 

CERTIFICATION

 

In connection with the quarterly report of Synergy CHC Corp. (the “Company”) on Form 10-Q for the quarter ended September 30, 2019, as filed with the Securities and Exchange Commission (the “Report”), I, Jack Ross, Chief Financial Officer (Principal Financial and Accounting Officer) of the Company, hereby certify as of the date hereof, solely for purposes of Title 18, Chapter 63, Section 1350 of the United States Code, that to the best of my knowledge:

 

  (1) The Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, and
     
  (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated.

 

Date: November 14, 2019 By:  /s/ Jack Ross
    Jack Ross
    Chief Financial Officer
    (Principal Financial and Accounting Officer)

 

 
 

 

 EX-101.INS 6 snyr-20190930.xml XBRL INSTANCE FILE 0001562733 2018-12-31 0001562733 SNYR:JuneTwentySixTwoThousandFifteenMember SNYR:NeuragenCorpMember 2015-06-25 2015-06-26 0001562733 SNYR:JuneTwentySixTwoThousandFifteenMember SNYR:JuneThirtyTwoThousandSixteenMember 2015-06-26 0001562733 SNYR:JuneTwentySixTwoThousandFifteenMember SNYR:QuarterEndingSeptemberThirtyTwoThousandSaventeenMember 2015-06-26 0001562733 SNYR:JuneTwentySixTwoThousandFifteenMember SNYR:JuneThirtyTwoThousandSixteenMember srt:MinimumMember 2015-06-26 0001562733 country:US 2019-09-30 0001562733 SNYR:ForeignCountriesMember 2019-09-30 0001562733 SNYR:ThreeCustomersMember us-gaap:AccountsReceivableMember 2018-01-01 2018-12-31 0001562733 SNYR:TwoCustomersMember us-gaap:SalesRevenueNetMember 2018-01-01 2018-12-31 0001562733 SNYR:FactorNutritionLabsLLCMember 2015-01-22 0001562733 2019-01-01 2019-09-30 0001562733 2017-12-31 0001562733 SNYR:JuneTwentySixTwoThousandFifteenMember 2018-12-31 0001562733 country:US 2018-01-01 2018-09-30 0001562733 SNYR:ForeignCountriesMember 2018-01-01 2018-09-30 0001562733 country:US 2019-01-01 2019-09-30 0001562733 SNYR:ForeignCountriesMember 2019-01-01 2019-09-30 0001562733 SNYR:NutraceuticalsMember 2018-01-01 2018-09-30 0001562733 SNYR:NutraceuticalsMember 2019-01-01 2019-09-30 0001562733 us-gaap:OverTheCounterMember 2018-01-01 2018-09-30 0001562733 us-gaap:OverTheCounterMember 2019-01-01 2019-09-30 0001562733 SNYR:CosmeceuticalsMember 2018-01-01 2018-09-30 0001562733 SNYR:CosmeceuticalsMember 2019-01-01 2019-09-30 0001562733 SNYR:ConsumerGoodsMember 2018-01-01 2018-09-30 0001562733 SNYR:ConsumerGoodsMember 2019-01-01 2019-09-30 0001562733 SNYR:PerfektBeautyHoldingsLLCMember 2017-06-21 0001562733 SNYR:CDGHoldingsLLCMember 2017-06-21 0001562733 SNYR:JuneTwentySixTwoThousandFifteenMember SNYR:NeuragenCorpMember country:US 2015-06-25 2015-06-26 0001562733 SNYR:JuneTwentySixTwoThousandFifteenMember country:US 2015-06-25 2015-06-26 0001562733 SNYR:FOCUSfactorMember 2018-12-31 0001562733 SNYR:PerfektMemberMember 2018-12-31 0001562733 srt:ChiefExecutiveOfficerMember 2019-09-30 0001562733 SNYR:LoanAgreementMember SNYR:KnightTherapeuticsIncMember 2017-08-09 0001562733 SNYR:LoanAgreementMember SNYR:KnightTherapeuticsIncMember SNYR:OriginationFeeMember 2017-08-07 2017-08-09 0001562733 SNYR:LoanAgreementMember SNYR:KnightTherapeuticsIncMember SNYR:WorkFeeMember 2017-08-07 2017-08-09 0001562733 SNYR:LoanAgreementMember SNYR:KnightTherapeuticsIncMember 2017-08-07 2017-08-09 0001562733 SNYR:EmploymentAgreementMember 2017-10-14 2017-10-17 0001562733 SNYR:EmploymentAgreementMember SNYR:Mr.McCulloughMember 2017-10-14 2017-10-17 0001562733 SNYR:EmploymentAgreementMember SNYR:Mr.McCulloughMember SNYR:JanuaryOneTwoThousandAndEighteenMember 2017-10-14 2017-10-17 0001562733 SNYR:EmploymentAgreementMember SNYR:Mr.McCulloughMember SNYR:JulyOneTwoThousandAndEighteenMember 2017-10-14 2017-10-17 0001562733 SNYR:EmploymentAgreementMember SNYR:Mr.McCulloughMember srt:MaximumMember 2017-10-14 2017-10-17 0001562733 SNYR:EmploymentAgreementMember SNYR:Mr.McCulloughMember SNYR:RetailSalesMember 2017-10-14 2017-10-17 0001562733 SNYR:EmploymentAgreementMember SNYR:Mr.McCulloughMember SNYR:OptionGrantMember 2017-10-14 2017-10-17 0001562733 SNYR:StockOptionPlanMember 2018-12-31 0001562733 us-gaap:SalesRevenueNetMember 2019-01-01 2019-09-30 0001562733 SNYR:OnlineMember 2019-01-01 2019-09-30 0001562733 us-gaap:RetailMember 2019-01-01 2019-09-30 0001562733 us-gaap:RetailMember 2018-01-01 2018-09-30 0001562733 SNYR:OnlineMember 2018-01-01 2018-09-30 0001562733 SNYR:CocowhiteMember 2018-05-22 0001562733 us-gaap:CommonStockMember 2017-12-31 0001562733 us-gaap:AdditionalPaidInCapitalMember 2017-12-31 0001562733 us-gaap:ComprehensiveIncomeMember 2017-12-31 0001562733 us-gaap:RetainedEarningsMember 2017-12-31 0001562733 us-gaap:CommonStockMember 2018-12-31 0001562733 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0001562733 us-gaap:ComprehensiveIncomeMember 2018-12-31 0001562733 us-gaap:RetainedEarningsMember 2018-12-31 0001562733 SNYR:KnightTherapeuticsIncMember 2016-12-21 2016-12-23 0001562733 2018-09-30 0001562733 2018-07-01 2018-09-30 0001562733 2018-01-01 2018-09-30 0001562733 SNYR:CocowhiteMember 2018-12-31 0001562733 SNYR:HandMDMember 2016-12-21 2016-12-23 0001562733 SNYR:HandMDMember SNYR:CADMember 2016-12-23 0001562733 SNYR:LoanAgreementMember 2018-01-01 2018-12-31 0001562733 SNYR:LoanAgreementMember 2019-09-30 0001562733 SNYR:LoanAgreementMember srt:MinimumMember 2018-12-31 0001562733 SNYR:LoanAgreementMember srt:MaximumMember 2019-09-30 0001562733 SNYR:PerioEndAUDToUSDExchangeRateMember 2018-12-31 0001562733 SNYR:PerioEndCADToUSDExchangeRateMember 2018-12-31 0001562733 SNYR:TwoVendorsMember us-gaap:AccountsPayableMember 2018-01-01 2018-12-31 0001562733 SNYR:LoanAgreementMember 2017-08-07 2017-08-09 0001562733 SNYR:LoanAgreementMember SNYR:AdditionalTrancheMember srt:MinimumMember 2017-08-09 0001562733 SNYR:LoanAgreementMember SNYR:AdditionalTrancheMember 2017-08-07 2017-08-09 0001562733 SNYR:LoanAgreementMember srt:MaximumMember 2017-08-07 2017-08-09 0001562733 SNYR:LoanAgreementMember 2017-08-09 0001562733 SNYR:LoanAgreementMember srt:MinimumMember SNYR:QuartersEndingAfterMarchThirtyOneTwoThousandNineteenMember 2018-12-31 0001562733 SNYR:LoanAgreementMember srt:MinimumMember 2018-01-01 2018-12-31 0001562733 SNYR:LoanAgreementMember srt:MinimumMember SNYR:TwelveMonthsEndingMarchThirtyOneTwoThousandNineteenMember 2019-01-01 2019-09-30 0001562733 SNYR:LoanAgreementMember srt:MinimumMember SNYR:TwelveMonthsEndingJuneThirtyTwoThousandNineteenMember 2019-01-01 2019-09-30 0001562733 SNYR:LoanAgreementMember SNYR:PeriodAfterMarchThirtyOneTwoThousandNineteenMember 2018-01-01 2018-12-31 0001562733 SNYR:LoanAgreementMember 2018-09-29 2018-09-30 0001562733 SNYR:LoanAgreementMember 2018-09-30 0001562733 SNYR:LoanAgreementMember srt:MinimumMember 2018-09-30 0001562733 SNYR:LoanAgreementMember srt:MaximumMember 2018-09-30 0001562733 SNYR:LoanAmendmentAgreementMember 2018-09-30 0001562733 SNYR:FOCUSfactorMember srt:MinimumMember 2017-01-01 2017-12-31 0001562733 2018-06-30 0001562733 2019-09-30 0001562733 us-gaap:CommonStockMember 2018-09-30 0001562733 us-gaap:CommonStockMember 2019-09-30 0001562733 us-gaap:AdditionalPaidInCapitalMember 2018-09-30 0001562733 us-gaap:AdditionalPaidInCapitalMember 2019-09-30 0001562733 us-gaap:ComprehensiveIncomeMember 2018-09-30 0001562733 us-gaap:ComprehensiveIncomeMember 2019-09-30 0001562733 us-gaap:RetainedEarningsMember 2018-09-30 0001562733 us-gaap:RetainedEarningsMember 2019-09-30 0001562733 country:US 2018-12-31 0001562733 SNYR:ForeignCountriesMember 2018-12-31 0001562733 2018-01-01 2018-12-31 0001562733 SNYR:OptionsToPurchaseOfCommonStockMember 2019-01-01 2019-09-30 0001562733 SNYR:OptionsToPurchaseOfCommonStockMember 2018-01-01 2018-09-30 0001562733 SNYR:WarrantsToPurchaseOfCommonStockOutstandingMember 2018-01-01 2018-09-30 0001562733 SNYR:WarrantsToPurchaseOfCommonStockOutstandingMember 2019-01-01 2019-09-30 0001562733 SNYR:PerioEndAUDToUSDExchangeRateMember 2019-09-30 0001562733 SNYR:PerioEndCADToUSDExchangeRateMember 2019-09-30 0001562733 SNYR:AverageQuarterlyAUDToUSDExchangeRateMember 2019-09-30 0001562733 SNYR:AverageQuarterlyAUDToUSDExchangeRateMember 2018-09-30 0001562733 SNYR:AverageQuarterlyCADToUSDExchangeRateMember 2019-09-30 0001562733 SNYR:AverageQuarterlyCADToUSDExchangeRateMember 2018-09-30 0001562733 srt:MinimumMember 2019-09-30 0001562733 srt:MaximumMember 2019-09-30 0001562733 srt:MinimumMember 2019-01-01 2019-09-30 0001562733 srt:MaximumMember 2019-01-01 2019-09-30 0001562733 SNYR:StockOptionPlanMember 2019-01-01 2019-09-30 0001562733 SNYR:StockOptionPlanMember 2019-09-30 0001562733 SNYR:TwoCustomersMember us-gaap:SalesRevenueNetMember 2019-01-01 2019-09-30 0001562733 SNYR:ThreeCustomersMember us-gaap:SalesRevenueNetMember 2018-01-01 2018-09-30 0001562733 SNYR:TwoVendorsMember us-gaap:AccountsPayableMember 2019-01-01 2019-09-30 0001562733 SNYR:ThreeSuppliersMember 2018-01-01 2018-09-30 0001562733 SNYR:TwoSuppliersMember 2019-01-01 2019-09-30 0001562733 SNYR:FOCUSfactorMember 2019-09-30 0001562733 SNYR:PerfektMemberMember 2019-09-30 0001562733 SNYR:CocowhiteMember 2019-09-30 0001562733 SNYR:SecurityAgreementMember SNYR:KnightTherapeuticsIncMember 2019-09-30 0001562733 SNYR:ConsultingAgreementMember SNYR:MsHarshbargerMember 2015-08-18 0001562733 SNYR:HandMDLLCMember 2015-08-18 0001562733 SNYR:HandMDLLCMember 2019-09-30 0001562733 SNYR:LoanAgreementMember SNYR:KnightTherapeuticsBarbadosIncMember 2019-09-30 0001562733 SNYR:KnightTherapeuticsIncMember SNYR:CanadianDollarMember 2016-12-23 0001562733 SNYR:KnightTherapeuticsIncMember SNYR:CanadianDollarMember 2019-09-30 0001562733 SNYR:KnightTherapeuticsIncMember 2019-09-30 0001562733 SNYR:HandMDMember SNYR:CADMember 2019-09-30 0001562733 SNYR:HandMDMember 2019-09-30 0001562733 SNYR:NomadChoicePtyLimitedSMember 2019-01-01 2019-09-30 0001562733 SNYR:NomadChoicePtyLimitedSMember SNYR:RoyaltyDistributionAgreementMember 2019-01-01 2019-09-30 0001562733 SNYR:SneakyVauntCorpMember 2019-01-01 2019-09-30 0001562733 SNYR:SneakyVauntCorpMember SNYR:RoyaltyDistributionAgreementMember 2019-01-01 2019-09-30 0001562733 SNYR:CommissionAgreementOneMember 2019-01-01 2019-09-30 0001562733 SNYR:CommissionAgreementMember SNYR:SneakyVauntCorpMember 2019-01-01 2019-09-30 0001562733 SNYR:CommissionAgreementMember 2019-01-01 2019-09-30 0001562733 SNYR:HandMCorpMember 2019-01-01 2019-09-30 0001562733 SNYR:JuneTwentySixTwoThousandFifteenMember 2015-06-26 0001562733 SNYR:JuneTwentySixTwoThousandFifteenMember 2019-09-30 0001562733 SNYR:LoanAgreementMember srt:MinimumMember 2019-09-30 0001562733 SNYR:LoanAgreementMember SNYR:KnightTherapeuticsIncMember SNYR:SecondAmendmentMember 2019-09-30 0001562733 SNYR:LoanAgreementMember SNYR:KnightTherapeuticsIncMember SNYR:SecondAmendmentMember 2019-01-01 2019-09-30 0001562733 SNYR:PerfektBeautyHoldingsLLCMember 2019-01-01 2019-09-30 0001562733 SNYR:JuneTwentySixTwoThousandFifteenMember 2019-01-01 2019-09-30 0001562733 SNYR:LoanAgreementMember srt:MinimumMember SNYR:ThereafterMember 2019-01-01 2019-09-30 0001562733 us-gaap:StockOptionMember 2019-09-30 0001562733 SNYR:QueenPegasusMember 2019-01-01 2019-09-30 0001562733 2019-07-01 2019-09-30 0001562733 2018-04-01 2018-06-30 0001562733 us-gaap:CommonStockMember 2019-01-01 2019-03-31 0001562733 us-gaap:CommonStockMember 2018-01-01 2018-03-31 0001562733 us-gaap:CommonStockMember 2019-06-30 0001562733 us-gaap:CommonStockMember 2018-06-30 0001562733 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-03-31 0001562733 us-gaap:AdditionalPaidInCapitalMember 2018-01-01 2018-03-31 0001562733 us-gaap:AdditionalPaidInCapitalMember 2018-07-01 2018-09-30 0001562733 us-gaap:AdditionalPaidInCapitalMember 2019-07-01 2019-09-30 0001562733 us-gaap:AdditionalPaidInCapitalMember 2019-06-30 0001562733 us-gaap:AdditionalPaidInCapitalMember 2018-06-30 0001562733 us-gaap:ComprehensiveIncomeMember 2019-01-01 2019-03-31 0001562733 us-gaap:ComprehensiveIncomeMember 2018-01-01 2018-03-31 0001562733 us-gaap:ComprehensiveIncomeMember 2018-07-01 2018-09-30 0001562733 us-gaap:ComprehensiveIncomeMember 2019-07-01 2019-09-30 0001562733 us-gaap:ComprehensiveIncomeMember 2019-06-30 0001562733 us-gaap:ComprehensiveIncomeMember 2018-06-30 0001562733 us-gaap:RetainedEarningsMember 2019-01-01 2019-03-31 0001562733 us-gaap:RetainedEarningsMember 2018-01-01 2018-03-31 0001562733 us-gaap:RetainedEarningsMember 2018-07-01 2018-09-30 0001562733 us-gaap:RetainedEarningsMember 2019-07-01 2019-09-30 0001562733 us-gaap:RetainedEarningsMember 2019-06-30 0001562733 us-gaap:RetainedEarningsMember 2018-06-30 0001562733 2019-01-01 2019-03-31 0001562733 2018-01-01 2018-03-31 0001562733 2019-06-30 0001562733 SNYR:TwoCustomersMember us-gaap:SalesRevenueNetMember 2019-07-01 2019-09-30 0001562733 SNYR:TwoSuppliersMember 2019-07-01 2019-09-30 0001562733 SNYR:TwoSuppliersMember 2018-07-01 2018-09-30 0001562733 SNYR:HandMDLLCMember 2019-01-01 2019-09-30 0001562733 SNYR:HandMDLLCMember 2019-07-01 2019-09-30 0001562733 SNYR:NomadChoicePtyLimitedSMember 2019-07-01 2019-09-30 0001562733 SNYR:SneakyVauntCorpMember 2019-07-01 2019-09-30 0001562733 SNYR:CommissionAgreementOneMember 2019-07-01 2019-09-30 0001562733 SNYR:CommissionAgreementMember 2019-07-01 2019-09-30 0001562733 SNYR:HandMCorpMember 2019-07-01 2019-09-30 0001562733 SNYR:JuneTwentySixTwoThousandFifteenMember 2019-07-01 2019-09-30 0001562733 SNYR:LoanAgreementMember SNYR:KnightTherapeuticsIncMember SNYR:SecondAmendmentMember 2019-07-01 2019-09-30 0001562733 us-gaap:SalesRevenueNetMember 2019-07-01 2019-09-30 0001562733 country:US 2019-07-01 2019-09-30 0001562733 SNYR:ForeignCountriesMember 2019-07-01 2019-09-30 0001562733 country:US 2018-07-01 2018-09-30 0001562733 SNYR:ForeignCountriesMember 2018-07-01 2018-09-30 0001562733 SNYR:NutraceuticalsMember 2019-07-01 2019-09-30 0001562733 us-gaap:OverTheCounterMember 2019-07-01 2019-09-30 0001562733 SNYR:ConsumerGoodsMember 2019-07-01 2019-09-30 0001562733 SNYR:CosmeceuticalsMember 2019-07-01 2019-09-30 0001562733 SNYR:NutraceuticalsMember 2018-07-01 2018-09-30 0001562733 us-gaap:OverTheCounterMember 2018-07-01 2018-09-30 0001562733 SNYR:CosmeceuticalsMember 2018-07-01 2018-09-30 0001562733 SNYR:ConsumerGoodsMember 2018-07-01 2018-09-30 0001562733 SNYR:OnlineMember 2019-07-01 2019-09-30 0001562733 SNYR:OnlineMember 2018-07-01 2018-09-30 0001562733 us-gaap:RetailMember 2019-07-01 2019-09-30 0001562733 us-gaap:RetailMember 2018-07-01 2018-09-30 0001562733 2019-11-12 0001562733 us-gaap:CommonStockMember 2019-03-31 0001562733 us-gaap:AdditionalPaidInCapitalMember 2019-04-01 2019-06-30 0001562733 us-gaap:AdditionalPaidInCapitalMember 2019-03-31 0001562733 us-gaap:ComprehensiveIncomeMember 2019-04-01 2019-06-30 0001562733 us-gaap:ComprehensiveIncomeMember 2019-03-31 0001562733 us-gaap:RetainedEarningsMember 2019-04-01 2019-06-30 0001562733 us-gaap:RetainedEarningsMember 2019-03-31 0001562733 2019-04-01 2019-06-30 0001562733 2019-03-31 0001562733 us-gaap:CommonStockMember 2018-03-31 0001562733 us-gaap:AdditionalPaidInCapitalMember 2018-03-31 0001562733 us-gaap:ComprehensiveIncomeMember 2018-03-31 0001562733 us-gaap:RetainedEarningsMember 2018-03-31 0001562733 2018-03-31 0001562733 us-gaap:SubsequentEventMember 2019-11-14 0001562733 SNYR:ThreeCustomersMember us-gaap:AccountsReceivableMember 2019-01-01 2019-09-30 0001562733 SNYR:TwoCustomersMember us-gaap:SalesRevenueNetMember 2018-07-01 2018-09-30 0001562733 us-gaap:AdditionalPaidInCapitalMember 2018-04-01 2018-06-30 0001562733 us-gaap:ComprehensiveIncomeMember 2018-04-01 2018-06-30 0001562733 us-gaap:RetainedEarningsMember 2018-04-01 2018-06-30 0001562733 us-gaap:LoansPayableMember 2019-09-30 iso4217:USD iso4217:USD xbrli:shares xbrli:shares xbrli:pure SNYR:Segment SNYR:Integer iso4217:CAD 300000000 300000000 89862683 89889074 103782 93089 171824 103782 30820 30820 Synergy CHC Corp. 0001562733 10-Q 2019-09-30 false --12-31 Non-accelerated Filer 0.00001 0.00001 <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of September 30, 2019, and December 31, 2018, fixed assets and intangible assets consisted of the following:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">September 30, 2019</font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">December 31, 2018</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 55%"><font style="font: 10pt Times New Roman, Times, Serif">Property and equipment</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 19%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">566,445</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 19%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">566,445</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Less accumulated depreciation</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(400,163</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(296,674</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif"><b>Fixed assets, net</b></font></td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif"><b>$</b></font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif"><b>166,282</b></font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif"><b>$</b></font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif"><b>269,771</b></font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">September 30, 2019</font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">December 31, 2018</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 55%"><font style="font: 10pt Times New Roman, Times, Serif">FOCUS factor intellectual property</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 19%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,450,000</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 19%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,450,000</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Perfekt intellectual property</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">10,000</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Cocowhite intellectual property</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">50,000</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Intangible assets subject to amortization</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">5,388,230</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">7,150,165</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Less accumulated amortization</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(4,638,479</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(4,728,576</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Less accumulated impairment</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(924,068</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif"><b>Intangible assets, net</b></font></td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif"><b>$</b></font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif"><b>2,199,751</b></font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif"><b>$</b></font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif"><b>3,007,521</b></font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following table summarizes the options outstanding, option exercisability and the related prices for the shares of the Company&#8217;s common stock issued to employees and consultants under the Plan at September 30, 2019:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="10" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Options Outstanding</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Options Exercisable</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Exercise<br /> Prices ($)</b></font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Number<br /> Outstanding</b></font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Weighted<br /> Average<br /> Remaining<br /> Contractual<br /> Life<br /> (Years)</b></font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Weighted<br /> Average<br /> Exercise<br /> Price ($)</b></font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Number<br /> Exercisable</b></font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Weighted<br /> Average<br /> Exercise<br /> Price ($)</b></font></td> <td style="text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 17%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.25 - $0.70</font></td> <td style="width: 1%">&#160;</td> <td style="width: 2%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 13%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">6,166,667</font></td> <td style="width: 1%">&#160;</td> <td style="width: 2%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 13%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">5.8</font></td> <td style="width: 1%">&#160;</td> <td style="width: 2%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 13%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.54</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 12%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">5,750,000</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 12%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.53</font></td> <td style="width: 1%">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The stock option activity for the nine months ended September 30, 2019 is as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Options<br /> Outstanding</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Weighted<br /> Average<br /> Exercise Price</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 55%"><font style="font: 10pt Times New Roman, Times, Serif">Outstanding at December 31, 2018</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 19%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">7,166,667</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 19%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.50</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Granted</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Exercised</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Expired or canceled</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(1,000,000</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.25</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Outstanding at September 30, 2019</font></td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">6,166,667</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.54</font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Net sales attributed to customers in the United States and foreign countries for the three months ended September 30, 2019 and 2018 were as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>September 30, 2019</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>September 30, 2018</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 55%"><font style="font: 10pt Times New Roman, Times, Serif">United States</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 19%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">6,785,123</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 19%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">8,944,970</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Foreign countries</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">579,423</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">245,407</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">7,364,546</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">9,190,377</font></td> <td>&#160;</td></tr> </table> <p style="margin: 0pt">&#160;</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Net sales attributed to customers in the United States and foreign countries for the nine months ended September 30, 2019 and 2018 were as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>September 30, 2019</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>September 30, 2018</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 55%"><font style="font: 10pt Times New Roman, Times, Serif">United States</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 19%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">21,377,182</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 19%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">27,215,818</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Foreign countries</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,793,040</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,404,132</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">23,170,222</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">28,619,950</font></td> <td>&#160;</td></tr> </table> <p style="margin: 0pt"></p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company&#8217;s net sales by product group for the three months ended September 30, 2019 and 2018 were as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>September 30, 2019</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>September 30, 2018</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 55%"><font style="font: 10pt Times New Roman, Times, Serif">Nutraceuticals</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 19%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">7,094,211</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 19%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">8,540,044</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Over the Counter (OTC)</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">9,055</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">125,878</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Consumer Goods</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">224,724</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">260,027</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Cosmeceuticals</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">36,556</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">264,428</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">7,364,546</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">9,190,377</font></td> <td>&#160;</td></tr> </table> <p style="margin: 0pt">&#160;</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company&#8217;s net sales by product group for the nine months ended September 30, 2019 and 2018 were as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>September 30, 2019</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>September 30, 2018</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 55%"><font style="font: 10pt Times New Roman, Times, Serif">Nutraceuticals</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 19%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">22,151,047</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 19%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">26,450,312</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Over the Counter (OTC)</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">38,121</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">459,980</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Consumer Goods</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">576,754</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">822,959</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Cosmeceuticals</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">404,300</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">886,699</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">23,170,222</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">28,619,950</font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Long-lived assets (net) attributable to operations in the United States and foreign countries as of September 30, 2019 and December 31, 2018 were as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>September 30, 2019</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2018</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 55%"><font style="font: 10pt Times New Roman, Times, Serif">United States</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 19%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">10,150,670</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 19%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">11,058,528</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Foreign countries</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">8,603</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">12,004</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">10,159,273</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">11,070,532</font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p> 2019 Q3 162476 148990 1 0.83 0.41 0.10 0.77 0.47 0.50 0.73 0.49 0.39 0.58 0.46 0.48 0.10 0.57 0.58 0.02 0.05 0.05 1000000 11070532 10150670 8603 10159273 11058528 12004 P3Y 340000 37500 37500 3 .25 <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 1 &#8211; Nature of the Business</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Synergy CHC Corp. (&#8220;Synergy&#8221;, &#8220;we&#8221;, &#8220;us&#8221;, &#8220;our&#8221; or the &#8220;Company&#8221;) (formerly Synergy Strips Corp.) was incorporated on December 29, 2010 in Nevada under the name &#8220;Oro Capital Corporation.&#8221; On April 21, 2014, the Company changed its fiscal year end from July 31 to December 31. On April 28, 2014, the Company changed its name to &#8220;Synergy Strips Corp.&#8221;. On August 5, 2015, the Company changed its name to &#8220;Synergy CHC Corp.&#8221;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company is a consumer health care company that is in the process of building a portfolio of best-in-class consumer product brands. Synergy&#8217;s strategy is to grow its portfolio both organically and by further acquisition.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Effective January 1, 2019 the Company has merged its U.S. subsidiaries (Neuragen Corp., Breakthrough Products, Inc., Sneaky Vaunt Corp., and The Queen Pegasus Corp.) into the parent company.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Synergy is the sole owner of two subsidiaries: NomadChoice Pty Ltd., and Synergy CHC Inc. and the results have been consolidated in these statements.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 2 &#8211; Summary of Significant Accounting Policies</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>General</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The accompanying condensed consolidated financial statements as of September 30, 2019 and December 31, 2018 and for the three and nine months ended September 30, 2019 and 2018 are unaudited. These unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (&#8220;GAAP&#8221;) for interim financial information and are presented in accordance with the requirements of Rule S-X of the Securities and Exchange Commission (the &#8220;SEC&#8221;) and with the instructions to Form 10-Q. Accordingly, they do not include all the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three and nine months ended September 30, 2019 are not necessarily indicative of the results that may be expected for the fiscal year ending December 31, 2019. The unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements as of and for the year ended December 31, 2018 and footnotes thereto included in the Company&#8217;s Annual Report on Form 10-K filed with the SEC on March 29, 2019.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Basis of Presentation</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The unaudited condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Use of Estimates</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosure of contingent liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates. Significant estimates are assumptions about collection of accounts receivable, useful life of fixed and intangible assets, goodwill and assumptions used in Black-Scholes-Merton, or BSM, valuation methods, such as expected volatility, risk-free interest rate, and expected dividend rate.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Cash and Cash Equivalents</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company considers all cash on hand and in banks, including accounts in book overdraft positions, certificates of deposit and other highly-liquid investments with maturities of three months or less, when purchased, to be cash and cash equivalents. As of September 30, 2019, the Company had no cash equivalents. The Company maintains its cash and cash equivalents in banks insured by the Federal Deposit Insurance Corporation (FDIC) in accounts that at times may be in excess of the federally insured limit of $250,000 per bank. The Company minimizes this risk by placing its cash deposits with major financial institutions. At September 30, 2019, the uninsured balance amounted to $981,699.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Restricted Cash</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the statement of financial position that sum to the total of the same such amounts shown in the statement of cash flows.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: justify">&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>September 30, 2019</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2018</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>September 30, 2018</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify">&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: justify">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: justify">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 42%; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Cash and cash equivalents</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 16%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,389,311</font></td> <td style="width: 1%">&#160;</td> <td style="width: 2%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 16%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">459,736</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 15%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,605,381</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Restricted cash</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">100,000</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">136,180</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">137,096</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Total cash, cash equivalents, and restricted cash shown in the statement of cash flows</font></td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,489,311</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">595,916</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,742,477</font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Amounts included in restricted cash represent amounts held for credit card collateral.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Capitalization of Fixed Assets</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company capitalizes expenditures related to property and equipment, subject to a minimum rule, that have a useful life greater than one year for: (1) assets purchased; (2) existing assets that are replaced, improved or the useful lives have been extended; or (3) all land, regardless of cost. Acquisitions of new assets, additions, replacements and improvements (other than land) costing less than the minimum rule in addition to maintenance and repair costs, including any planned major maintenance activities, are expensed as incurred.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Intangible Assets</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We evaluate the recoverability of intangible assets periodically and take into account events or circumstances that warrant revised estimates of useful lives or that indicate that impairment exists. All of our intangible assets are subject to amortization except intellectual property of $1,450,000 acquired as part of an Asset Purchase Agreement entered into with Factor Nutrition Labs LLC on January 22, 2015, $10,000 acquired as part of an Asset Purchase Agreement entered into with Perfekt Beauty Holdings LLC and CDG Holdings, LLC on June 21, 2017 and $50,000 acquired as&#160;part of&#160;an Asset Purchase&#160;Agreement&#160;entered into with Cocowhite on May 22, 2018. Intangible assets are amortized on a straight line basis over the useful lives. During the year ended December 31, 2018, the Company fully impaired intangible assets related to Perfekt and Cocowhite and charged to operations impairment loss of $60,000. As of September 30, 2019, our qualitative analysis of intangible assets with indefinite lives did not indicate any impairment.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Long-lived Assets</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Long-lived assets include equipment and intangible assets other than those with indefinite lives. We assess the carrying value of our long-lived asset groups when indicators of impairment exist and recognize an impairment loss when the carrying amount of a long-lived asset is not recoverable when compared to undiscounted cash flows expected to result from the use and eventual disposition of the asset.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Indicators of impairment include significant underperformance relative to historical or projected future operating results, significant changes in our use of the assets or in our business strategy, loss of or changes in customer relationships and significant negative industry or economic trends. When indications of impairment arise for a particular asset or group of assets, we assess the future recoverability of the carrying value of the asset (or asset group) based on an undiscounted cash flow analysis. If carrying value exceeds projected, net, undiscounted cash flows, an additional analysis is performed to determine the fair value of the asset (or asset group), typically a discounted cash flow analysis, and an impairment charge is recorded for the excess of carrying value over fair value. However, as of December 31, 2018 our review of intangible assets related to two of our subsidiaries did indicate that the carrying amount of the asset may not be recoverable. During the year ended December 31, 2018, the Company fully impaired related intangible assets and charged to operations impairment loss of $864,067. As of September 30, 2019, our qualitative analysis of long-lived assets did not indicate any impairment.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Goodwill</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">An asset purchase is accounted for under the purchase method of accounting. Under that method, assets and liabilities of the business acquired are recorded at their estimated fair values as of the date of the acquisition, with any excess of the cost of the acquisition over the estimated fair value of the net tangible and intangible assets acquired recorded as goodwill. As of September 30, 2019, our qualitative analysis of goodwill did not indicate any impairment.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Revenue Recognition</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company recognizes revenue in accordance with the Financial Accounting Standards Board&#8217;s (&#8220;FASB&#8221;), Accounting Standards Codification (&#8220;ASC&#8221;) ASC 606, Revenue from Contracts with Customers (&#8220;ASC 606&#8221;). Revenues are recognized when control is transferred to customers in amounts that reflect the consideration the Company expects to be entitled to receive in exchange for those goods. Revenue recognition is evaluated through the following five steps: (i) identification of the contract, or contracts, with a customer; (ii) identification of the performance obligations in the contract; (iii) determination of the transaction price; (iv) allocation of the transaction price to the performance obligations in the contract; and (v) recognition of revenue when or as a performance obligation is satisfied.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company recognizes revenue upon shipment from its fulfillment centers. Certain of our distributors may also perform a separate function as a co-packer on our behalf. In such cases, ownership of and title to our products that are co-packed on our behalf by those co-packers who are also distributors, passes to such distributors when we are notified by them that they have taken transfer or possession of the relevant portion of our finished goods. Freight billed to customers is presented as revenues, and the related freight costs are presented as cost of goods sold. Cancelled orders are refunded if not already dispatched, refunds are only paid if stock is damaged in transit, discounts are only offered with specific promotions and orders will be refilled if lost in transit.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Contract Assets</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company does not have any contract assets such as work-in-process. All trade receivables on the Company&#8217;s condensed consolidated balance sheet are from contracts with customers.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Contract Costs</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Costs incurred to obtain a contract are capitalized unless short term in nature. As a practical expedient, costs to obtain a contract that are short term in nature are expensed as incurred. The Company does not have any contract costs capitalized as of September 30, 2019.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Contract Liabilities - Deferred Revenue</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company&#8217;s contract liabilities consist of advance customer payments and deferred revenue. Deferred revenue results from transactions in which the Company has been paid for products by customers, but for which all revenue recognition criteria have not yet been met. Once all revenue recognition criteria have been met, the deferred revenues are recognized.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Accounts receivable</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Accounts receivable are generally unsecured. The Company establishes an allowance for doubtful accounts receivable based on the age of outstanding invoices and management&#8217;s evaluation of collectability. Accounts are written off after all reasonable collection efforts have been exhausted and management concludes that likelihood of collection is remote. Any future recoveries are applied against the allowance for doubtful accounts. As of both September 30, 2019 and December 31, 2018, allowance for doubtful accounts was $0.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Advertising Expense</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company expenses marketing, promotions and advertising costs as incurred. Such costs are included in selling expense in the accompanying unaudited condensed consolidated statements of operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Research and Development</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Costs incurred in connection with the development of new products and processing methods are charged to general and administrative expenses as incurred.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Income Taxes</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company utilizes FASB ASC 740, &#8220;Income Taxes,&#8221; which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns. Under this method, deferred tax assets and liabilities are determined based on the difference between the tax basis of assets and liabilities and their financial reporting amounts based on enacted tax laws and statutory tax rates applicable to the periods in which the differences are expected to affect taxable income. A valuation allowance is recorded when it is &#8220;more likely-than-not&#8221; that a deferred tax asset will not be realized.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company generated a deferred tax asset through net operating loss carry-forward. However, a valuation allowance of 100% has been established due to the uncertainty of the Company&#8217;s realization of the net operating loss carry forward prior to its expiration.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">NomadChoice Pty Ltd, the Company&#8217;s wholly-owned foreign subsidiary, is subject to income taxes in the jurisdictions in which it operates. Significant judgment is required in determining the provision for income tax. There are many transactions and calculations undertaken during the ordinary course of business for which the ultimate tax determination is uncertain. The company recognizes liabilities for anticipated tax audit issues based on the Company&#8217;s current understanding of the tax law. Where the final tax outcome of these matters is different from the carrying amounts, such differences will impact the current and deferred tax provisions in the period in which such determination is made.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Synergy CHC Inc. is a wholly-owned foreign subsidiary, is subject to income taxes in the jurisdictions in which it operates. Significant judgment is required in determining the provision for income tax. There are many transactions and calculations undertaken during the ordinary course of business for which the ultimate tax determination is uncertain. The company recognizes liabilities for anticipated tax audit issues based on the Company&#8217;s current understanding of the tax law. Where the final tax outcome of these matters is different from the carrying amounts, such differences will impact the current and deferred tax provisions in the period in which such determination is made.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Net Earnings (Loss) Per Common Share</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company computes earnings per share under ASC subtopic 260-10, Earnings Per Share. Basic earnings (loss) per share is computed by dividing the net income (loss) attributable to the common stockholders (the numerator) by the weighted average number of shares of common stock outstanding (the denominator) during the reporting periods. Diluted earnings per share is computed by increasing the denominator by the weighted average number of additional shares that could have been outstanding from securities convertible into common stock (using the &#8220;treasury stock&#8221; method), unless their effect on net loss per share is anti-dilutive. As of September 30, 2019, and 2018, options to purchase 6,166,667 and 7,166,667 shares of common stock, respectively, were outstanding. As of September 30, 2018, warrants to purchase 1,000,000 shares of common stock were outstanding.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following is a reconciliation of the number of shares used in the calculation of basic earnings per share and diluted earnings per share for the three and nine months ended September 30, 2019, and 2018:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>For the three months ended</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>For the nine months ended</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>September 30, 2019</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>September 30, 2018</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>September 30, 2019</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>September 30, 2018</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 26%"><font style="font: 10pt Times New Roman, Times, Serif">Net income (loss) after tax</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 16%; border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">107,864</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 16%; border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">345,590</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 15%; border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,893,613</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 15%; border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(493,296</font></td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Weighted average common shares outstanding</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">89,889,044</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">89,862,683</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">89,881,223</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">89,862,683</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Incremental shares from the assumed exercise of dilutive stock options</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Incremental shares from the assumed exercise of dilutive stock warrants</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Dilutive potential common shares</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">89,889,044</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">89,862,683</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">89,881,223</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">89,862,683</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Net earnings (loss) per share:</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Basic</font></td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.00</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.00</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.02</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(0.01</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Diluted</font></td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.00</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.00</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.02</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(0.01</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following securities were not included in the computation of diluted net earnings per share as their effect would have been antidilutive:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: justify">&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>2019</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>2018</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify">&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: justify">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: justify">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 55%; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Options to purchase common stock</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 19%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">6,166,667</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 19%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">7,166,667</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Warrants to purchase common stock</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,000,000</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">6,166,667</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">8,166,667</font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Fair Value Measurements</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company measures and discloses the fair value of assets and liabilities required to be carried at fair value in accordance with ASC 820, Fair Value Measurements and Disclosures. ASC 820 defines fair value, establishes a framework for measuring fair value, and enhances fair value measurement disclosure.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">ASC 825 defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required or permitted to be recorded at fair value, the Company considers the principal or most advantageous market in which it would transact and considers assumptions that market participants would use when pricing the asset or liability, such as inherent risk, transfer restrictions, and risk of nonperformance. ASC 825 establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 825 establishes three levels of inputs that may be used to measure fair value:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Level 1 - Quoted prices for identical assets or liabilities in active markets to which we have access at the measurement date.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Level 2 - Inputs other than quoted prices within Level 1 that are observable for the asset or liability, either directly or indirectly.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Level 3 - Unobservable inputs for the asset or liability.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The determination of where assets and liabilities fall within this hierarchy is based upon the lowest level of input that is significant to the fair value measurement.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of September 30, 2019, the Company has determined that there were no assets or liabilities measured at fair value.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Inventory</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Inventory consists of raw materials, components and finished goods. The Company&#8217;s inventory is stated at the lower of cost (FIFO cost basis) or net realizable value. Finished goods include the cost of labor to assemble the items.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Stock-Based Compensation</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">ASC 718, &#8220;Compensation &#8211; Stock Compensation,&#8221; prescribes accounting and reporting standards for all share-based payment transactions in which employee services are acquired. Transactions include incurring liabilities, or issuing or offering to issue shares, options, and other equity instruments such as employee stock ownership plans and stock appreciation rights. Share-based payments to employees, including grants of employee stock options, are recognized as compensation expense in the financial statements based on their fair values. That expense is recognized over the period during which an employee is required to provide services in exchange for the award, known as the requisite service period (usually the vesting period).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company accounts for stock-based compensation issued to non-employees and consultants in accordance with the provisions of ASC 505-50, &#8220;Equity &#8211; Based Payments to Non-Employees.&#8221; Measurement of share-based payment transactions with non-employees is based on the fair value of whichever is more reliably measurable: (a) the goods or services received; or (b) the equity instruments issued. The fair value of the share-based payment transaction is determined at the earlier of performance commitment date or performance completion date.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Foreign Currency Translation</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The functional currency of one of the Company&#8217;s foreign subsidiaries (Nomadchoice Pty Ltd.) is the U.S. Dollar. The Company&#8217;s foreign subsidiary maintains its records using local currency (Australian Dollar). All monetary assets and liabilities of the foreign subsidiary were translated into U.S. Dollars at quarter end exchange rates, non-monetary assets and liabilities of the foreign subsidiary were translated into U.S. Dollars at transaction day exchange rates. Income and expense items related to non-monetary items were translated at exchange rates prevailing during the transaction date and other incomes and expenses were translated using average exchange rate for the period. The resulting translation adjustments, net of income taxes, were recorded in statements of operations as Remeasurement gain or loss on translation of foreign subsidiary.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The functional currency of the Company&#8217;s other foreign subsidiary (Synergy CHC Inc.) is the Canadian Dollar (CAD). The Company&#8217;s foreign subsidiary maintains its records using local currency (CAD). All assets and liabilities of the foreign subsidiary were translated into U.S. Dollars at period end exchange rates and stockholders&#8217; equity is translated at the historical rates. Income and expense items were translated using average exchange rate for the period. The resulting translation adjustments, net of income taxes, are reported as other comprehensive income and accumulated other comprehensive income in the stockholder&#8217;s equity in accordance with ASC 220 &#8211; Comprehensive Income.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The exchange rates used to translate amounts in AUD and CAD into USD for the purposes of preparing the consolidated financial statements were as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Balance sheet:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>September 30, 2019</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2018</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 50%"><font style="font: 10pt Times New Roman, Times, Serif">Period-end AUD: USD exchange rate</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 22%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.6746</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 21%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.7046</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Period-end CAD: USD exchange rate</font></td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.7551</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.7330</font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Income statement:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>September 30, 2019</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>September 30, 2018</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 50%; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Average Quarterly AUD: USD exchange rate</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 22%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.6994</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 21%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.7579</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Average Quarterly CAD: USD exchange rate</font></td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.7524</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.7768</font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Translation gains and losses that arise from exchange rate fluctuations from transactions denominated in a currency other than the functional currency are translated into either Australian Dollars or Canadian Dollars, as the case may be, at the rate on the date of the transaction and included in the results of operations as incurred.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Concentrations of Credit Risk</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In the normal course of business, the Company provides credit terms to its customers; however, collateral is not required. Accordingly, the Company performs credit evaluations of its customers and maintains allowances for possible losses which, when realized, were within the range of management&#8217;s expectations. From time to time, a higher concentration of credit risk exists on outstanding accounts receivable for a select number of customers due to individual buying patterns.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Warehousing costs</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Warehouse costs include all third party warehouse rent fees and are charged to selling and marketing expenses as incurred. Any additional costs relating to assembly or special pack-outs of the Company&#8217;s products are charged to cost of sales.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Product display costs</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">All displays manufactured and purchased by the Company are for placement of product in retail stores. This also includes all costs for display execution and setup and retail services are charged to cost of sales and expensed as incurred.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Cost of Sales</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Cost of sales includes the purchase cost of products sold and all costs associated with getting the products into the retail stores including buying and transportation costs.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><u>Debt Issuance Costs</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">Debt issuance costs consist primarily of arrangement fees, professional fees and legal fees. These costs are netted off with the related loan and are being amortized to interest expense over the term of the related debt facilities.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><u>Shipping Costs</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">Shipping and handling costs billed to customers are recorded in sales. Shipping costs incurred by the company are recorded in selling and marketing expenses.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><u>Related parties</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">Parties are considered to be related to the Company if the parties, directly or indirectly, through one or more intermediaries, control, are controlled by, or are under common control with the Company. Related parties also include principal owners of the Company, its management, members of the immediate families of principal owners of the Company and its management and other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests. All transactions with related parties are recorded at fair value of the goods or services exchanged.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><u>Segment Reporting</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">Segment identification and selection is consistent with the management structure used by the Company&#8217;s chief operating decision maker to evaluate performance and make decisions regarding resource allocation, as well as the materiality of financial results consistent with that structure. Based on the Company&#8217;s management structure and method of internal reporting, the Company has one operating segment. The Company&#8217;s chief operating decision maker does not review operating results on a disaggregated basis; rather, the chief operating decision maker reviews operating results on an aggregate basis.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Presentation of Financial Statements &#8211; Going Concern</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Going Concern Evaluation</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In connection with preparing unaudited condensed consolidated financial statements for the three and nine months ended September 30, 2019, management evaluated whether there were conditions and events, considered in the aggregate, that raised substantial doubt about the Company&#8217;s ability to continue as a going concern within one year from the date that the financial statements are issued.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company considered the following:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#9679; At September 30, 2019, the Company had an accumulated deficit of $13,133,509.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#9679; At September 30, 2019, the Company had working capital deficit of&#160;$3,980,990.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#9679; Revenue decline in 2019 as compared to 2018 of $5,449,728.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Ordinarily, conditions or events that raise substantial doubt about an entity&#8217;s ability to continue as a going concern relate to the entity&#8217;s ability to meet its obligations as they become due.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company evaluated its ability to meet its obligations as they become due within one year from the date that the financial statements are issued by considering the following:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#9679; The Company raised $10.0 million via debt financing during the year ended December 31, 2017.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#9679; In 2019, the Company repaid $1,537,500 of loans.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#9679; The Company generated net income of $107,864 for the three months ended September 30, 2019 and $1,893,613 for the nine months ended September 30, 2019.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#9679; In 2019, the Company has generated $2,529,885 of cash from operating activities.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#9679; Working capital deficit of $3,980,990 at September 30, 2019, includes loans payable to related party of $5,937,576, payables to related party of $370,939 and deferred revenue of $9,947.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#9679; The Company has line of credit facility of $20 million available from its current lender for future mergers and acquisition.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Management concluded that above factors alleviate doubts about the Company&#8217;s ability to generate enough cash from operations and other available sources to satisfy its obligations for the next twelve months from the issuance date.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company will take the following actions if it starts to trend unfavorably to its internal profitability and cash flow projections, in order to mitigate conditions or events that would raise substantial doubt about its ability to continue as a going concern:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#9679;&#160;Raise additional capital through line of credit and/or loan financing for future mergers and acquisition.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#9679;&#160;Implement additional restructuring and cost reductions.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#9679;&#160;Raise additional capital through a private placement.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of November&#160;14,&#160;2019 and September 30, 2019, the Company had&#160;$684,916&#160;and $1,489,311, respectively, in cash and cash equivalents.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Recent Accounting Pronouncements</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">ASU 2018-13</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In August 2018, the FASB issued ASU 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework &#8211; Changes in Disclosure Requirements for Fair Value Measurement, which removes, modifies and adds certain disclosure requirements in Topic 820 &#8220;Fair Value Measurement&#8221;. ASU 2018-13 is effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. Early adoption is permitted. The adoption of ASU 2018-13 is not expected to have any impact on the Company&#8217;s unaudited condensed consolidated financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">ASU 2018-07</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In June 2018, the FASB issued ASU 2018-07, Compensation &#8211; Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting, which simplifies the accounting for share-based payments to nonemployees by aligning it with the accounting for share-based payments to employees, with certain exceptions. ASU 2018-07 is effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. Early adoption is permitted. The adoption of ASU 2018-07 did not have any impact on the Company&#8217;s unaudited condensed consolidated financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">ASU 2018-05</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">This Accounting Standards Update adds SEC paragraphs pursuant to the SEC Staff Accounting Bulletin No. 118, which expresses the view of the staff regarding application of Topic 740, Income Taxes, in the reporting period that includes December 22, 2017 - the date on which the Tax Cuts and Jobs Act (H.R.1, An Act to Provide for Reconciliation Pursuant to Titles II and V of the Concurrent Resolution on the Budget for Fiscal Year 2018) was signed into law. We are currently evaluating the impact of adopting ASU 2017-13 on our consolidated financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">ASU 2018-02</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On December 22, 2017, the U.S. federal government enacted a tax bill, H.R.1, An Act to Provide for Reconciliation Pursuant to Titles II and V of the Concurrent Resolution on the Budget for Fiscal Year 2018 (Tax Cuts and Jobs Act of 2017). Stakeholders raised a narrow-scope financial reporting issue that arose as a consequence of the Tax Cuts and Jobs Act of 2017. The amendments in this Update allow a reclassification from accumulated other comprehensive income to retained earnings for stranded tax effects resulting from the Tax Cuts and Jobs Act of 2017. The amendments in this Update affect any entity that is required to apply the provisions of Topic 220, Income Statement-Reporting Comprehensive Income, and has items of other comprehensive income for which the related tax effects are presented in other comprehensive income as required by GAAP. The amendments in this update is effective for all entities for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. Early adoption of the amendments in this Update is permitted, including adoption in any interim period, (1) for public business entities for reporting periods for which financial statements have not yet been issued and (2) for all other entities for reporting periods for which financial statements have not yet been made available for issuance. The amendments in this Update should be applied either in the period of adoption or retrospectively to each period (or periods) in which the effect of the change in the U.S. federal corporate income tax rate in the Tax Cuts and Jobs Act is recognized.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">This Accounting Standards Update is the final version of Proposed Accounting Standards Update 2018-210&#8212;Income Statement&#8212;Reporting Comprehensive Income (Topic 220), which has been deleted. We are currently evaluating the impact of adopting ASU 2017-13 on our consolidated financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">ASU 2018-01</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The amendments in this Update provide an optional transition practical expedient to not evaluate under Topic 842 existing or expired land easements that were not previously accounted for as leases under Topic 840, Leases. An entity that elects this practical expedient should evaluate new or modified land easements under Topic 842 beginning at the date that the entity adopts Topic 842. An entity that does not elect this practical expedient should evaluate all existing or expired land easements in connection with the adoption of the new lease requirements in Topic 842 to assess whether they meet the definition of a lease. We are currently evaluating the impact of adopting ASU 2017-13 on our consolidated financial statements.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 3 &#8211; Inventory</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Inventory consists of finished goods, components and raw materials. The Company&#8217;s inventory is stated at the lower of cost (FIFO cost basis) or net realizable value.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The carrying value of inventory consisted of the following:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">September 30, 2019</font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">December 31, 2018</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 55%"><font style="font: 10pt Times New Roman, Times, Serif">Finished goods</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 19%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,825,086</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 19%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,956,942</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Components</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">290,056</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">441,282</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Inventory in transit</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">101,980</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">256,051</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Raw materials</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">16,030</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">16,030</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif"><b>Total inventory</b></font></td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif"><b>$</b></font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif"><b>2,233,152</b></font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif"><b>$</b></font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif"><b>2,670,305</b></font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On January 22, 2015, inventory was pledged to Knight Therapeutics under the Loan Agreement (see note 10).</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 4 &#8211; Accounts Receivable</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Accounts receivable, net of allowances for sales returns and doubtful accounts, consisted of the following:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">September 30, 2019</font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">December 31, 2018</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 55%"><font style="font: 10pt Times New Roman, Times, Serif">Trade accounts receivable</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 19%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,902,130</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 19%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">4,458,225</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Less allowances</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif"><b>Total accounts receivable, net</b></font></td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif"><b>$</b></font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif"><b>1,902,130</b></font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif"><b>$</b></font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif"><b>4,458,225</b></font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 6 &#8211; Concentration of Credit Risk</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Cash and cash equivalents</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company maintains its cash and cash equivalents in banks insured by the Federal Deposit Insurance Corporation (FDIC) in accounts that at times may be in excess of the federally insured limit of $250,000 per bank. The Company minimizes this risk by placing its cash deposits with major financial institutions. At September 30, 2019 and December 31, 2018, the uninsured balances amounted to $981,699 and $162,729, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Accounts receivable</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of September 30, 2019, three customers accounted for 57% of the Company&#8217;s accounts receivable. As of December 31, 2018, three customers accounted for 83% of the Company&#8217;s accounts receivable.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Major customers</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For the nine months ended September 30, 2019, two customers accounted for approximately 47% of the Company&#8217;s net revenue. For the three months ended September 30, 2019, two customers accounted for approximately 58% of the Company&#8217;s net revenue. For the nine months ended September 30, 2018, three customers accounted for approximately 50% of the Company&#8217;s net revenue. For the three months ended September 30, 2018, two customers accounted for approximately 58% of the Company&#8217;s net revenue. For the year ended December 31, 2018, two customers accounted for approximately 41% of the Company&#8217;s net revenues. Substantially all of the Company&#8217;s business is with companies in the United States.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Accounts payable</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of September 30, 2019 and December 31, 2018, two vendors accounted for 73% and 77%, respectively, of the Company&#8217;s accounts payable.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Major suppliers</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For the nine months ended September 30, 2019, two suppliers accounted for approximately 39% of the Company&#8217;s purchases. For the nine months ended September 30, 2018, three suppliers accounted for approximately 49% of the Company&#8217;s purchases. For the three months ended September 30, 2019, two suppliers accounted for approximately 46% of the Company&#8217;s purchases. For the three months ended September 30, 2018, two suppliers accounted for approximately 48% of the Company&#8217;s purchases. Substantially all of the Company&#8217;s business is with suppliers in the United States.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 7 &#8211; Fixed Assets and Intangible Assets</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of September 30, 2019, and December 31, 2018, fixed assets and intangible assets consisted of the following:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">September 30, 2019</font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">December 31, 2018</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 55%"><font style="font: 10pt Times New Roman, Times, Serif">Property and equipment</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 19%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">566,445</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 19%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">566,445</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Less accumulated depreciation</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(400,163</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(296,674</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif"><b>Fixed assets, net</b></font></td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif"><b>$</b></font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif"><b>166,282</b></font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif"><b>$</b></font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif"><b>269,771</b></font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Depreciation expense for the three months ended September 30, 2019 and 2018 was $31,166 and $38,299, respectively. Depreciation expense for the nine months ended September 30, 2019 and 2018 was $103,489 and $114,461, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">September 30, 2019</font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">December 31, 2018</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 55%"><font style="font: 10pt Times New Roman, Times, Serif">FOCUS factor intellectual property</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 19%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,450,000</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 19%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,450,000</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Perfekt intellectual property</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">10,000</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Cocowhite intellectual property</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">50,000</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Intangible assets subject to amortization</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">5,388,230</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">7,150,165</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Less accumulated amortization</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(4,638,479</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(4,728,576</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Less accumulated impairment</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(924,068</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif"><b>Intangible assets, net</b></font></td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif"><b>$</b></font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif"><b>2,199,751</b></font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif"><b>$</b></font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif"><b>3,007,521</b></font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Amortization expense for the three months ended September 30, 2019 and 2018 was $270,222 and $417,280, respectively. Amortization expense for the nine months ended September 30, 2019 and 2018 was $807,770 and $1,248,555, respectively. These intangible assets were acquired through an Asset Purchase Agreement and Stock Purchase Agreements.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 8 &#8211; Related Party Transactions</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company accrued and paid consulting fees of $57,917 per month and management fees of $129,478 to a company owned by Mr. Jack Ross, Chief Executive Officer of the Company. The Company expensed $226,515 during the three months ended September 30, 2019 and $650,728 during the nine months ended September 30, 2019. As of September 30, 2019, the total outstanding balance was $0 for consulting fees and reimbursements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On June 26, 2015, the Company entered into a Security Agreement with Knight Therapeutics, Inc., through its wholly owned subsidiary Neuragen Corp., for the purchase of Knight Therapeutics, Inc.&#8217;s assets. At September 30, 2019, the Company owed Knight $487,500 in relation to this agreement (see Note 10). The Company recorded present value of future payments of $263,546 and $272,151 as of September 30, 2019 and December 31, 2018, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On August 18, 2015, the Company entered into a Consulting Agreement with Kara Harshbarger, the co-founder of Hand MD, LLC, pursuant to which she will provide marketing and sales related service. The Company pays Ms. Harshbarger $10,000 a month for one year unless the Consulting Agreement is terminated earlier by either party. The Company has extended this agreement on a month to month basis. Hand MD, LLC is a 50% owner in Hand MD Corp. The Company expensed $30,000 through payroll for the three months ended September 30, 2019 and $90,000 for the nine months ended September 30, 2019. As of September 30, 2019, the total outstanding balance was $0.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On August 9, 2017, the Company entered into a Loan Agreement with Knight Therapeutics (Barbados) Inc., a related party, for a working capital loan. At September 30, 2019, the Company owed Knight $5,924,522 on this loan, net of debt issuance cost (see Note 10).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On December 23, 2016, we entered into an agreement with Knight Therapeutics for the distribution rights of FOCUSFactor in Canada. In conjunction with this agreement, we are required to pay Knight a distribution fee equal to 30% of gross sales for sales achieved through a direct sales channel and 5% of gross sales for sales achieved through retail sales. The minimum due to Knight under this agreement is $100,000 Canadian dollars. As of September 30, 2019, the total outstanding balance was $200,000 Canadian dollars (approximately $152,834 USD).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On December 23, 2016, we entered into an agreement with Knight Therapeutics for the distribution rights of Hand MD into Canada. In conjunction with this agreement, we are required to pay Knight a distribution fee equal to 60% of gross sales for sales achieved through a direct sales channel until the sales in the calendar year equal the threshold amount and then 40% of all such gross sales in such calendar year in excess of the threshold amount and 5% of gross sales for sales achieved through retail sales. The minimum due to Knight under this agreement is $25,000 Canadian dollars. As of September 30, 2019, the total outstanding balance was $25,000 Canadian dollars (approximately $18,325 USD).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company expensed royalty of $36,082 during the three months ended September 30, 2019 and $175,391 during the nine months ended September 30, 2019. At September 30, 2019 NomadChoice Pty Ltd., a subsidiary of the Company, owed Knight Therapeutics $36,082 in connection with a royalty distribution agreement.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company expensed royalty of $1,067 during the three months ended September 30, 2019 and $4,252 for the nine months ended September 30, 2019. At September 30, 2019 the Company owed Knight Therapeutics $1,067 in connection with a royalty distribution agreement for Sneaky Vaunt.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company expensed commissions of $0 during the three months ended September 30, 2019 and $9,065 for the nine months ended September 30, 2019. At September 30, 2019, the Company owed Founded Ventures, owned by a shareholder in the Company, $0 in connection with a commission agreement for Sneaky Vaunt.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company expensed commissions of $0 during the three months ended September 30, 2019 and $644 for the nine months ended September 30, 2019. At September 30, 2019, the Company owed Founded Ventures $0 in connection with a commission agreement for The Queen Pegasus.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company paid $6,180 during the three months ended September 30, 2019 and $14,801 for the nine months ended September 30, 2019 to Hand MD, Corp, related to a royalty agreement. At September 30, 2019, the Company owed Hand MD Corp. $0 in minimum future royalties.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 9 &#8211; Accounts Payable and Accrued Liabilities</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of September 30, 2019, and December 31, 2018, accounts payable and accrued liabilities consisted of the following:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">September 30, 2019</font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">December 31, 2018</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 55%"><font style="font: 10pt Times New Roman, Times, Serif">Accrued payroll</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 19%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">243,730</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 19%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">217,069</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Legal fees</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">116,769</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">71,236</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Commissions</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">255,170</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">134,784</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Manufacturers</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2,529,037</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3,898,896</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Promotions</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">140,359</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,262,503</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Returns allowance</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">850,627</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Accounting fees</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">97,714</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">104,198</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Rent</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">61,738</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Customers</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,800</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">76,617</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Interest</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">49,306</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Royalties, related party</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">191,211</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">304,434</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Warehousing</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">11,106</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">64,289</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Sales taxes</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">302,870</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">180,222</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Taxes</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">178,069</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Severance Accrual</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">270,333</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">506,250</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Related Party Reimbursements</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">131,650</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">178,825</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Others</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">156,561</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">307,463</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif"><b>Total</b></font></td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif"><b>$</b></font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif"><b>4,497,616</b></font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif"><b>$</b></font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif"><b>8,397,220</b></font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 10 &#8211; Notes Payable</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">The Company&#8217;s loans payable at September 30, 2019 and December 31, 2018 are as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; background-color: white">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">September 30, 2019</font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">December 31, 2018</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 55%"><font style="font: 10pt Times New Roman, Times, Serif">Loans payable</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 19%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">6,263,545</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 19%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">7,772,150</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Unamortized debt issuance cost</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(75,478</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(179,261</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Total</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">6,188,067</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">7,592,889</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Less: Current portion</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(5,937,576</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(1,963,887</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Long-term portion</font></td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">250,491</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">5,629,002</font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>$950,000 June 26, 2015 Security Agreement:</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On June 26, 2015, the Company issued a 0% promissory note in a principal amount of $950,000 in connection with an Asset Purchase Agreement. The note requires $250,000 to be paid on or before June 30, 2016, and $700,000 to be paid in quarterly installments (beginning with the quarter ended September 30, 2015) equal to the greater of $12,500 or 5% of U.S. net sales, and 2% of U.S. net sales of Neuragen for 60 months thereafter. The payment of such amounts is secured by a security interest in certain assets, undertakings and property (&#8220;Collateral&#8221;) pursuant to the Security Agreement, which will be released upon receipt of total payments of $1.2 million.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company recorded present value of future payments of $263,546 and $272,151 as of September 30, 2019 and December 31, 2018, respectively. The Company recorded imputed interest expense of $9,526 for the three months ended September 30, 2019 and $28,896 for the nine months ended September 30, 2019.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the three and nine months ended September 30, 2019, the Company made payments of $12,500 and $37,500, respectively, in connection with this Security Agreement.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>$10,000,000 August 9, 2017 Loan:</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On August 9, 2017, we entered into a Second Amendment to Loan Agreement (&#8220;Second Amendment&#8221;) with Knight, pursuant to which Knight agreed to loan us an additional $10 million, and an ongoing credit facility of up to $20 million, and which amount was borrowed at closing (the &#8220;Financing&#8221;) for working capital purposes. At closing, we paid Knight an origination fee of $200,000 and a work fee of $100,000 and also paid $100,000 of Knight&#8217;s expenses associated with the Loan.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Additional Tranches under the Loan Agreement are available to the Company until August 9, 2022 provided that no event of default exists. Each Additional Tranche must be for a minimum amount of $1.0 million, may only be used to finance qualified acquisitions (as defined in the Loan Agreement), and can be denied in Knight&#8217;s absolute discretion. If an Additional Tranche is denied, the Company can effect a qualified acquisition through a special purpose entity with such special purpose entity being entitled to obtain financing from third parties so long as such financing does not adversely affect Knight or Knight&#8217;s rights under the Loan Agreement. Upon the closing of any Additional Tranche, the Company will pay Knight an origination fee equal to 2% of the Additional Tranche, a work fee equal to 1% of the amount of the Additional Tranche, and reimburse Knight for its expenses incurred in connection with its consideration of any Additional Tranche (whether or not advanced).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Loan bears interest at 10.5% per annum. The amended Loan Agreement matures on August 8, 2020 and (b) the date that Knight, in its discretion, accelerates the Company&#8217;s obligations due to an event of default.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On the Maturity Date of the Third Tranche and every Additional Tranche (or upon the acceleration of each such loan), the Company must pay Knight a success fee (the &#8220;Success Fee&#8221;) of that number of Company common shares equal to 10% of the loan, divided by the lesser of (a) $1.50, (b) the lowest price at which any common shares were issued by the Company in any offering or equity financing or other transaction between the Closing Date and the date the Success Fee is due, and (c) the current market price on the date the Success Fee is due. The Company may also pay the Success Fee in cash pursuant to the terms of the Loan Agreement.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Loan Agreement includes customary representations, warranties, and affirmative and restrictive covenants, including covenants to attain and maintain certain financial metrics, and to not merge or dispose of assets, acquire other businesses (except for businesses substantially similar or complementary to the Company&#8217;s business, and provided that the aggregate consideration to be paid does not exceed $100,000 and the acquired business guarantees the Company&#8217;s obligations under the Loan Agreement) or make capital expenditures in excess of $500,000. The Loan Agreement also includes customary events of default, including payment defaults, breaches of covenants, change of control and material adverse effect defaults. Upon the occurrence of an event of default and during the continuation thereof, the principal amount of all loans under the Loan Agreement will bear a default interest rate of an additional 5%.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company&#8217;s obligations and liabilities under the Loan Agreement are secured and unconditionally guaranteed by certain of the Company&#8217;s wholly owned subsidiaries as provided in the Loan Agreement.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We have met all the covenants except for the TTM EBITDA of $5 million during the period ending March 31, 2018. Default Interest rate of 5% (from 10.5% to 15.5%) applies in accordance to our current agreement and will be in effect starting April 1, 2018 and will be in effect until the $5 million TTM EDITDA covenant is achieved. When we entered into Loan Amendment Agreement on May 14, 2018, the interest rate was reduced to 13% due to reducing payroll expenses. Also, Synergy will maintain Focus Factor Net Sales as measured on a year-end basis of at least USD $15 million for each fiscal year starting with December 31, 2017.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We have amended our covenants under our loan agreement on March 27, 2019 and are currently in compliance with all covenants. The new covenants are as follows: we will maintain a minimum EBITDA of $1,900,000 for the twelve months ending on December 31, 2018, $2,500,000 for the twelve months ending March 31, 2019, $3,500,000 for the twelve months ending&#160;September&#160;30, 2019 and $5,000,000 for the twelve months period ending on last day of each fiscal quarters thereafter. We shall maintain a net debt to TTM EBITDA ratio of no more than 8:1 for the twelve month period ending on December 31, 2018 until March 31, 2019 and shall maintain a net debt to TTM EBITDA ratio of no more than 6:1 thereafter. We shall maintain at all times a positive cash balance of $575,000 for the three month period ending December 31, 2018, $750,000 for the three month period ending March 31, 2019 and $1,000,000 thereafter. The default interest rate of 2.5% applies (from 13% to 15.5%) in accordance to our current agreement and will be in effect from October 1, 2018 to June 30, 2019. Effective June 30, 2019 the interest rate referred back to 10.5%.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company also recorded deferred financing costs of $452,869 with respect to the above loan. The Company recognized amortization of deferred financing costs of $30,820 and $103,782 during the three and nine months ended September 30, 2019, respectively. Unamortized debt issuance cost as of September 30, 2019 amounted to $75,478.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company recognized interest expense of $166,833 and paid $166,833 during the three months ended September 30, 2019 and $759,069 and paid $709,763 during the nine months ended September 30, 2019. Accrued interest was $49,306 as of September 30, 2019. The loan balance at September 30, 2019 was $6,000,000.</p> <p style="margin: 0pt"></p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 11 &#8211; Stockholders&#8217; Equity</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The total number of shares of all classes of capital stock which the Company is authorized to issue is 300,000,000 shares of common stock with $0.00001 par value.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the nine months ended September 30, 2019, the Company issued 26,391 shares of its common stock valued at $39,585 in full and final settlement on the Perfekt transaction.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of September 30, 2019 and December 31, 2018, there were 89,889,074 and 89,862,683, respectively, shares of the Company&#8217;s common stock issued and outstanding.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 12 &#8211; Commitments &#38; Contingencies</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Litigation:</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">From time to time the Company may become a party to litigation in the normal course of business. Management believes that there are no current legal matters that would have a material effect on the Company&#8217;s financial position or results of operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Employee Commitments</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company and Mr. McCullough entered into an employment agreement on October 17, 2017 (the &#8220;Employment Agreement&#8221;) with an initial term of 3 years. In exchange for his service as President, Mr. McCullough will receive an annual base salary of $340,000. He received a cash signing bonus of $37,500 paid on January 1, 2018, and an additional cash signing bonus of $37,500 paid on July 1, 2018. Mr. McCullough will be eligible for an annual bonus of up to twenty-five percent (25%) of his base salary. The annual bonus will be determined at the discretion of our Board or compensation committee based upon the achievement of financial goals established by the Company&#8217;s Chief Executive Officer. Mr. McCullough will also be eligible for additional bonus compensation based on the Company&#8217;s achievement of certain annual earnings and retail sales goals established each year by the Company&#8217;s Chief Executive Officer. Subject to the Company&#8217;s achievement of an annual overall earnings goal and certain adjustments in the event of future acquisitions by the Company, Mr. McCullough will be eligible to receive five percent (5%) of all retail sales by the Company in excess of the annual retail sales goal set by the Chief Executive Officer.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company granted Mr. McCullough an option to purchase 1,000,000 shares of the Company&#8217;s common stock (the &#8220;Option Grant&#8221;). The Option Grant vests in three (3) equal annual installments on the first three anniversaries of Mr. McCullough&#8217;s start date with the Company, provided that Mr. McCullough remains employed by the Company on each such date. The Option Grant was granted under the Company&#8217;s 2014 Stock Incentive Plan pursuant to a stock grant agreement between the Company and Mr. McCullough.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Other Commitments</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the nine months ended September 30, 2019 the Company received a 60 day Proposition 65 letter that one of its products did not have California&#8217;s Proposition 65 label. The Company has settled the matter and made a one-time payment of $85,000 in full satisfaction of the matter.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 13 &#8211; Stock Options</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following table summarizes the options outstanding, option exercisability and the related prices for the shares of the Company&#8217;s common stock issued to employees and consultants under the Plan at September 30, 2019:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="10" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Options Outstanding</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Options Exercisable</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Exercise<br /> Prices ($)</b></font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Number<br /> Outstanding</b></font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Weighted<br /> Average<br /> Remaining<br /> Contractual<br /> Life<br /> (Years)</b></font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Weighted<br /> Average<br /> Exercise<br /> Price ($)</b></font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Number<br /> Exercisable</b></font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Weighted<br /> Average<br /> Exercise<br /> Price ($)</b></font></td> <td style="text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 17%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.25 - $0.70</font></td> <td style="width: 1%">&#160;</td> <td style="width: 2%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 13%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">6,166,667</font></td> <td style="width: 1%">&#160;</td> <td style="width: 2%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 13%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">5.8</font></td> <td style="width: 1%">&#160;</td> <td style="width: 2%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 13%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.54</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 12%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">5,750,000</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 12%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.53</font></td> <td style="width: 1%">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The stock option activity for the nine months ended September 30, 2019 is as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Options<br /> Outstanding</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Weighted<br /> Average<br /> Exercise Price</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 55%"><font style="font: 10pt Times New Roman, Times, Serif">Outstanding at December 31, 2018</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 19%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">7,166,667</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 19%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.50</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Granted</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Exercised</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Expired or canceled</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(1,000,000</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.25</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Outstanding at September 30, 2019</font></td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">6,166,667</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.54</font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Stock-based compensation expense related to vested options was $38,679 and $122,891 during the three and nine months ended September 30, 2019, respectively, which is a component of general and administrative expense in the statement of income. The Company determined the value of share-based compensation for options vesting during the period using the Black-Scholes fair value option-pricing model with the following weighted average assumptions: estimated fair value of Company&#8217;s common stock of $0.48-0.50, risk-free interest rate of 1.95-1.99%, volatility of 116-117%, expected lives of 10 years, and dividend yield of 0%. Stock options outstanding as of September 30, 2019, as disclosed in the above table, have an intrinsic value of $0. As of September 30, 2019, unamortized stock-based compensation costs related to options was $167,608, and will be recognized over a period of 1 year.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 14 &#8211; Segments</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Segment identification and selection is consistent with the management structure used by the Company&#8217;s chief operating decision maker to evaluate performance and make decisions regarding resource allocation, as well as the materiality of financial results consistent with that structure. Based on the Company&#8217;s management structure and method of internal reporting, the Company has one operating segment. The Company&#8217;s chief operating decision maker does not review operating results on a disaggregated basis; rather, the chief operating decision maker reviews operating results on an aggregate basis.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Net sales attributed to customers in the United States and foreign countries for the three months ended September 30, 2019 and 2018 were as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>September 30, 2019</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>September 30, 2018</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 55%"><font style="font: 10pt Times New Roman, Times, Serif">United States</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 19%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">6,785,123</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 19%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">8,944,970</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Foreign countries</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">579,423</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">245,407</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">7,364,546</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">9,190,377</font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Foreign countries primarily consist of Australia and Canada.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company&#8217;s net sales by product group for the three months ended September 30, 2019 and 2018 were as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>September 30, 2019</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>September 30, 2018</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 55%"><font style="font: 10pt Times New Roman, Times, Serif">Nutraceuticals</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 19%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">7,094,211</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 19%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">8,540,044</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Over the Counter (OTC)</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">9,055</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">125,878</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Consumer Goods</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">224,724</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">260,027</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Cosmeceuticals</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">36,556</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">264,428</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">7,364,546</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">9,190,377</font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(1) Net sales for any other product group of similar products are less than 10% of consolidated net sales.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company&#8217;s net sales by major sales channel for the three months ended September 30, 2019 and 2018 were as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>September 30, 2019</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>September 30, 2018</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 55%"><font style="font: 10pt Times New Roman, Times, Serif">Online</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 19%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2,318,455</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 19%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">4,902,161</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Retail</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">5,046,091</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">4,288,216</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">7,364,546</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">9,190,377</font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Net sales attributed to customers in the United States and foreign countries for the nine months ended September 30, 2019 and 2018 were as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>September 30, 2019</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>September 30, 2018</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 55%"><font style="font: 10pt Times New Roman, Times, Serif">United States</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 19%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">21,377,182</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 19%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">27,215,818</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Foreign countries</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,793,040</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,404,132</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">23,170,222</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">28,619,950</font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company&#8217;s net sales by product group for the nine months ended September 30, 2019 and 2018 were as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>September 30, 2019</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>September 30, 2018</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 55%"><font style="font: 10pt Times New Roman, Times, Serif">Nutraceuticals</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 19%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">22,151,047</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 19%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">26,450,312</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Over the Counter (OTC)</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">38,121</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">459,980</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Consumer Goods</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">576,754</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">822,959</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Cosmeceuticals</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">404,300</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">886,699</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">23,170,222</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">28,619,950</font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(1) Net sales for any other product group of similar products are less than 10% of consolidated net sales.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company&#8217;s net sales by major sales channel for the nine months ended September 30, 2019 and 2018 were as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>September 30, 2019</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>September 30, 2018</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 55%"><font style="font: 10pt Times New Roman, Times, Serif">Online</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 19%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">8,841,272</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 19%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">13,926,758</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Retail</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">14,328,950</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">14,693,192</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">23,170,222</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">28,619,950</font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Long-lived assets (net) attributable to operations in the United States and foreign countries as of September 30, 2019 and December 31, 2018 were as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>September 30, 2019</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2018</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 55%"><font style="font: 10pt Times New Roman, Times, Serif">United States</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 19%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">10,150,670</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 19%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">11,058,528</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Foreign countries</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">8,603</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">12,004</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">10,159,273</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">11,070,532</font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 16 &#8211; Subsequent Events</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Management evaluated all activities of the Company through the issuance date of the Company&#8217;s unaudited condensed consolidated financial statements and concluded that no subsequent events have occurred that would require adjustments or disclosure into the unaudited condensed consolidated financial statements.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The carrying value of inventory consisted of the following:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">September 30, 2019</font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">December 31, 2018</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 55%"><font style="font: 10pt Times New Roman, Times, Serif">Finished goods</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 19%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,825,086</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 19%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,956,942</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Components</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">290,056</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">441,282</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Inventory in transit</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">101,980</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">256,051</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Raw materials</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">16,030</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">16,030</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif"><b>Total inventory</b></font></td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif"><b>$</b></font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif"><b>2,233,152</b></font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif"><b>$</b></font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif"><b>2,670,305</b></font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Accounts receivable, net of allowances for sales returns and doubtful accounts, consisted of the following:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">September 30, 2019</font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">December 31, 2018</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 55%"><font style="font: 10pt Times New Roman, Times, Serif">Trade accounts receivable</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 19%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,902,130</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 19%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">4,458,225</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Less allowances</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif"><b>Total accounts receivable, net</b></font></td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif"><b>$</b></font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif"><b>1,902,130</b></font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif"><b>$</b></font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif"><b>4,458,225</b></font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of September 30, 2019, and December 31, 2018, accounts payable and accrued liabilities consisted of the following:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">September 30, 2019</font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">December 31, 2018</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 55%"><font style="font: 10pt Times New Roman, Times, Serif">Accrued payroll</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 19%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">243,730</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 19%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">217,069</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Legal fees</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">116,769</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">71,236</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Commissions</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">255,170</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">134,784</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Manufacturers</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2,529,037</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3,898,896</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Promotions</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">140,359</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,262,503</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Returns allowance</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">850,627</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Accounting fees</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">97,714</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">104,198</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Rent</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">61,738</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Customers</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,800</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">76,617</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Interest</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">49,306</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Royalties, related party</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">191,211</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">304,434</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Warehousing</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">11,106</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">64,289</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Sales taxes</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">302,870</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">180,222</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Taxes</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">178,069</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Severance Accrual</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">270,333</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">506,250</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Related Party Reimbursements</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">131,650</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">178,825</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Others</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">156,561</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">307,463</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif"><b>Total</b></font></td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif"><b>$</b></font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif"><b>4,497,616</b></font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif"><b>$</b></font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif"><b>8,397,220</b></font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">The Company&#8217;s loans payable at September 30, 2019 and December 31, 2018 are as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; background-color: white">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">September 30, 2019</font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">December 31, 2018</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 55%"><font style="font: 10pt Times New Roman, Times, Serif">Loans payable</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 19%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">6,263,545</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 19%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">7,772,150</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Unamortized debt issuance cost</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(75,478</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(179,261</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Total</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">6,188,067</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">7,592,889</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Less: Current portion</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(5,937,576</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(1,963,887</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Long-term portion</font></td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">250,491</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">5,629,002</font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p> true false false 459736 1605381 1389311 684916 3007521 2199751 7793240 7793240 3970693 9433279 899 18376801 -77989 -8866432 899 18817800 179116 -15027122 9174796 8937179 5927792 899 899 18525791 18980276 7838 80126 -9359732 -13133509 899 899 18941597 18616187 33115 25415 -13241373 -9705322 5734238 899 18902919 108176 -13559835 5452159 899 18496418 -17476 -8921928 9557913 16531741 6244988 20119893 4874102 23170222 27215818 1404132 21377182 1793040 26450312 22151047 459980 38121 886699 404300 822959 576754 8841272 14328950 14693192 13926758 9190377 28619950 7364546 6785123 579423 8944970 245407 7094211 9055 224724 36556 8540044 125878 264428 260027 2318455 4902161 5046091 4288216 13639825 5605391 19150332 4510896 3997437 1189681 4425826 1437624 8731129 3960131 13361490 2771884 2891916 639597 969561 363206 1893613 345590 -493296 107864 -783393 1467287 -55493 345590 107864 1467287 -55493 318462 318462 -783393 1870740 219400 -236484 50443 0.02 0.00 -0.01 0.00 0.02 0.00 -0.01 0.00 89881223 89862683 89862683 89889044 89881223 89862683 89862683 89889044 1794623 328012 -407470 154875 -98990 -17578 85826 47011 42891 -70940 60513 -17577 47011 -70940 60513 -75061 -75061 42891 <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 15 &#8211; Income Taxes</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Income tax (benefit) expense was ($57,421) and ($22,873) for the three and nine months ended September 30, 2019, respectively, compared to ($126,190) and $256,812, respectively, for the same periods in 2018. The current provision is attributable to Australian operations and the current tax rate in effect in that country.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On December 22, 2017, the Tax Cuts and Jobs Act (the TCJA), which significantly modified U.S. corporate income tax law, was signed into law by President Trump. The TCJA contains significant changes to corporate income taxation, including but not limited to the reduction of the corporate income tax rate from a top marginal rate of 35% to a flat rate of 21%, limitation of the tax deduction for interest expense to 30% of earnings (except for certain small businesses), limitation of the deduction for net operating losses to 80% of current year taxable income and generally eliminating net operating loss carrybacks, allowing net operating losses to carryforward without expiration, one-time taxation of offshore earnings at reduced rates regardless of whether they are repatriated, elimination of U.S. tax on foreign earnings (subject to certain important exceptions), immediate deductions for certain new investments instead of deductions for depreciation expense over time, and modifying or repealing many business deductions and credits (including changes to the orphan drug tax credit and changes to the deductibility of research and experimental expenditures that will be effective in the future). Notwithstanding the reduction in the corporate income tax rate, the overall impact of the new federal tax law is uncertain, including to what extent various states will conform to the newly enacted federal tax law.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company has not recorded the necessary provisional adjustments in the financial statements in accordance with its current understanding of the TCJA and guidance currently available as of this filing.&#160;The Company&#160;is reviewing the TCJA&#8217;s potential ramifications.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The total deferred tax asset is calculated by multiplying a domestic (US) 21% marginal tax rate by the cumulative net operating loss carryforwards (&#8220;NOL&#8221;). The domestic marginal tax rate does not include any state &#38; local marginal tax rate attributable to the Company. The Company currently has estimated NOLs, which expire through 2035. Management has determined based on all the available information that a 100% valuation reserve is required.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For U.S. purposes, the Company has not completed its evaluation of NOL utilization limitations under Internal Revenue Code, as amended (the &#8220;Code&#8221;) Section 382/383, change of ownership rules. If the Company has had a change in ownership, the NOL&#8217;s would be limited or eliminated, as to the amount that could be utilized each year, based on the Code. NOL&#8217;s attributable to Breakthrough Products, Inc., which are the majority of the Company&#8217;s domestic NOL&#8217;s are Separate Return Limitation Year (SRLY) NOL&#8217;s. Such losses may generally not be available for use (limited or eliminated).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company has not filed its State &#38; Local Income/Franchise tax returns in States it is required to file for the last few years, so such returns and liability remain&#160;open, but the Company does not believe such amounts are material</p> <p style="margin: 0pt"></p> 2670305 2233152 89862683 89862683 89862683 89889074 89889074 89862683 89889074 89862683 -90396 38679 119769 45534 119617 -90396 38679 45534 119617 38679 38679 119769 136180 137096 100000 4458225 1902130 8939979 6464149 269771 166282 20010511 16623422 8397220 4497616 49709 9947 1963887 5937576 10410816 10445139 5629002 250491 5629002 250491 16039818 10695630 899 899 18817800 18980276 179116 80126 -15027122 -13133509 20010511 16623422 805172 288479 864342 180759 -2556095 -2309350 -437155 539438 -4024983 -1545260 2529885 2043765 129087 -194300 1537500 2287500 -1537500 -2287500 -98990 85827 893395 -352208 595916 2094685 1742477 1489311 723892 983130 38919 224114 <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company&#8217;s net sales by major sales channel for the three months ended September 30, 2019 and 2018 were as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>September 30, 2019</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>September 30, 2018</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 55%"><font style="font: 10pt Times New Roman, Times, Serif">Online</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 19%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2,318,455</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 19%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">4,902,161</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Retail</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">5,046,091</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">4,288,216</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">7,364,546</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">9,190,377</font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company&#8217;s net sales by major sales channel for the nine months ended September 30, 2019 and 2018 were as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>September 30, 2019</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>September 30, 2018</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 55%"><font style="font: 10pt Times New Roman, Times, Serif">Online</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 19%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">8,841,272</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 19%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">13,926,758</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Retail</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">14,328,950</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">14,693,192</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">23,170,222</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">28,619,950</font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following is a reconciliation of the number of shares used in the calculation of basic earnings per share and diluted earnings per share for the three and nine months ended September 30, 2019, and 2018:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>For the three months ended</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>For the nine months ended</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>September 30, 2019</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>September 30, 2018</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>September 30, 2019</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>September 30, 2018</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 26%"><font style="font: 10pt Times New Roman, Times, Serif">Net income (loss) after tax</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 16%; border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">107,864</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 16%; border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">345,590</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 15%; border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,893,613</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 15%; border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(493,296</font></td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Weighted average common shares outstanding</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">89,889,044</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">89,862,683</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">89,881,223</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">89,862,683</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Incremental shares from the assumed exercise of dilutive stock options</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Incremental shares from the assumed exercise of dilutive stock warrants</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Dilutive potential common shares</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">89,889,044</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">89,862,683</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">89,881,223</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">89,862,683</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Net earnings (loss) per share:</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Basic</font></td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.00</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.00</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.02</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(0.01</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Diluted</font></td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.00</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.00</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.02</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(0.01</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following securities were not included in the computation of diluted net earnings per share as their effect would have been antidilutive:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: justify">&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>2019</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>2018</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify">&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: justify">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: justify">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 55%; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Options to purchase common stock</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 19%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">6,166,667</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 19%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">7,166,667</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Warrants to purchase common stock</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,000,000</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">6,166,667</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">8,166,667</font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the statement of financial position that sum to the total of the same such amounts shown in the statement of cash flows.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: justify">&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>September 30, 2019</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2018</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>September 30, 2018</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify">&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: justify">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: justify">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 42%; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Cash and cash equivalents</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 16%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,389,311</font></td> <td style="width: 1%">&#160;</td> <td style="width: 2%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 16%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">459,736</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 15%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,605,381</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Restricted cash</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">100,000</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">136,180</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">137,096</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Total cash, cash equivalents, and restricted cash shown in the statement of cash flows</font></td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,489,311</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">595,916</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,742,477</font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> -39763 44983 <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Basis of Presentation</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The unaudited condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Use of Estimates</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosure of contingent liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates. Significant estimates are assumptions about collection of accounts receivable, useful life of fixed and intangible assets, goodwill and assumptions used in Black-Scholes-Merton, or BSM, valuation methods, such as expected volatility, risk-free interest rate, and expected dividend rate.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Cash and Cash Equivalents</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company considers all cash on hand and in banks, including accounts in book overdraft positions, certificates of deposit and other highly-liquid investments with maturities of three months or less, when purchased, to be cash and cash equivalents. As of September 30, 2019, the Company had no cash equivalents. The Company maintains its cash and cash equivalents in banks insured by the Federal Deposit Insurance Corporation (FDIC) in accounts that at times may be in excess of the federally insured limit of $250,000 per bank. The Company minimizes this risk by placing its cash deposits with major financial institutions. At September 30, 2019, the uninsured balance amounted to $981,699.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Restricted Cash</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the statement of financial position that sum to the total of the same such amounts shown in the statement of cash flows.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: justify">&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>September 30, 2019</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2018</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>September 30, 2018</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify">&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: justify">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: justify">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 42%; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Cash and cash equivalents</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 16%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,389,311</font></td> <td style="width: 1%">&#160;</td> <td style="width: 2%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 16%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">459,736</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 15%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,605,381</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Restricted cash</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">100,000</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">136,180</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">137,096</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Total cash, cash equivalents, and restricted cash shown in the statement of cash flows</font></td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,489,311</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">595,916</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,742,477</font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Amounts included in restricted cash represent amounts held for credit card collateral.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Capitalization of Fixed Assets</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company capitalizes expenditures related to property and equipment, subject to a minimum rule, that have a useful life greater than one year for: (1) assets purchased; (2) existing assets that are replaced, improved or the useful lives have been extended; or (3) all land, regardless of cost. Acquisitions of new assets, additions, replacements and improvements (other than land) costing less than the minimum rule in addition to maintenance and repair costs, including any planned major maintenance activities, are expensed as incurred.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Intangible Assets</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We evaluate the recoverability of intangible assets periodically and take into account events or circumstances that warrant revised estimates of useful lives or that indicate that impairment exists. All of our intangible assets are subject to amortization except intellectual property of $1,450,000 acquired as part of an Asset Purchase Agreement entered into with Factor Nutrition Labs LLC on January 22, 2015, $10,000 acquired as part of an Asset Purchase Agreement entered into with Perfekt Beauty Holdings LLC and CDG Holdings, LLC on June 21, 2017 and $50,000 acquired as part of an Asset Purchase Agreement entered into with Cocowhite on May 22, 2018. Intangible assets are amortized on a straight line basis over the useful lives. During the year ended December 31, 2018, the Company fully impaired intangible assets related to Perfekt and Cocowhite and charged to operations impairment loss of $60,000. As of September 30, 2019, our qualitative analysis of intangible assets with indefinite lives did not indicate any impairment.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Long-lived Assets</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Long-lived assets include equipment and intangible assets other than those with indefinite lives. We assess the carrying value of our long-lived asset groups when indicators of impairment exist and recognize an impairment loss when the carrying amount of a long-lived asset is not recoverable when compared to undiscounted cash flows expected to result from the use and eventual disposition of the asset.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Indicators of impairment include significant underperformance relative to historical or projected future operating results, significant changes in our use of the assets or in our business strategy, loss of or changes in customer relationships and significant negative industry or economic trends. When indications of impairment arise for a particular asset or group of assets, we assess the future recoverability of the carrying value of the asset (or asset group) based on an undiscounted cash flow analysis. If carrying value exceeds projected, net, undiscounted cash flows, an additional analysis is performed to determine the fair value of the asset (or asset group), typically a discounted cash flow analysis, and an impairment charge is recorded for the excess of carrying value over fair value. However, as of December 31, 2018 our review of intangible assets related to two of our subsidiaries did indicate that the carrying amount of the asset may not be recoverable. During the year ended December 31, 2018, the Company fully impaired related intangible assets and charged to operations impairment loss of $864,067. As of September 30, 2019, our qualitative analysis of long-lived assets did not indicate any impairment.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Goodwill</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">An asset purchase is accounted for under the purchase method of accounting. Under that method, assets and liabilities of the business acquired are recorded at their estimated fair values as of the date of the acquisition, with any excess of the cost of the acquisition over the estimated fair value of the net tangible and intangible assets acquired recorded as goodwill. As of September 30, 2019, our qualitative analysis of goodwill did not indicate any impairment.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Revenue Recognition</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company recognizes revenue in accordance with the Financial Accounting Standards Board&#8217;s (&#8220;FASB&#8221;), Accounting Standards Codification (&#8220;ASC&#8221;) ASC 606, Revenue from Contracts with Customers (&#8220;ASC 606&#8221;). Revenues are recognized when control is transferred to customers in amounts that reflect the consideration the Company expects to be entitled to receive in exchange for those goods. Revenue recognition is evaluated through the following five steps: (i) identification of the contract, or contracts, with a customer; (ii) identification of the performance obligations in the contract; (iii) determination of the transaction price; (iv) allocation of the transaction price to the performance obligations in the contract; and (v) recognition of revenue when or as a performance obligation is satisfied.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company recognizes revenue upon shipment from its fulfillment centers. Certain of our distributors may also perform a separate function as a co-packer on our behalf. In such cases, ownership of and title to our products that are co-packed on our behalf by those co-packers who are also distributors, passes to such distributors when we are notified by them that they have taken transfer or possession of the relevant portion of our finished goods. Freight billed to customers is presented as revenues, and the related freight costs are presented as cost of goods sold. Cancelled orders are refunded if not already dispatched, refunds are only paid if stock is damaged in transit, discounts are only offered with specific promotions and orders will be refilled if lost in transit.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Contract Liabilities - Deferred Revenue</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company&#8217;s contract liabilities consist of advance customer payments and deferred revenue. Deferred revenue results from transactions in which the Company has been paid for products by customers, but for which all revenue recognition criteria have not yet been met. Once all revenue recognition criteria have been met, the deferred revenues are recognized.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Accounts receivable</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Accounts receivable are generally unsecured. The Company establishes an allowance for doubtful accounts receivable based on the age of outstanding invoices and management&#8217;s evaluation of collectability. Accounts are written off after all reasonable collection efforts have been exhausted and management concludes that likelihood of collection is remote. Any future recoveries are applied against the allowance for doubtful accounts. As of both September 30, 2019 and December 31, 2018, allowance for doubtful accounts was $0.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Advertising Expense</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company expenses marketing, promotions and advertising costs as incurred. Such costs are included in selling expense in the accompanying unaudited condensed consolidated statements of operations.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Research and Development</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Costs incurred in connection with the development of new products and processing methods are charged to general and administrative expenses as incurred.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Income Taxes</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company utilizes FASB ASC 740, &#8220;Income Taxes,&#8221; which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns. Under this method, deferred tax assets and liabilities are determined based on the difference between the tax basis of assets and liabilities and their financial reporting amounts based on enacted tax laws and statutory tax rates applicable to the periods in which the differences are expected to affect taxable income. A valuation allowance is recorded when it is &#8220;more likely-than-not&#8221; that a deferred tax asset will not be realized.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company generated a deferred tax asset through net operating loss carry-forward. However, a valuation allowance of 100% has been established due to the uncertainty of the Company&#8217;s realization of the net operating loss carry forward prior to its expiration.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">NomadChoice Pty Ltd, the Company&#8217;s wholly-owned foreign subsidiary, is subject to income taxes in the jurisdictions in which it operates. Significant judgment is required in determining the provision for income tax. There are many transactions and calculations undertaken during the ordinary course of business for which the ultimate tax determination is uncertain. The company recognizes liabilities for anticipated tax audit issues based on the Company&#8217;s current understanding of the tax law. Where the final tax outcome of these matters is different from the carrying amounts, such differences will impact the current and deferred tax provisions in the period in which such determination is made.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Synergy CHC Inc. is a wholly-owned foreign subsidiary, is subject to income taxes in the jurisdictions in which it operates. Significant judgment is required in determining the provision for income tax. There are many transactions and calculations undertaken during the ordinary course of business for which the ultimate tax determination is uncertain. The company recognizes liabilities for anticipated tax audit issues based on the Company&#8217;s current understanding of the tax law. Where the final tax outcome of these matters is different from the carrying amounts, such differences will impact the current and deferred tax provisions in the period in which such determination is made.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Net Earnings (Loss) Per Common Share</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company computes earnings per share under ASC subtopic 260-10, Earnings Per Share. Basic earnings (loss) per share is computed by dividing the net income (loss) attributable to the common stockholders (the numerator) by the weighted average number of shares of common stock outstanding (the denominator) during the reporting periods. Diluted earnings per share is computed by increasing the denominator by the weighted average number of additional shares that could have been outstanding from securities convertible into common stock (using the &#8220;treasury stock&#8221; method), unless their effect on net loss per share is anti-dilutive. As of September 30, 2019, and 2018, options to purchase 6,166,667 and 7,166,667 shares of common stock, respectively, were outstanding. As of September 30, 2018, warrants to purchase 1,000,000 shares of common stock were outstanding.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following is a reconciliation of the number of shares used in the calculation of basic earnings per share and diluted earnings per share for the three and nine months ended September 30, 2019, and 2018:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>For the three months ended</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>For the nine months ended</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>September 30, 2019</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>September 30, 2018</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>September 30, 2019</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>September 30, 2018</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 26%"><font style="font: 10pt Times New Roman, Times, Serif">Net income (loss) after tax</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 16%; border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">107,864</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 16%; border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">345,590</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 15%; border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,893,613</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 15%; border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(493,296</font></td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Weighted average common shares outstanding</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">89,889,044</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">89,862,683</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">89,881,223</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">89,862,683</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Incremental shares from the assumed exercise of dilutive stock options</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Incremental shares from the assumed exercise of dilutive stock warrants</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Dilutive potential common shares</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">89,889,044</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">89,862,683</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">89,881,223</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">89,862,683</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Net earnings (loss) per share:</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Basic</font></td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.00</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.00</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.02</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(0.01</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Diluted</font></td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.00</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.00</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.02</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(0.01</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following securities were not included in the computation of diluted net earnings per share as their effect would have been antidilutive:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: justify">&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>2019</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>2018</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify">&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: justify">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: justify">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 55%; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Options to purchase common stock</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 19%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">6,166,667</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 19%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">7,166,667</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Warrants to purchase common stock</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,000,000</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">6,166,667</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">8,166,667</font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Fair Value Measurements</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company measures and discloses the fair value of assets and liabilities required to be carried at fair value in accordance with ASC 820, Fair Value Measurements and Disclosures. ASC 820 defines fair value, establishes a framework for measuring fair value, and enhances fair value measurement disclosure.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">ASC 825 defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required or permitted to be recorded at fair value, the Company considers the principal or most advantageous market in which it would transact and considers assumptions that market participants would use when pricing the asset or liability, such as inherent risk, transfer restrictions, and risk of nonperformance. ASC 825 establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 825 establishes three levels of inputs that may be used to measure fair value:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Level 1 - Quoted prices for identical assets or liabilities in active markets to which we have access at the measurement date.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Level 2 - Inputs other than quoted prices within Level 1 that are observable for the asset or liability, either directly or indirectly.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Level 3 - Unobservable inputs for the asset or liability.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The determination of where assets and liabilities fall within this hierarchy is based upon the lowest level of input that is significant to the fair value measurement.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of September 30, 2019, the Company has determined that there were no assets or liabilities measured at fair value.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Inventory</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Inventory consists of raw materials, components and finished goods. The Company&#8217;s inventory is stated at the lower of cost (FIFO cost basis) or net realizable value. Finished goods include the cost of labor to assemble the items.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Stock-Based Compensation</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">ASC 718, &#8220;Compensation &#8211; Stock Compensation,&#8221; prescribes accounting and reporting standards for all share-based payment transactions in which employee services are acquired. Transactions include incurring liabilities, or issuing or offering to issue shares, options, and other equity instruments such as employee stock ownership plans and stock appreciation rights. Share-based payments to employees, including grants of employee stock options, are recognized as compensation expense in the financial statements based on their fair values. That expense is recognized over the period during which an employee is required to provide services in exchange for the award, known as the requisite service period (usually the vesting period).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company accounts for stock-based compensation issued to non-employees and consultants in accordance with the provisions of ASC 505-50, &#8220;Equity &#8211; Based Payments to Non-Employees.&#8221; Measurement of share-based payment transactions with non-employees is based on the fair value of whichever is more reliably measurable: (a) the goods or services received; or (b) the equity instruments issued. The fair value of the share-based payment transaction is determined at the earlier of performance commitment date or performance completion date.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Foreign Currency Translation</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The functional currency of one of the Company&#8217;s foreign subsidiaries (Nomadchoice Pty Ltd.) is the U.S. Dollar. The Company&#8217;s foreign subsidiary maintains its records using local currency (Australian Dollar). All monetary assets and liabilities of the foreign subsidiary were translated into U.S. Dollars at quarter end exchange rates, non-monetary assets and liabilities of the foreign subsidiary were translated into U.S. Dollars at transaction day exchange rates. Income and expense items related to non-monetary items were translated at exchange rates prevailing during the transaction date and other incomes and expenses were translated using average exchange rate for the period. The resulting translation adjustments, net of income taxes, were recorded in statements of operations as Remeasurement gain or loss on translation of foreign subsidiary.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The functional currency of the Company&#8217;s other foreign subsidiary (Synergy CHC Inc.) is the Canadian Dollar (CAD). The Company&#8217;s foreign subsidiary maintains its records using local currency (CAD). All assets and liabilities of the foreign subsidiary were translated into U.S. Dollars at period end exchange rates and stockholders&#8217; equity is translated at the historical rates. Income and expense items were translated using average exchange rate for the period. The resulting translation adjustments, net of income taxes, are reported as other comprehensive income and accumulated other comprehensive income in the stockholder&#8217;s equity in accordance with ASC 220 &#8211; Comprehensive Income.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The exchange rates used to translate amounts in AUD and CAD into USD for the purposes of preparing the consolidated financial statements were as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Balance sheet:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>September 30, 2019</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2018</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 50%"><font style="font: 10pt Times New Roman, Times, Serif">Period-end AUD: USD exchange rate</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 22%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.6746</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 21%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.7046</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Period-end CAD: USD exchange rate</font></td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.7551</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.7330</font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Income statement:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>September 30, 2019</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>September 30, 2018</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 50%; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Average Quarterly AUD: USD exchange rate</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 22%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.6994</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 21%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.7579</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Average Quarterly CAD: USD exchange rate</font></td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.7524</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.7768</font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Translation gains and losses that arise from exchange rate fluctuations from transactions denominated in a currency other than the functional currency are translated into either Australian Dollars or Canadian Dollars, as the case may be, at the rate on the date of the transaction and included in the results of operations as incurred.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Concentrations of Credit Risk</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In the normal course of business, the Company provides credit terms to its customers; however, collateral is not required. Accordingly, the Company performs credit evaluations of its customers and maintains allowances for possible losses which, when realized, were within the range of management&#8217;s expectations. From time to time, a higher concentration of credit risk exists on outstanding accounts receivable for a select number of customers due to individual buying patterns.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Warehousing costs</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Warehouse costs include all third party warehouse rent fees and are charged to selling and marketing expenses as incurred. Any additional costs relating to assembly or special pack-outs of the Company&#8217;s products are charged to cost of sales.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Product display costs</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">All displays manufactured and purchased by the Company are for placement of product in retail stores. This also includes all costs for display execution and setup and retail services are charged to cost of sales and expensed as incurred.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Cost of Sales</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Cost of sales includes the purchase cost of products sold and all costs associated with getting the products into the retail stores including buying and transportation costs.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><u>Debt Issuance Costs</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">Debt issuance costs consist primarily of arrangement fees, professional fees and legal fees. These costs are netted off with the related loan and are being amortized to interest expense over the term of the related debt facilities.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><u>Shipping Costs</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">Shipping and handling costs billed to customers are recorded in sales. Shipping costs incurred by the company are recorded in selling and marketing expenses.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><u>Related parties</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">Parties are considered to be related to the Company if the parties, directly or indirectly, through one or more intermediaries, control, are controlled by, or are under common control with the Company. Related parties also include principal owners of the Company, its management, members of the immediate families of principal owners of the Company and its management and other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests. All transactions with related parties are recorded at fair value of the goods or services exchanged.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><u>Segment Reporting</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">Segment identification and selection is consistent with the management structure used by the Company&#8217;s chief operating decision maker to evaluate performance and make decisions regarding resource allocation, as well as the materiality of financial results consistent with that structure. Based on the Company&#8217;s management structure and method of internal reporting, the Company has one operating segment. The Company&#8217;s chief operating decision maker does not review operating results on a disaggregated basis; rather, the chief operating decision maker reviews operating results on an aggregate basis.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Presentation of Financial Statements &#8211; Going Concern</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Going Concern Evaluation</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In connection with preparing unaudited condensed consolidated financial statements for the three and nine months ended September 30, 2019, management evaluated whether there were conditions and events, considered in the aggregate, that raised substantial doubt about the Company&#8217;s ability to continue as a going concern within one year from the date that the financial statements are issued.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company considered the following:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#9679; At September 30, 2019, the Company had an accumulated deficit of $13,133,509.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#9679; At September 30, 2019, the Company had working capital deficit of&#160;$3,980,990.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#9679; Revenue decline in 2019 as compared to 2018 of $5,449,728.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Ordinarily, conditions or events that raise substantial doubt about an entity&#8217;s ability to continue as a going concern relate to the entity&#8217;s ability to meet its obligations as they become due.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company evaluated its ability to meet its obligations as they become due within one year from the date that the financial statements are issued by considering the following:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#9679; The Company raised $10.0 million via debt financing during the year ended December 31, 2017.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#9679; In 2019, the Company repaid $1,537,500 of loans.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#9679; The Company generated net income of $107,864 for the three months ended September 30, 2019 and $1,893,613 for the nine months ended September 30, 2019.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#9679; In 2019, the Company has generated $2,529,885 of cash from operating activities.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#9679; Working capital deficit of $3,980,990 at September 30, 2019, includes loans payable to related party of $5,937,576, payables to related party of $370,939 and deferred revenue of $9,947.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#9679; The Company has line of credit facility of $20 million available from its current lender for future mergers and acquisition.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Management concluded that above factors alleviate doubts about the Company&#8217;s ability to generate enough cash from operations and other available sources to satisfy its obligations for the next twelve months from the issuance date.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company will take the following actions if it starts to trend unfavorably to its internal profitability and cash flow projections, in order to mitigate conditions or events that would raise substantial doubt about its ability to continue as a going concern:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#9679;&#160;Raise additional capital through line of credit and/or loan financing for future mergers and acquisition.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#9679;&#160;Implement additional restructuring and cost reductions.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#9679;&#160;Raise additional capital through a private placement.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of November&#160;14,&#160;2019 and September 30, 2019, the Company had&#160;$684,916&#160;and $1,489,311, respectively, in cash and cash equivalents.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Recent Accounting Pronouncements</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">ASU 2018-13</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In August 2018, the FASB issued ASU 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework &#8211; Changes in Disclosure Requirements for Fair Value Measurement, which removes, modifies and adds certain disclosure requirements in Topic 820 &#8220;Fair Value Measurement&#8221;. ASU 2018-13 is effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. Early adoption is permitted. The adoption of ASU 2018-13 is not expected to have any impact on the Company&#8217;s unaudited condensed consolidated financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">ASU 2018-07</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In June 2018, the FASB issued ASU 2018-07, Compensation &#8211; Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting, which simplifies the accounting for share-based payments to nonemployees by aligning it with the accounting for share-based payments to employees, with certain exceptions. ASU 2018-07 is effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. Early adoption is permitted. The adoption of ASU 2018-07 did not have any impact on the Company&#8217;s unaudited condensed consolidated financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">ASU 2018-05</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">This Accounting Standards Update adds SEC paragraphs pursuant to the SEC Staff Accounting Bulletin No. 118, which expresses the view of the staff regarding application of Topic 740, Income Taxes, in the reporting period that includes December 22, 2017 - the date on which the Tax Cuts and Jobs Act (H.R.1, An Act to Provide for Reconciliation Pursuant to Titles II and V of the Concurrent Resolution on the Budget for Fiscal Year 2018) was signed into law. We are currently evaluating the impact of adopting ASU 2017-13 on our consolidated financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">ASU 2018-02</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On December 22, 2017, the U.S. federal government enacted a tax bill, H.R.1, An Act to Provide for Reconciliation Pursuant to Titles II and V of the Concurrent Resolution on the Budget for Fiscal Year 2018 (Tax Cuts and Jobs Act of 2017). Stakeholders raised a narrow-scope financial reporting issue that arose as a consequence of the Tax Cuts and Jobs Act of 2017. The amendments in this Update allow a reclassification from accumulated other comprehensive income to retained earnings for stranded tax effects resulting from the Tax Cuts and Jobs Act of 2017. The amendments in this Update affect any entity that is required to apply the provisions of Topic 220, Income Statement-Reporting Comprehensive Income, and has items of other comprehensive income for which the related tax effects are presented in other comprehensive income as required by GAAP. The amendments in this update is effective for all entities for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. Early adoption of the amendments in this Update is permitted, including adoption in any interim period, (1) for public business entities for reporting periods for which financial statements have not yet been issued and (2) for all other entities for reporting periods for which financial statements have not yet been made available for issuance. The amendments in this Update should be applied either in the period of adoption or retrospectively to each period (or periods) in which the effect of the change in the U.S. federal corporate income tax rate in the Tax Cuts and Jobs Act is recognized.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">This Accounting Standards Update is the final version of Proposed Accounting Standards Update 2018-210&#8212;Income Statement&#8212;Reporting Comprehensive Income (Topic 220), which has been deleted. We are currently evaluating the impact of adopting ASU 2017-13 on our consolidated financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">ASU 2018-01</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The amendments in this Update provide an optional transition practical expedient to not evaluate under Topic 842 existing or expired land easements that were not previously accounted for as leases under Topic 840, Leases. An entity that elects this practical expedient should evaluate new or modified land easements under Topic 842 beginning at the date that the entity adopts Topic 842. An entity that does not elect this practical expedient should evaluate all existing or expired land easements in connection with the adoption of the new lease requirements in Topic 842 to assess whether they meet the definition of a lease. We are currently evaluating the impact of adopting ASU 2017-13 on our consolidated financial statements.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The exchange rates used to translate amounts in AUD and CAD into USD for the purposes of preparing the consolidated financial statements were as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Balance sheet:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>September 30, 2019</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2018</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 50%"><font style="font: 10pt Times New Roman, Times, Serif">Period-end AUD: USD exchange rate</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 22%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.6746</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 21%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.7046</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Period-end CAD: USD exchange rate</font></td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.7551</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.7330</font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Income statement:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>September 30, 2019</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>September 30, 2018</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 50%; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Average Quarterly AUD: USD exchange rate</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 22%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.6994</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 21%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.7579</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Average Quarterly CAD: USD exchange rate</font></td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.7524</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.7768</font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> 386686 404391 28895 58014 911259 455579 1363016 301388 250000 162729 981699 1450000 10000 10000 50000 60000 864067 0 0 1.00 6166667 8166667 6166667 7166667 1000000 -3980990 1537500 709763 37500 12500 166833 175391 36082 4252 1067 14801 36082 1067 6180 20000000 9947 0.7046 0.7330 0.6746 0.7551 0.6994 0.7579 0.7524 0.7768 1956942 1825086 441282 290056 256051 101980 16030 16030 4458225 1902130 0.48 0.50 0.0195 0.0199 1.16 1.17 0.00 0.25 0.70 P5Y9M18D 7166667 6166667 1000000 0.50 0.54 0.25 0.21 2035 103489 38299 114461 31166 807770 417280 1248555 270222 566445 566445 296674 400163 1450000 10000 50000 1450000 7150165 5388230 4728576 4638479 -924068 3007521 2199751 57917 129478 650728 226515 25000 370939 487500 10000 5924522 100000 5937576 0.50 217069 243730 0 200000 152834 25000 18325 Knight a distribution fee equal to 30% of gross sales for sales achieved through a direct sales channel and 5% of gross sales for sales achieved through retail sales. Knight a distribution fee equal to 60% of gross sales for sales achieved through a direct sales channel until the sales in the calendar year equal the threshold amount and then 40% of all such gross sales in such calendar year in excess of the threshold amount and 5% of gross sales for sales achieved through retail sales. 9065 0 644 0 0 0 0 71236 116769 134784 255170 3898896 2529037 1262503 140359 850627 104198 97714 61738 76617 1800 49306 304434 191211 64289 11106 180222 302870 178069 506250 270333 178825 131650 307463 156561 0.105 0.025 0.155 0.05 0.05 0.105 0.155 0.13 0.00 0.13 0.105 250000 700000 12500 950000 6000000 1200000 272151 272151 263546 263546 10000000 1000000 200000 100000 100000 2020-08-08 20000000 Additional Tranches under the Loan Agreement are available to the Company until August 9, 2022 provided that no event of default exists. Each Additional Tranche must be for a minimum amount of $1.0 million, may only be used to finance qualified acquisitions (as defined in the Loan Agreement), and can be denied in Knight's absolute discretion. If an Additional Tranche is denied, the Company can effect a qualified acquisition through a special purpose entity with such special purpose entity being entitled to obtain financing from third parties so long as such financing does not adversely affect Knight or Knight's rights under the Loan Agreement. Upon the closing of any Additional Tranche, the Company will pay Knight an origination fee equal to 2% of the Additional Tranche, a work fee equal to 1% of the amount of the Additional Tranche, and reimburse Knight for its expenses incurred in connection with its consideration of any Additional Tranche (whether or not advanced). On the Maturity Date of the Third Tranche and every Additional Tranche (or upon the acceleration of each such loan), the Company must pay Knight a success fee (the "Success Fee") of that number of Company common shares equal to 10% of the loan, divided by the lesser of (a) $1.50, (b) the lowest price at which any common shares were issued by the Company in any offering or equity financing or other transaction between the Closing Date and the date the Success Fee is due, and (c) the current market price on the date the Success Fee is due. The Company may also pay the Success Fee in cash pursuant to the terms of the Loan Agreement. 100000 500000 5000000 1900000 2500000 3500000 5000000 8:1 6:1 575000 1000000 750000 179261 75478 75478 7772150 6263545 7592889 6188067 1963887 5937576 5629002 250491 26391 39585 89862683 89889074 39585 39585 26391 5449728 0 759069 28896 9526 166833 122891 38679 P10Y 167608 P1Y 6166667 0.54 5750000 0.53 0.21 1.00 <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>General</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The accompanying condensed consolidated financial statements as of September 30, 2019 and December 31, 2018 and for the three and nine months ended September 30, 2019 and 2018 are unaudited. These unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (&#8220;GAAP&#8221;) for interim financial information and are presented in accordance with the requirements of Rule S-X of the Securities and Exchange Commission (the &#8220;SEC&#8221;) and with the instructions to Form 10-Q. Accordingly, they do not include all the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three and nine months ended September 30, 2019 are not necessarily indicative of the results that may be expected for the fiscal year ending December 31, 2019. The unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements as of and for the year ended December 31, 2018 and footnotes thereto included in the Company&#8217;s Annual Report on Form 10-K filed with the SEC on March 29, 2019.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Contract Assets</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company does not have any contract assets such as work-in-process. All trade receivables on the Company&#8217;s condensed consolidated balance sheet are from contracts with customers.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Contract Costs</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Costs incurred to obtain a contract are capitalized unless short term in nature. As a practical expedient, costs to obtain a contract that are short term in nature are expensed as incurred. The Company does not have any contract costs capitalized as of September 30, 2019.</p> 0 15000000 Yes Yes false 15213 50000 30309 33286 45144 10257 25170 14571 20791 13302 29183 103912 86354 58333 34440 48962 40783 7415 35617 23745 9467 90000 30000 10000000 452869 49306 -393683 -375795 89889074 -22873 -126190 256812 -57421 828847 435165 828847 435165 <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 5 &#8211; Prepaid Expenses and Other Current Assets</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Prepaid expenses and other current assets consisted of the following:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">September 30, 2019</font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">December 31, 2018</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 55%"><font style="font: 10pt Times New Roman, Times, Serif">Advances for inventory</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 19%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">14,571</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 19%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">25,170</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Media production</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">20,791</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Insurance</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">29,183</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">13,302</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Deposits</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">10,257</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">45,144</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Trademarks</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">19,707</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">78,826</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Rent</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">86,354</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">103,912</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Promotion</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">114,018</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">342,220</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">License agreement</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">58,333</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Software subscriptions</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">48,962</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">34,440</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Rebranding</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">7,415</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">40,783</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Clinical research</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">23,745</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">35,617</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Miscellaneous</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">33,286</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">30,309</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Related party receivables</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">9,467</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Capital asset deposit</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">38,200</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif"><b>Total</b></font></td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif"><b>$</b></font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif"><b>435,165</b></font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif"><b>$</b></font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif"><b>828,847</b></font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Prepaid expenses and other current assets consisted of the following:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">September 30, 2019</font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">December 31, 2018</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 55%"><font style="font: 10pt Times New Roman, Times, Serif">Advances for inventory</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 19%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">14,571</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 19%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">25,170</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Media production</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">20,791</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Insurance</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">29,183</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">13,302</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Deposits</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">10,257</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">45,144</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Trademarks</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">19,707</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">78,826</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Rent</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">86,354</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">103,912</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Promotion</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">114,018</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">342,220</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">License agreement</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">58,333</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Software subscriptions</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">48,962</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">34,440</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Rebranding</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">7,415</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">40,783</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Clinical research</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">23,745</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">35,617</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Miscellaneous</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">33,286</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">30,309</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Related party receivables</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">9,467</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Capital asset deposit</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">38,200</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif"><b>Total</b></font></td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif"><b>$</b></font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif"><b>435,165</b></font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif"><b>$</b></font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif"><b>828,847</b></font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p> -112551 -66353 -197674 -101289 6638481 2945389 8500057 2490444 329 50 121 105 27674 27674 38200 85000 4878 47887 1021176 420197 1206045 312763 1000000 78826 19707 On December 22, 2017, the Tax Cuts and Jobs Act (the TCJA), which significantly modified U.S. corporate income tax law, was signed into law by President Trump. The TCJA contains significant changes to corporate income taxation, including but not limited to the reduction of the corporate income tax rate from a top marginal rate of 35% to a flat rate of 21%, limitation of the tax deduction for interest expense to 30% of earnings (except for certain small businesses), limitation of the deduction for net operating losses to 80% of current year taxable income and generally eliminating net operating loss carrybacks, allowing net operating losses to carryforward without expiration, one-time taxation of offshore earnings at reduced rates regardless of whether they are repatriated, elimination of U.S. tax on foreign earnings (subject to certain important exceptions), immediate deductions for certain new investments instead of deductions for depreciation expense over time, and modifying or repealing many business deductions and credits (including changes to the orphan drug tax credit and changes to the deductibility of research and experimental expenditures that will be effective in the future). -342220 -114018 EX-101.SCH 7 snyr-20190930.xsd XBRL SCHEMA FILE 00000001 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Condensed Consolidated Statements of Operations and Comprehensive (Loss) Income (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - Nature of the Business link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - Inventory link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - Accounts Receivable link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - Prepaid Expenses and Other Current Assets link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - Concentration of Credit Risk link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - Fixed Assets and Intangible Assets link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - Related Party Transactions link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - Accounts Payable and Accrued Liabilities link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - Notes Payable link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - Commitments & Contingencies link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - Stock Options link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - Segments link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - Inventory (Tables) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - Accounts Receivable (Tables) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - Prepaid Expenses and Other Current Assets (Tables) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - Fixed Assets and Intangible Assets (Tables) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - Accounts Payable and Accrued Liabilities (Tables) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - Notes Payable (Tables) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - Stock Options (Tables) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - Segments (Tables) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - Summary of Significant Accounting Policies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - Summary of Significant Accounting Policies - Schedule of Cash, Cash Equivalents, and Restricted Cash (Details) link:presentationLink link:calculationLink link:definitionLink 00000035 - Disclosure - Summary of Significant Accounting Policies - Schedule of Number of Shares Used in Calculation of Earnings Per Share Basic and Diluted (Details) link:presentationLink link:calculationLink link:definitionLink 00000036 - Disclosure - Summary of Significant Accounting Policies - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 00000037 - Disclosure - Summary of Significant Accounting Policies - Schedule of Foreign Currencies Translation Exchange Rate (Details) link:presentationLink link:calculationLink link:definitionLink 00000038 - Disclosure - Inventory - Schedule of Carrying Value of Inventory (Details) link:presentationLink link:calculationLink link:definitionLink 00000039 - Disclosure - Accounts Receivable - Accounts Receivable, Net of Allowances for Sales Returns and Doubtful Accounts (Details) link:presentationLink link:calculationLink link:definitionLink 00000040 - Disclosure - Prepaid Expenses and Other Current Assets - Schedule of Prepaid Expenses and Other Current Assets (Details) link:presentationLink link:calculationLink link:definitionLink 00000041 - Disclosure - Concentration of Credit Risk (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000042 - Disclosure - Fixed Assets and Intangible Assets (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000043 - Disclosure - Fixed Assets and Intangible Assets - Summary of Fixed and Intangible Assets (Details) link:presentationLink link:calculationLink link:definitionLink 00000044 - Disclosure - Related Party Transactions (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000045 - Disclosure - Accounts Payable and Accrued Liabilities - Schedule of Accounts Payable and Accrued Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 00000046 - Disclosure - Notes Payable (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000047 - Disclosure - Notes Payable - Schedule of Loans Payable (Details) link:presentationLink link:calculationLink link:definitionLink 00000048 - Disclosure - Stockholders' Equity (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000049 - Disclosure - Commitments & Contingencies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000050 - Disclosure - Stock Options (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000051 - Disclosure - Stock Options - Summary of Options Outstanding by Price Range (Details) link:presentationLink link:calculationLink link:definitionLink 00000052 - Disclosure - Stock Options - Schedule of Stock Options Activity (Details) link:presentationLink link:calculationLink link:definitionLink 00000053 - Disclosure - Segments (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000054 - Disclosure - Segments - Summary of Net Sales Attributed to Customers Geographical Segment (Details) link:presentationLink link:calculationLink link:definitionLink 00000055 - Disclosure - Segments - Summary of Net Sales Attributed to Customers Product Group (Details) link:presentationLink link:calculationLink link:definitionLink 00000056 - Disclosure - Segments - Summary of Net Sales Attributed to Major Sales Channel (Details) link:presentationLink link:calculationLink link:definitionLink 00000057 - Disclosure - Segments - Summary of Long-lived Assets (Net) Attributable to Operations Geographical Segment (Details) link:presentationLink link:calculationLink link:definitionLink 00000058 - Disclosure - Income Taxes (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 8 snyr-20190930_cal.xml XBRL CALCULATION FILE EX-101.DEF 9 snyr-20190930_def.xml XBRL DEFINITION FILE EX-101.LAB 10 snyr-20190930_lab.xml XBRL LABEL FILE Debt Instrument [Axis] June 26, 2015 Security Agreement [Member] Legal Entity [Axis] Neuragen Corp [Member] Scenario [Axis] June 30, 2016 [Member] Quarter Ending September 30, 2015 [Member] Range [Axis] Minimum [Member] Geographical [Axis] United States [Member] Foreign Countries [Member] Customer [Axis] Three Customers [Member] Concentration Risk Benchmark [Axis] Accounts Receivable [Member] Two Customers [Member] Sales Revenue, Net [Member] Factor Nutrition Labs LLC [Member] Segments [Axis] Nutraceuticals [Member] Over the Counter (OTC) [Member] Cosmeceuticals [Member] Consumer Goods [Member] Perfekt Beauty Holdings LLC [Member] CDG Holdings, LLC [Member] Finite-Lived Intangible Assets by Major Class [Axis] Focus Factor [Member] Perfekt [Member] Title of Individual [Axis] Mr. Jack Ross [Member] Type of Arrangement and Non-arrangement Transactions [Axis] Loan Agreement [Member] Knight Therapeutics Inc [Member] Nature of Expense [Axis] Origination Fee [Member] Work Fee [Member] Employment Agreement [Member] Mr. McCullough [Member] Award Type [Axis] January 1, 2018 [Member] July 1, 2018 [Member] Maximum [Member] Business Acquisition [Axis] Retail Sales [Member] Equity Components [Axis] Option Grant [Member] Plan Name [Axis] Stock Option Plan [Member] Concentration Risk Type [Axis] Product and Service [Axis] Online [Member] Retail [Member] Cocowhite [Member] Common Stock [Member] Additional Paid in Capital [Member] Accumulated Other Comprehensive Income (Loss) [Member] Accumulated Deficit [Member] Related Party [Axis] Hand MD [Member] CAD [Member] Intercompany Foreign Currency Balance by Description [Axis] Period-End AUD: USD Exchange Rate [Member] Period-End CAD: USD Exchange Rate [Member] Two Vendors [Member] Accounts Payable [Member] Vesting [Axis] Additional Tranche [Member] Award Date [Axis] Quarters Ending After March 31, 2019 [Member] Twelve Months Ending March 31, 2019 [Member] Twelve Months Ending June 30, 2019 [Member] After March 31, 2019 [Member] Loan Amendment Agreement [Member] Antidilutive Securities [Axis] Options to Purchase of Common Stock [Member] Warrants to Purchase of Common Stock [Member] Average Quarterly AUD: USD Exchange Rate [Member] Average Quarterly CAD: USD Exchange Rate [Member] Three Suppliers [Member] Two Suppliers [Member] Security Agreement [Member] Consulting Agreement [Member] Ms. Harshbarger [Member] Ownership [Axis] Hand MD LLC [Member] Knight [Member] CAD [Member] NomadChoice Pty Limited's [Member] Royalty Distribution Agreement [Member] Sneaky Vaunt Corp [Member] Commission Agreement One [Member] Commission Agreement [Member] Hand MD Corp [Member] Second Amendment [Member] Thereafter [Member] Derivative Instrument [Axis] Stock Option [Member] Queen Pegasus [Member] Subsequent Event Type [Axis] Subsequent Event [Member] Loans Payable [Member] Document And Entity Information [Abstract] Entity Registrant Name Entity Central Index Key Document Type Document Period End Date Amendment Flag Current Fiscal Year End Date Entity's Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Flag Entity Emerging Growth Company Entity Ex Transition Period Entity Shell Company Entity Common Stock, Shares Outstanding Document Fiscal Period Focus Document Fiscal Year Focus Statement of Financial Position [Abstract] Assets Current Assets: Cash and cash equivalents Restricted cash Accounts receivable, net Prepaid expenses and other current assets Income taxes receivable Inventory, net Total Current Assets Fixed assets, net Goodwill Intangible assets, net Total Assets Liabilities and Stockholders' Equity Current Liabilities: Accounts payable and accrued liabilities Deferred revenue Current portion of long-term debt, net of debt discount and debt issuance cost, related party Total Current Liabilities Long-term Liabilities: Note payable, net of debt discount and debt issuance cost, related party Total Long-term Liabilities Total Liabilities Commitments and contingencies Stockholders' Equity: Common stock, $0.00001 par value; 300,000,000 shares authorized; 89,889,074 and 89,862,683 shares issued and outstanding, respectively Additional paid in capital Accumulated other comprehensive income Accumulated deficit Total stockholders' equity Total Liabilities and Stockholders' Equity Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Income Statement [Abstract] Revenue Cost of sales Gross profit Operating expenses Selling and marketing General and administrative Depreciation and amortization Total operating expenses Income from operations Other (income) expenses Interest income Interest expense Other income Remeasurement loss on translation of foreign subsidiary Amortization of debt issuance cost Total other expenses Net income (loss) before income taxes Income tax (benefit) expense Net income (loss) after tax Net income (loss) per share - basic Net income (loss) per share - diluted Weighted average common shares outstanding Basic Diluted Comprehensive (loss) income: Net income (loss) Foreign currency translation adjustment Comprehensive income (loss) Statement [Table] Statement [Line Items] Balance Balance, shares Fair value of vested stock options Foreign currency translation gain (loss) Common stock issued for Per-fekt settlement Common stock issued for Per-fekt settlement, shares Net income loss Balance Balance, shares Statement of Cash Flows [Abstract] Cash Flows from Operating Activities Adjustments to reconcile net income (loss) to net cash provided by operating activities: Stock based compensation expense Foreign currency transaction gain Non cash implied interest Changes in operating assets and liabilities: Accounts receivable Inventory Other current assets Accounts payable and accrued liabilities Deferred revenue Net cash provided by operating activities Cash Flows from Investing Activities Payments for acquisition of fixed assets Payment for acquisition of domain name Purchase of intangible assets Net cash used in investing activities Cash Flows from Financing Activities Repayment of notes payable Net cash used in financing activities Effect of exchange rate on cash, cash equivalents and restricted cash Net increase (decrease) in cash, cash equivalents and restricted cash Cash, Cash Equivalents and restricted cash, beginning of period Cash, Cash Equivalents and restricted cash, end of period Supplemental Disclosure of Cash Flow Information: Cash paid during the period for: Interest Income taxes Supplemental Disclosure of Non-cash Investing and Financing Activities: Organization, Consolidation and Presentation of Financial Statements [Abstract] Nature of the Business Accounting Policies [Abstract] Summary of Significant Accounting Policies Inventory Disclosure [Abstract] Inventory Receivables [Abstract] Accounts Receivable Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract] Prepaid Expenses and Other Current Assets Risks and Uncertainties [Abstract] Concentration of Credit Risk Assets [Abstract] Fixed Assets and Intangible Assets Related Party Transactions [Abstract] Related Party Transactions Payables and Accruals [Abstract] Accounts Payable and Accrued Liabilities Debt Disclosure [Abstract] Notes Payable Equity [Abstract] Stockholders' Equity Commitments and Contingencies Disclosure [Abstract] Commitments & Contingencies Share-based Payment Arrangement [Abstract] Stock Options Segment Reporting [Abstract] Segments Income Tax Disclosure [Abstract] Income Taxes Subsequent Events [Abstract] Subsequent Events General Basis of Presentation Use of Estimates Cash and Cash Equivalents Restricted Cash Capitalization of Fixed Assets Intangible Assets Long-lived Assets Goodwill Revenue Recognition Contract Assets Contract Costs Contract Liabilities - Deferred Revenue Accounts Receivable Advertising Expense Research and Development Income Taxes Net Earnings (Loss) Per Common Share Fair Value Measurements Inventory Stock-Based Compensation Foreign Currency Translation Concentrations of Credit Risk Warehousing Costs Product Display Costs Cost of Sales Debt Issuance Costs Shipping Costs Related Parties Segment Reporting Presentation of Financial Statements - Going Concern Recent Accounting Pronouncements Schedule of Cash, Cash Equivalents, and Restricted Cash Schedule of Number of Shares Used in Calculation of Earnings Per Share Basic and Diluted Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share Schedule of Foreign Currencies Translation Exchange Rate Schedule of Carrying Value of Inventory Accounts Receivable, Net of Allowances for Sales Returns and Doubtful Accounts Schedule of Prepaid Expenses and Other Current Assets Summary of Fixed and Intangible Assets Schedule of Accounts Payable and Accrued Liabilities Schedule of Loans Payable Summary of Options Outstanding by Price Range Schedule of Stock Options Activity Summary of Net Sales Attributed to Customers Geographical Segment Summary of Net Sales Attributed to Customers Product Group Summary of Net Sales Attributed to Major Sales Channel Summary of Long-lived Assets (Net) Attributable to Operations Geographical Segment Related Party [Member] Cash equivalents Cash federally insured limit per bank Cash uninsured amount Value of intellectual property acquired Intangible assets and charged to operations impairment loss Goodwill and charged to operations impairment loss Allowance for doubtful accounts Percentage of valuation allowance Anti-dilutive securities Warrant to purchase common stock Number of operating segment Working capital deficit Revenue decline Debt financing Repayment of loans payable Cash from operating activities Due to related party Deferred revenue Available line of credit Total cash, cash equivalents, and restricted cash shown in the statement of cash flows Net income (loss) after tax Weighted average common shares outstanding Incremental shares from the assumed exercise of dilutive stock options Incremental shares from the assumed exercise of dilutive stock warrants Dilutive potential common shares Net earnings (loss) per share - Basic Net earnings (loss) per share - Diluted Foreign currency translation exchange rate Finished goods Components Inventory in transit Raw materials Total inventory Trade accounts receivable Less allowances Total accounts receivable, net Advances for inventory Media production Insurance Deposits Trademarks Rent Promotion License agreement Software subscriptions Rebranding Clinical research Miscellaneous Related party receivables Capital asset deposit Total Concentration risk percentage Depreciation expense Amortization expense Property and equipment Less accumulated depreciation Fixed assets, net Intellectual property Intangible assets subject to amortization Less accumulated amortization Less accumulated impairment Intangible assets, net Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Accrued consulting fees per month Management fees Consulting fees Outstanding balance of consulting fees and reimbursement Present value of future payments Percentage of ownership interest Payroll expense Debt outstanding balance Distribution gross sale percentage description Royal expense Commissions expense Minimum royalty payment Receivables related to services Accrued payroll Legal fees Commissions Manufacturers Promotions Returns allowance Accounting fees Rent Customers Interest Royalties, related party Warehousing Sales taxes Taxes Severance Accrual Related Party Reimbursements Others Total Statistical Measurement [Axis] Debt instrument interest rate percentage Note principal amount Note payable Percentage of sale revenue net Total payments of acquire assets Interest expense Payments of debt Loan amount Credit facility maximum borrowing amount Expenses associated with loan Note maturity date Percentage of loan, description Loan agreement, description Payment for business acquisition consideration Capital expenditures Debt EBITDA Net sales Debt covenants, minimum EBITDA Debt covenants, net debt to TTM EBITDA ratio Debt covenants, minimum cash balance Deferred financing costs Recognized amortization of deferred financing costs Unamortized debt issuance costs Accrued interest Loans payable Unamortized debt issuance cost Total Less: Current portion Long-term portion Class of Stock [Axis] Number of capital stock shares authorized Common stock par value Number of common stock issued shares Number of common stock issued Agreement initial term Salary received Received annual bonus Percentage of bonus based salary Purchase of granted option of stock based payments Number of vesting annual installments Other commitments one time payment Stock-based compensation expense Estimated fair value of company's common stock Risk-free interest rate Volatility rate Expected lives Dividend yield Stock option outstanding intrinsic value Unamortized stock-based compensation Recognized, period for recognition Options Outstanding, Exercise Prices Lower Limit Options Outstanding, Exercise Prices Upper Limit Options Outstanding, Number Outstanding Options Outstanding, Weighted Average Remaining Contractual Life (Years) Options Outstanding, Weighted Average Exercise Price Options Exercisable, Number Exercisable Options Exercisable, Weighted Average Exercise Price Options Outstanding, at Beginning balance Options Outstanding, Granted Options Outstanding, Exercised Options Outstanding, Expired or canceled Options Outstanding, at Ending balance Weighted Average Exercise Price, at Beginning balance Weighted Average Exercise Price, Granted Weighted Average Exercise Price, Exercised Weighted Average Exercise Price, Expired or canceled Weighted Average Exercise Price, at Ending balance Number of operating segments Long-lived assets net Income tax (benefit) Income tax examination description Effective corporate income tax rate Percentage of marginal tax rate used for calculation of deferred tax asset Operating loss carryforwards expiration year Valuation allowance percentage Additional Options [Member] Additional Tranche [Member] Agreement initial term. Asset Purchase Agreement [Member] AUD [Member] Average Yearly AUD: USD Exchange Rate [Member] Average Yearly CAD: USD Exchange Rate [Member] Blogger Database [Member] Breakthrough Products, Inc [Member] CAD [Member] CDG Holdings LLC [Member] Canadian Dollars Currency [Member] CAD [Member] Cash paid during the period. Cocowhite Intellectual Property [Member] Cocowhite [Member] Commission Agreement [Member] Commission Agreement One [Member] Common Stock One [Member] Common Stock To Be Issued [Member] Consulting Agreement [Member] Consumer Goods [Member] Contribution Agreement [Member] Cosmeceuticals [Member] Covenants [Member] Direct Sales [Member] Distribution Option Agreement [Member] Distribution Option Agreement One [Member] Distribution Option Agreement Two [Member] Document and Entity Information [Abstract] Employee [Member] Employee One [Member] Employment Agreement [Member] Exercise Price Range One [Member] Focus Factor [Member] Factor Nutrition Labs LLC [Member] First Amendment [Member] Fixed Assets and Intangible Assets [Text Block] Flat Rate [Member] Focus Factor Brand and Patent [Member] Focus Factor Business [Member] FocusFactor Distribution Agreement [Member] Foreign Countries [Member] Former Shareholder [Member] Hand MD Corp [Member] Hand Md Corp [Member] Hand MD LLC [Member] Hand MD [Member] Initial Option [Member] January 1, 2018 [Member] January 22, 2015 Loan One [Member] January 22, 2015 Loan Two [Member] January 20, 2017 [Member] January 22, 2017 [Member] January 22, 2016 [Member] January 22, 2015 Loan Two [Member] January 22, 2015 [Member] July 1, 2018 [Member] June 30, 2015 [Member]. June 26, 2015 Security Agreement [Member] Knight Therapeutics Barbados Inc [Member] Knight Therapeutics Inc [Member]. Knight Warrant Shares [Member] Knight Warrant Shares [Member] Knight Warrants [Member] Knight Warrants One [Member] LT Warrant [Member] License Agreement [Member] Loan Agreement [Member] Loan Amendment Agreement [Member] Long-lived assets [Policy Text Block] Long term Debt Net Related Party Current. March 31, 2020 [Member] March 27, 2019 [Member] March 2017 [Member] Mr. McCullough [Member] Mr.Kadanoff [Member] Ms. Harshbarger [Member] Neuragen Corp [Member] Nomad Choice [Member] NomadChoice Pty Limited's [Member] Nomad Choice Pty Ltd [Member] NomadChoice's [Member] Non-Compete Agreement [Member] November 12, 2015 Loan [Member] Number of vesting annual installments. Nutraceuticals [Member] Online [Member] Option Grant [Member] Options to Purchase Common Stock [Member] Options To Purchase Of Common Stock [Member] Origination Fee [Member] Percentage of bonus based salary. Percentage of sale revenue net. Perfekt Beauty Holdings LLC [Member] Perfekt Beauty Holdings LLC and CDG Holdings, LLC [Member] Per-fekt [Member] Period-End AUD: USD Exchange Rate [Member] Period-End CAD: USD Exchange Rate [Member] After March 31, 2019 [Member] Period-average RM [Member] Presentation of Financial Statements - Going Concern [Policy Text Block] Product display costs [Policy Text Block] Quarter Ending March 31, 2019 [Member] Quarter Ending September 30, 2015 [Member] Quarters Ending After March 31, 2019 [Member] Received annual bonus. Related parties [Policy Text Block] Related Party [Member] Retail Sales [Member] Royalty Distribution Agreement [Member] ST Warrant [Member] Second Amendment [Member] Second Year [Member] Security Agreement [Member] Settlement Agreement [Member] Shipping Costs Handling Cost Policy text Block Sneaky Vaunt Corp [Member] Stock Option Plan [Member] Stock Purchase Agreement [Member] Stock Purchase Agreement One [Member] Stock Purchase Agreement Two [Member] Stock Warrant [Member] Subscription Agreement [Member] Subsequent To December 31, 2018 [Member] Summary of fixed and intangible assets [Table Text Block] Summary of Net Sales Attributed to Customers Product Group [Table Text Block] Summary of Net Sales Attributed to Major Sales Channel [Table Text Block] Suppliers Eight [Member] Suppliers Five [Member] Suppliers Four [Member] Suppliers One [Member] Suppliers Seven [Member] Suppliers Six [Member] Suppliers Three [Member] Suppliers Two [Member] TPR Investments Pty Ltd [Member] The Queen Pegasus [Member] Third Year [Member] Three Customers [Member] Three Suppliers [Member] Through April 2017 Through December 2018 [Member] Twelve Months Ending June 30, 2019 [Member] Twelve Months Ending March 31, 2019 [Member] Two Customers [Member] Two Suppliers [Member] 2014 Equity Incentive Plan [Member] 2019 [Member] Two Vendors [Member] United States [Member] UrgentRx Sellers [Member] Warehousing costs [Policy Text Block] Warrant and Option [Member] Warrant Derivative Liabilities [Member] Warrants to Purchase Common Stock [Member] Warrants to Purchase of Common Stock Outstanding [Member] Work Fee [Member] Supplemental disclosure of non-cash investing and financing activities. General [Policy Text Block] Contract Assets [Policy Text Block] Contract Costs [Policy Text Block] Non cash implied interest. Value of intellectual property acquired. Working capital deficit. Revenue decline. Average Quarterly AUD: USD Exchange Rate [Member] Average Quarterly CAD: USD Exchange Rate [Member] License agreement. Software subscriptions. Clinical Research. Percentage of marginal tax rate used for calculation of deferred tax asset. Valuation allowance percentage. Operating loss carryforwards expiration year. Impairment. CAD [Member] Accrued Consulting Fees Per Month. Consulting fees. Distribution gross sale percentage description. Commissions expense. Minimum royalty payment. Carrying value as of the balance sheet date of obligations incurred through that date and payable for accrued legal fees. Manufactures liabilities current. Carrying value as of the balance sheet date of obligations incurred through that date and payable for returns allowance. Carrying value as of the balance sheet date of obligations incurred through that date and payable for accounting fees. Carrying value as of the balance sheet date of obligations incurred through that date and payable for customers. Royalties, related party. Accrued Warehousing Current. Taxes Current. Severance Accrual. Percentage of loan, description. Debt EBITDA. Debt covenants, minimum EBITDA. Debt covenants, net debt to TTM EBITDA ratio. Outstanding balance of consulting fees and reimbursement. Thereafter [Member] Queen Pegasus [Member] Net sales. April 30, 2019 [Member] Payment for acquisition of domain name. Advances for inventory. Media production, current Insurance, current. Rent, current. Rebranding, current. Related party receivable, current. Four Customers [Member] Payroll expense. Prepaid expenses and other current assets. Promotion. Capital asset deposit. Other commitments one time payment. CanadianDollarMember Assets, Current Assets [Default Label] Liabilities, Current Liabilities, Noncurrent Liabilities Stockholders' Equity Attributable to Parent Liabilities and Equity Gross Profit Operating Expenses Operating Income (Loss) Interest Income, Other Other Income Foreign Currency Transaction Gain (Loss), Realized Comprehensive Income (Loss), Net of Tax, Attributable to Parent Shares, Outstanding Foreign Currency Transaction Gain, before Tax Increase (Decrease) in Accounts Receivable Increase (Decrease) in Inventories Increase (Decrease) in Other Current Assets Increase (Decrease) in Accounts Payable and Accrued Liabilities Increase (Decrease) in Contract with Customer, Liability Payments to Acquire Property, Plant, and Equipment PaymentsToAcquireIntangibleAssets1 Payments to Acquire Intangible Assets Net Cash Provided by (Used in) Investing Activities Repayments of Notes Payable Net Cash Provided by (Used in) Financing Activities Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block] Accounts Receivable [Policy Text Block] Income Tax, Policy [Policy Text Block] Inventory, Policy [Policy Text Block] Contract with Customer, Liability Accounts Receivable, Allowance for Credit Loss, Current Promotion Other Assets, Current Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Finite-Lived Intangible Assets, Accumulated Amortization Finite-Lived Intangible Assets, Net Accrued Rent, Current Interest Payable, Current Interest Expense, Debt Loans Payable Loans Payable, Current Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price EX-101.PRE 11 snyr-20190930_pre.xml XBRL PRESENTATION FILE XML 12 R13.htm IDEA: XBRL DOCUMENT v3.19.3
Fixed Assets and Intangible Assets
 9 Months Ended
Sep. 30, 2019
Assets  
Fixed Assets and Intangible Assets

Note 7 – Fixed Assets and Intangible Assets

 

As of September 30, 2019, and December 31, 2018, fixed assets and intangible assets consisted of the following:

 

    September 30, 2019     December 31, 2018  
             
Property and equipment   $ 566,445     $ 566,445  
Less accumulated depreciation     (400,163 )     (296,674 )
Fixed assets, net   $ 166,282     $ 269,771  

 

Depreciation expense for the three months ended September 30, 2019 and 2018 was $31,166 and $38,299, respectively. Depreciation expense for the nine months ended September 30, 2019 and 2018 was $103,489 and $114,461, respectively.

 

    September 30, 2019     December 31, 2018  
             
FOCUS factor intellectual property   $ 1,450,000     $ 1,450,000  
Perfekt intellectual property     -       10,000  
Cocowhite intellectual property     -       50,000  
Intangible assets subject to amortization     5,388,230       7,150,165  
Less accumulated amortization     (4,638,479 )     (4,728,576 )
Less accumulated impairment     -       (924,068 )
Intangible assets, net   $ 2,199,751     $ 3,007,521  

 

Amortization expense for the three months ended September 30, 2019 and 2018 was $270,222 and $417,280, respectively. Amortization expense for the nine months ended September 30, 2019 and 2018 was $807,770 and $1,248,555, respectively. These intangible assets were acquired through an Asset Purchase Agreement and Stock Purchase Agreements.
XML 13 R17.htm IDEA: XBRL DOCUMENT v3.19.3
Stockholders' Equity
 9 Months Ended
Sep. 30, 2019
Equity [Abstract]  
Stockholders' Equity

Note 11 – Stockholders’ Equity

 

The total number of shares of all classes of capital stock which the Company is authorized to issue is 300,000,000 shares of common stock with $0.00001 par value.

 

During the nine months ended September 30, 2019, the Company issued 26,391 shares of its common stock valued at $39,585 in full and final settlement on the Perfekt transaction.

 

As of September 30, 2019 and December 31, 2018, there were 89,889,074 and 89,862,683, respectively, shares of the Company’s common stock issued and outstanding.
XML 14 R38.htm IDEA: XBRL DOCUMENT v3.19.3
Inventory - Schedule of Carrying Value of Inventory (Details) - USD ($)
Sep. 30, 2019
Dec. 31, 2018
Inventory Disclosure [Abstract]    
Finished goods $ 1,825,086 $ 1,956,942
Components 290,056 441,282
Inventory in transit 101,980 256,051
Raw materials 16,030 16,030
Total inventory $ 2,233,152 $ 2,670,305
XML 15 R34.htm IDEA: XBRL DOCUMENT v3.19.3
Summary of Significant Accounting Policies - Schedule of Cash, Cash Equivalents, and Restricted Cash (Details) - USD ($)
Sep. 30, 2019
Dec. 31, 2018
Sep. 30, 2018
Dec. 31, 2017
Accounting Policies [Abstract]        
Cash and cash equivalents $ 1,389,311 $ 459,736 $ 1,605,381  
Restricted cash 100,000 136,180 137,096  
Total cash, cash equivalents, and restricted cash shown in the statement of cash flows $ 1,489,311 $ 595,916 $ 1,742,477 $ 2,094,685
XML 16 R30.htm IDEA: XBRL DOCUMENT v3.19.3
Notes Payable (Tables)
 9 Months Ended
Sep. 30, 2019
Debt Disclosure [Abstract]  
Schedule of Loans Payable

The Company’s loans payable at September 30, 2019 and December 31, 2018 are as follows:

 

    September 30, 2019     December 31, 2018  
             
Loans payable   $ 6,263,545     $ 7,772,150  
Unamortized debt issuance cost     (75,478 )     (179,261 )
Total     6,188,067       7,592,889  
Less: Current portion     (5,937,576 )     (1,963,887 )
Long-term portion   $ 250,491     $ 5,629,002  
XML 17 R51.htm IDEA: XBRL DOCUMENT v3.19.3
Stock Options - Summary of Options Outstanding by Price Range (Details)
 9 Months Ended
Sep. 30, 2019
$ / shares
shares
Share-based Payment Arrangement [Abstract]  
Options Outstanding, Exercise Prices Lower Limit $ 0.25
Options Outstanding, Exercise Prices Upper Limit $ 0.70
Options Outstanding, Number Outstanding | shares 6,166,667
Options Outstanding, Weighted Average Remaining Contractual Life (Years) 5 years 9 months 18 days
Options Outstanding, Weighted Average Exercise Price $ 0.54
Options Exercisable, Number Exercisable | shares 5,750,000
Options Exercisable, Weighted Average Exercise Price $ 0.53
XML 18 R55.htm IDEA: XBRL DOCUMENT v3.19.3
Segments - Summary of Net Sales Attributed to Customers Product Group (Details) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Revenue $ 7,364,546 $ 9,190,377 $ 23,170,222 $ 28,619,950
Nutraceuticals [Member]        
Revenue 7,094,211 8,540,044 22,151,047 26,450,312
Over the Counter (OTC) [Member]        
Revenue 9,055 125,878 38,121 459,980
Consumer Goods [Member]        
Revenue 224,724 260,027 576,754 822,959
Cosmeceuticals [Member]        
Revenue $ 36,556 $ 264,428 $ 404,300 $ 886,699
XML 19 R5.htm IDEA: XBRL DOCUMENT v3.19.3
Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)
Common Stock [Member]
Additional Paid in Capital [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Accumulated Deficit [Member]
Total
Balance at Dec. 31, 2017 $ 899 $ 18,376,801 $ (77,989) $ (8,866,432) $ 9,433,279
Balance, shares at Dec. 31, 2017 89,862,683
Fair value of vested stock options $ 119,617 $ 119,617
Foreign currency translation gain (loss) 60,513 60,513
Net income loss       (55,493) (55,493)
Balance at Mar. 31, 2018 $ 899 18,496,418 (17,476) (8,921,928) 9,557,913
Balance, shares at Mar. 31, 2018 89,862,683        
Balance at Dec. 31, 2017 $ 899 $ 18,376,801 $ (77,989) $ (8,866,432) $ 9,433,279
Balance, shares at Dec. 31, 2017 89,862,683
Foreign currency translation gain (loss)         $ 85,826
Net income loss         (493,296)
Balance at Sep. 30, 2018 $ 899 $ 18,525,791 $ 7,838 $ (9,359,732) 9,174,796
Balance, shares at Sep. 30, 2018 89,862,683        
Balance at Mar. 31, 2018 $ 899 18,496,418 (17,476) (8,921,928) 9,557,913
Balance, shares at Mar. 31, 2018 89,862,683        
Fair value of vested stock options   119,769     119,769
Foreign currency translation gain (loss)     42,891   42,891
Net income loss       (783,393) (783,393)
Balance at Jun. 30, 2018 $ 899 18,616,187 25,415 (9,705,322) 8,937,179
Balance, shares at Jun. 30, 2018 89,862,683        
Fair value of vested stock options   (90,396)     (90,396)
Foreign currency translation gain (loss)     (17,577)   (17,578)
Net income loss       345,590 345,590
Balance at Sep. 30, 2018 $ 899 18,525,791 7,838 (9,359,732) 9,174,796
Balance, shares at Sep. 30, 2018 89,862,683        
Balance at Dec. 31, 2018 $ 899 18,817,800 179,116 (15,027,122) 3,970,693
Balance, shares at Dec. 31, 2018 89,862,683        
Fair value of vested stock options   45,534     45,534
Foreign currency translation gain (loss)     (70,940)   (70,940)
Common stock issued for Per-fekt settlement   39,585     39,585
Common stock issued for Per-fekt settlement, shares 26,391        
Net income loss       1,467,287 1,467,287
Balance at Mar. 31, 2019 $ 899 18,902,919 108,176 (13,559,835) 5,452,159
Balance, shares at Mar. 31, 2019 89,889,074        
Balance at Dec. 31, 2018 $ 899 18,817,800 179,116 (15,027,122) 3,970,693
Balance, shares at Dec. 31, 2018 89,862,683        
Foreign currency translation gain (loss)         (98,990)
Net income loss         1,893,613
Balance at Sep. 30, 2019 $ 899 18,980,276 80,126 (13,133,509) 5,927,792
Balance, shares at Sep. 30, 2019 89,889,074        
Balance at Mar. 31, 2019 $ 899 18,902,919 108,176 (13,559,835) 5,452,159
Balance, shares at Mar. 31, 2019 89,889,074        
Fair value of vested stock options   38,679     38,679
Foreign currency translation gain (loss)     (75,061)   (75,061)
Net income loss       318,462 318,462
Balance at Jun. 30, 2019 $ 899 18,941,597 33,115 (13,241,373) 5,734,238
Balance, shares at Jun. 30, 2019 89,889,074        
Fair value of vested stock options   38,679     38,679
Foreign currency translation gain (loss)     47,011   47,011
Net income loss       107,864 107,864
Balance at Sep. 30, 2019 $ 899 $ 18,980,276 $ 80,126 $ (13,133,509) $ 5,927,792
Balance, shares at Sep. 30, 2019 89,889,074        
XML 20 R1.htm IDEA: XBRL DOCUMENT v3.19.3
Document and Entity Information - shares
 9 Months Ended
Sep. 30, 2019
Nov. 12, 2019
Document And Entity Information [Abstract]    
Entity Registrant Name Synergy CHC Corp.  
Entity Central Index Key 0001562733  
Document Type 10-Q  
Document Period End Date Sep. 30, 2019  
Amendment Flag false  
Current Fiscal Year End Date --12-31  
Entity's Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business Flag true  
Entity Emerging Growth Company false  
Entity Ex Transition Period false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   89,889,074
Document Fiscal Period Focus Q3  
Document Fiscal Year Focus 2019  
XML 21 R9.htm IDEA: XBRL DOCUMENT v3.19.3
Inventory
 9 Months Ended
Sep. 30, 2019
Inventory Disclosure [Abstract]  
Inventory

Note 3 – Inventory

 

Inventory consists of finished goods, components and raw materials. The Company’s inventory is stated at the lower of cost (FIFO cost basis) or net realizable value.

 

The carrying value of inventory consisted of the following:

 

    September 30, 2019     December 31, 2018  
Finished goods   $ 1,825,086     $ 1,956,942  
Components     290,056       441,282  
Inventory in transit     101,980       256,051  
Raw materials     16,030       16,030  
Total inventory   $ 2,233,152     $ 2,670,305  

 

On January 22, 2015, inventory was pledged to Knight Therapeutics under the Loan Agreement (see note 10).
XML 22 R48.htm IDEA: XBRL DOCUMENT v3.19.3
Stockholders' Equity (Details Narrative) - USD ($)
 9 Months Ended
Sep. 30, 2019
Dec. 31, 2018
Number of capital stock shares authorized 300,000,000 300,000,000
Common stock par value $ 0.00001 $ 0.00001
Common stock, shares issued 89,889,074 89,862,683
Common stock, shares outstanding 89,889,074 89,862,683
Perfekt Beauty Holdings LLC [Member]    
Number of common stock issued shares 26,391  
Number of common stock issued $ 39,585  
XML 23 R44.htm IDEA: XBRL DOCUMENT v3.19.3
Related Party Transactions (Details Narrative)
 3 Months Ended 9 Months Ended
Dec. 23, 2016
CAD ($)
Sep. 30, 2019
USD ($)
Sep. 30, 2019
USD ($)
Sep. 30, 2019
CAD ($)
Dec. 31, 2018
USD ($)
Aug. 18, 2015
USD ($)
Consulting fees   $ 226,515 $ 650,728      
Outstanding balance of consulting fees and reimbursement   0 0      
Due to related party   370,939 370,939      
Present value of future payments   263,546 263,546   $ 272,151  
NomadChoice Pty Limited's [Member]            
Royal expense   36,082 175,391      
Sneaky Vaunt Corp [Member]            
Royal expense   1,067 4,252      
Queen Pegasus [Member]            
Commissions expense     0      
Hand MD Corp [Member]            
Royal expense   6,180 14,801      
Minimum royalty payment     0      
Hand MD LLC [Member]            
Percentage of ownership interest           50.00%
Payroll expense   30,000 90,000      
Debt outstanding balance   0 0      
Knight Therapeutics Inc [Member]            
Debt outstanding balance   152,834 152,834      
Distribution gross sale percentage description Knight a distribution fee equal to 30% of gross sales for sales achieved through a direct sales channel and 5% of gross sales for sales achieved through retail sales.          
Hand MD [Member]            
Debt outstanding balance   18,325 18,325      
Distribution gross sale percentage description Knight a distribution fee equal to 60% of gross sales for sales achieved through a direct sales channel until the sales in the calendar year equal the threshold amount and then 40% of all such gross sales in such calendar year in excess of the threshold amount and 5% of gross sales for sales achieved through retail sales.          
Security Agreement [Member] | Knight Therapeutics Inc [Member]            
Due to related party   487,500 487,500      
Loan Agreement [Member] | Knight [Member]            
Due to related party   5,924,522 5,924,522      
Royalty Distribution Agreement [Member] | NomadChoice Pty Limited's [Member]            
Royal expense     36,082      
Royalty Distribution Agreement [Member] | Sneaky Vaunt Corp [Member]            
Royal expense     1,067      
Commission Agreement One [Member]            
Commissions expense   0 9,065      
Commission Agreement [Member]            
Commissions expense   0 644      
Commission Agreement [Member] | Sneaky Vaunt Corp [Member]            
Commissions expense     0      
CAD [Member] | Knight Therapeutics Inc [Member]            
Due to related party $ 100,000          
Debt outstanding balance       $ 200,000    
CAD [Member] | Hand MD [Member]            
Due to related party $ 25,000          
Debt outstanding balance       $ 25,000    
Mr. Jack Ross [Member]            
Accrued consulting fees per month   57,917 57,917      
Management fees   $ 129,478 $ 129,478      
Ms. Harshbarger [Member] | Consulting Agreement [Member]            
Due to related party           $ 10,000
XML 24 R40.htm IDEA: XBRL DOCUMENT v3.19.3
Prepaid Expenses and Other Current Assets - Schedule of Prepaid Expenses and Other Current Assets (Details) - USD ($)
Sep. 30, 2019
Dec. 31, 2018
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]    
Advances for inventory $ 14,571 $ 25,170
Media production 20,791
Insurance 29,183 13,302
Deposits 10,257 45,144
Trademarks 19,707 78,826
Rent 86,354 103,912
Promotion 114,018 342,220
License agreement 58,333
Software subscriptions 48,962 34,440
Rebranding 7,415 40,783
Clinical research 23,745 35,617
Miscellaneous 33,286 30,309
Related party receivables 9,467
Capital asset deposit 38,200
Total $ 435,165 $ 828,847
XML 25 R21.htm IDEA: XBRL DOCUMENT v3.19.3
Income Taxes
 9 Months Ended
Sep. 30, 2019
Income Tax Disclosure [Abstract]  
Income Taxes

Note 15 – Income Taxes

 

Income tax (benefit) expense was ($57,421) and ($22,873) for the three and nine months ended September 30, 2019, respectively, compared to ($126,190) and $256,812, respectively, for the same periods in 2018. The current provision is attributable to Australian operations and the current tax rate in effect in that country.

 

On December 22, 2017, the Tax Cuts and Jobs Act (the TCJA), which significantly modified U.S. corporate income tax law, was signed into law by President Trump. The TCJA contains significant changes to corporate income taxation, including but not limited to the reduction of the corporate income tax rate from a top marginal rate of 35% to a flat rate of 21%, limitation of the tax deduction for interest expense to 30% of earnings (except for certain small businesses), limitation of the deduction for net operating losses to 80% of current year taxable income and generally eliminating net operating loss carrybacks, allowing net operating losses to carryforward without expiration, one-time taxation of offshore earnings at reduced rates regardless of whether they are repatriated, elimination of U.S. tax on foreign earnings (subject to certain important exceptions), immediate deductions for certain new investments instead of deductions for depreciation expense over time, and modifying or repealing many business deductions and credits (including changes to the orphan drug tax credit and changes to the deductibility of research and experimental expenditures that will be effective in the future). Notwithstanding the reduction in the corporate income tax rate, the overall impact of the new federal tax law is uncertain, including to what extent various states will conform to the newly enacted federal tax law.

 

The Company has not recorded the necessary provisional adjustments in the financial statements in accordance with its current understanding of the TCJA and guidance currently available as of this filing. The Company is reviewing the TCJA’s potential ramifications.

 

The total deferred tax asset is calculated by multiplying a domestic (US) 21% marginal tax rate by the cumulative net operating loss carryforwards (“NOL”). The domestic marginal tax rate does not include any state & local marginal tax rate attributable to the Company. The Company currently has estimated NOLs, which expire through 2035. Management has determined based on all the available information that a 100% valuation reserve is required.

 

For U.S. purposes, the Company has not completed its evaluation of NOL utilization limitations under Internal Revenue Code, as amended (the “Code”) Section 382/383, change of ownership rules. If the Company has had a change in ownership, the NOL’s would be limited or eliminated, as to the amount that could be utilized each year, based on the Code. NOL’s attributable to Breakthrough Products, Inc., which are the majority of the Company’s domestic NOL’s are Separate Return Limitation Year (SRLY) NOL’s. Such losses may generally not be available for use (limited or eliminated).

 

The Company has not filed its State & Local Income/Franchise tax returns in States it is required to file for the last few years, so such returns and liability remain open, but the Company does not believe such amounts are material
XML 26 R25.htm IDEA: XBRL DOCUMENT v3.19.3
Inventory (Tables)
 9 Months Ended
Sep. 30, 2019
Inventory Disclosure [Abstract]  
Schedule of Carrying Value of Inventory

The carrying value of inventory consisted of the following:

 

    September 30, 2019     December 31, 2018  
Finished goods   $ 1,825,086     $ 1,956,942  
Components     290,056       441,282  
Inventory in transit     101,980       256,051  
Raw materials     16,030       16,030  
Total inventory   $ 2,233,152     $ 2,670,305  
XML 27 R29.htm IDEA: XBRL DOCUMENT v3.19.3
Accounts Payable and Accrued Liabilities (Tables)
 9 Months Ended
Sep. 30, 2019
Payables and Accruals [Abstract]  
Schedule of Accounts Payable and Accrued Liabilities

As of September 30, 2019, and December 31, 2018, accounts payable and accrued liabilities consisted of the following:

 

    September 30, 2019     December 31, 2018  
Accrued payroll   $ 243,730     $ 217,069  
Legal fees     116,769       71,236  
Commissions     255,170       134,784  
Manufacturers     2,529,037       3,898,896  
Promotions     140,359       1,262,503  
Returns allowance     -       850,627  
Accounting fees     97,714       104,198  
Rent     -       61,738  
Customers     1,800       76,617  
Interest     49,306       -  
Royalties, related party     191,211       304,434  
Warehousing     11,106       64,289  
Sales taxes     302,870       180,222  
Taxes     -       178,069  
Severance Accrual     270,333       506,250  
Related Party Reimbursements     131,650       178,825  
Others     156,561       307,463  
Total   $ 4,497,616     $ 8,397,220  
XML 28 R45.htm IDEA: XBRL DOCUMENT v3.19.3
Accounts Payable and Accrued Liabilities - Schedule of Accounts Payable and Accrued Liabilities (Details) - USD ($)
Sep. 30, 2019
Dec. 31, 2018
Payables and Accruals [Abstract]    
Accrued payroll $ 243,730 $ 217,069
Legal fees 116,769 71,236
Commissions 255,170 134,784
Manufacturers 2,529,037 3,898,896
Promotions 140,359 1,262,503
Returns allowance 850,627
Accounting fees 97,714 104,198
Rent 61,738
Customers 1,800 76,617
Interest 49,306
Royalties, related party 191,211 304,434
Warehousing 11,106 64,289
Sales taxes 302,870 180,222
Taxes 178,069
Severance Accrual 270,333 506,250
Related Party Reimbursements 131,650 178,825
Others 156,561 307,463
Total $ 4,497,616 $ 8,397,220
XML 29 R41.htm IDEA: XBRL DOCUMENT v3.19.3
Concentration of Credit Risk (Details Narrative) - USD ($)
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Dec. 31, 2018
Cash federally insured limit per bank $ 250,000   $ 250,000    
Cash uninsured amount $ 981,699   $ 981,699   $ 162,729
Three Customers [Member] | Accounts Receivable [Member]          
Concentration risk percentage     57.00%   83.00%
Three Customers [Member] | Sales Revenue, Net [Member]          
Concentration risk percentage       50.00%  
Two Customers [Member] | Sales Revenue, Net [Member]          
Concentration risk percentage 58.00% 58.00% 47.00%   41.00%
Two Vendors [Member] | Accounts Payable [Member]          
Concentration risk percentage     73.00%   77.00%
Two Suppliers [Member]          
Concentration risk percentage 46.00% 48.00% 39.00%    
Three Suppliers [Member]          
Concentration risk percentage       49.00%  
XML 30 R49.htm IDEA: XBRL DOCUMENT v3.19.3
Commitments & Contingencies (Details Narrative)
 9 Months Ended
Oct. 17, 2017
USD ($)
Integer
shares
Sep. 30, 2019
USD ($)
Other commitments one time payment   $ 85,000
Employment Agreement [Member]    
Agreement initial term 3 years  
Employment Agreement [Member] | Mr. McCullough [Member]    
Salary received $ 340,000  
Employment Agreement [Member] | Mr. McCullough [Member] | Retail Sales [Member]    
Percentage of sale revenue net 5.00%  
Employment Agreement [Member] | Mr. McCullough [Member] | Maximum [Member]    
Percentage of bonus based salary 25.00%  
Employment Agreement [Member] | Mr. McCullough [Member] | January 1, 2018 [Member]    
Received annual bonus $ 37,500  
Employment Agreement [Member] | Mr. McCullough [Member] | July 1, 2018 [Member]    
Received annual bonus $ 37,500  
Employment Agreement [Member] | Mr. McCullough [Member] | Option Grant [Member]    
Purchase of granted option of stock based payments | shares 1,000,000  
Number of vesting annual installments | Integer 3  
EXCEL 31 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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htm IDEA: XBRL DOCUMENT v3.19.3
Fixed Assets and Intangible Assets (Tables)
 9 Months Ended
Sep. 30, 2019
Assets  
Summary of Fixed and Intangible Assets

As of September 30, 2019, and December 31, 2018, fixed assets and intangible assets consisted of the following:

 

    September 30, 2019     December 31, 2018  
             
Property and equipment   $ 566,445     $ 566,445  
Less accumulated depreciation     (400,163 )     (296,674 )
Fixed assets, net   $ 166,282     $ 269,771  

 

    September 30, 2019     December 31, 2018  
             
FOCUS factor intellectual property   $ 1,450,000     $ 1,450,000  
Perfekt intellectual property     -       10,000  
Cocowhite intellectual property     -       50,000  
Intangible assets subject to amortization     5,388,230       7,150,165  
Less accumulated amortization     (4,638,479 )     (4,728,576 )
Less accumulated impairment     -       (924,068 )
Intangible assets, net   $ 2,199,751     $ 3,007,521  
XML 33 R20.htm IDEA: XBRL DOCUMENT v3.19.3
Segments
 9 Months Ended
Sep. 30, 2019
Segment Reporting [Abstract]  
Segments

Note 14 – Segments

 

Segment identification and selection is consistent with the management structure used by the Company’s chief operating decision maker to evaluate performance and make decisions regarding resource allocation, as well as the materiality of financial results consistent with that structure. Based on the Company’s management structure and method of internal reporting, the Company has one operating segment. The Company’s chief operating decision maker does not review operating results on a disaggregated basis; rather, the chief operating decision maker reviews operating results on an aggregate basis.

 

Net sales attributed to customers in the United States and foreign countries for the three months ended September 30, 2019 and 2018 were as follows:

 

    September 30, 2019     September 30, 2018  
United States   $ 6,785,123     $ 8,944,970  
Foreign countries     579,423       245,407  
    $ 7,364,546     $ 9,190,377  

 

Foreign countries primarily consist of Australia and Canada.

 

The Company’s net sales by product group for the three months ended September 30, 2019 and 2018 were as follows:

 

    September 30, 2019     September 30, 2018  
Nutraceuticals   $ 7,094,211     $ 8,540,044  
Over the Counter (OTC)     9,055       125,878  
Consumer Goods     224,724       260,027  
Cosmeceuticals     36,556       264,428  
    $ 7,364,546     $ 9,190,377  

 

(1) Net sales for any other product group of similar products are less than 10% of consolidated net sales.

 

The Company’s net sales by major sales channel for the three months ended September 30, 2019 and 2018 were as follows:

 

    September 30, 2019     September 30, 2018  
Online   $ 2,318,455     $ 4,902,161  
Retail     5,046,091       4,288,216  
    $ 7,364,546     $ 9,190,377  

 

Net sales attributed to customers in the United States and foreign countries for the nine months ended September 30, 2019 and 2018 were as follows:

 

    September 30, 2019     September 30, 2018  
United States   $ 21,377,182     $ 27,215,818  
Foreign countries     1,793,040       1,404,132  
    $ 23,170,222     $ 28,619,950  

 

The Company’s net sales by product group for the nine months ended September 30, 2019 and 2018 were as follows:

 

    September 30, 2019     September 30, 2018  
Nutraceuticals   $ 22,151,047     $ 26,450,312  
Over the Counter (OTC)     38,121       459,980  
Consumer Goods     576,754       822,959  
Cosmeceuticals     404,300       886,699  
    $ 23,170,222     $ 28,619,950  

 

(1) Net sales for any other product group of similar products are less than 10% of consolidated net sales.

 

The Company’s net sales by major sales channel for the nine months ended September 30, 2019 and 2018 were as follows:

 

    September 30, 2019     September 30, 2018  
Online   $ 8,841,272     $ 13,926,758  
Retail     14,328,950       14,693,192  
    $ 23,170,222     $ 28,619,950  

 

Long-lived assets (net) attributable to operations in the United States and foreign countries as of September 30, 2019 and December 31, 2018 were as follows:

 

    September 30, 2019     December 31, 2018  
United States   $ 10,150,670     $ 11,058,528  
Foreign countries     8,603       12,004  
    $ 10,159,273     $ 11,070,532  
XML 34 R24.htm IDEA: XBRL DOCUMENT v3.19.3
Summary of Significant Accounting Policies (Tables)
 9 Months Ended
Sep. 30, 2019
Accounting Policies [Abstract]  
Schedule of Cash, Cash Equivalents, and Restricted Cash

The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the statement of financial position that sum to the total of the same such amounts shown in the statement of cash flows.

 

    September 30, 2019     December 31, 2018     September 30, 2018  
                   
Cash and cash equivalents   $ 1,389,311     $ 459,736     $ 1,605,381  
Restricted cash     100,000       136,180       137,096  
Total cash, cash equivalents, and restricted cash shown in the statement of cash flows   $ 1,489,311     $ 595,916     $ 1,742,477  
Schedule of Number of Shares Used in Calculation of Earnings Per Share Basic and Diluted

The following is a reconciliation of the number of shares used in the calculation of basic earnings per share and diluted earnings per share for the three and nine months ended September 30, 2019, and 2018:

 

    For the three months ended     For the nine months ended  
    September 30, 2019     September 30, 2018     September 30, 2019     September 30, 2018  
                         
Net income (loss) after tax   $ 107,864     $ 345,590     $ 1,893,613     $ (493,296 )
                                 
Weighted average common shares outstanding     89,889,044       89,862,683       89,881,223       89,862,683  
Incremental shares from the assumed exercise of dilutive stock options     -       -       -       -  
Incremental shares from the assumed exercise of dilutive stock warrants     -       -       -       -  
Dilutive potential common shares     89,889,044       89,862,683       89,881,223       89,862,683  
                                 
Net earnings (loss) per share:                                
Basic   $ 0.00     $ 0.00     $ 0.02     $ (0.01 )
Diluted   $ 0.00     $ 0.00     $ 0.02     $ (0.01 )
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

The following securities were not included in the computation of diluted net earnings per share as their effect would have been antidilutive:

 

    2019     2018  
             
Options to purchase common stock     6,166,667       7,166,667  
Warrants to purchase common stock     -       1,000,000  
      6,166,667       8,166,667  
Schedule of Foreign Currencies Translation Exchange Rate

The exchange rates used to translate amounts in AUD and CAD into USD for the purposes of preparing the consolidated financial statements were as follows:

 

Balance sheet:

 

    September 30, 2019     December 31, 2018  
Period-end AUD: USD exchange rate   $ 0.6746     $ 0.7046  
Period-end CAD: USD exchange rate   $ 0.7551     $ 0.7330  

 

Income statement:

 

    September 30, 2019     September 30, 2018  
Average Quarterly AUD: USD exchange rate   $ 0.6994     $ 0.7579  
Average Quarterly CAD: USD exchange rate   $ 0.7524     $ 0.7768  
XML 35 R12.htm IDEA: XBRL DOCUMENT v3.19.3
Concentration of Credit Risk
 9 Months Ended
Sep. 30, 2019
Risks and Uncertainties [Abstract]  
Concentration of Credit Risk

Note 6 – Concentration of Credit Risk

 

Cash and cash equivalents

 

The Company maintains its cash and cash equivalents in banks insured by the Federal Deposit Insurance Corporation (FDIC) in accounts that at times may be in excess of the federally insured limit of $250,000 per bank. The Company minimizes this risk by placing its cash deposits with major financial institutions. At September 30, 2019 and December 31, 2018, the uninsured balances amounted to $981,699 and $162,729, respectively.

 

Accounts receivable

 

As of September 30, 2019, three customers accounted for 57% of the Company’s accounts receivable. As of December 31, 2018, three customers accounted for 83% of the Company’s accounts receivable.

 

Major customers

 

For the nine months ended September 30, 2019, two customers accounted for approximately 47% of the Company’s net revenue. For the three months ended September 30, 2019, two customers accounted for approximately 58% of the Company’s net revenue. For the nine months ended September 30, 2018, three customers accounted for approximately 50% of the Company’s net revenue. For the three months ended September 30, 2018, two customers accounted for approximately 58% of the Company’s net revenue. For the year ended December 31, 2018, two customers accounted for approximately 41% of the Company’s net revenues. Substantially all of the Company’s business is with companies in the United States.

 

Accounts payable

 

As of September 30, 2019 and December 31, 2018, two vendors accounted for 73% and 77%, respectively, of the Company’s accounts payable.

 

Major suppliers

 

For the nine months ended September 30, 2019, two suppliers accounted for approximately 39% of the Company’s purchases. For the nine months ended September 30, 2018, three suppliers accounted for approximately 49% of the Company’s purchases. For the three months ended September 30, 2019, two suppliers accounted for approximately 46% of the Company’s purchases. For the three months ended September 30, 2018, two suppliers accounted for approximately 48% of the Company’s purchases. Substantially all of the Company’s business is with suppliers in the United States.
XML 36 R16.htm IDEA: XBRL DOCUMENT v3.19.3
Notes Payable
 9 Months Ended
Sep. 30, 2019
Debt Disclosure [Abstract]  
Notes Payable

Note 10 – Notes Payable

 

The Company’s loans payable at September 30, 2019 and December 31, 2018 are as follows:

 

    September 30, 2019     December 31, 2018  
             
Loans payable   $ 6,263,545     $ 7,772,150  
Unamortized debt issuance cost     (75,478 )     (179,261 )
Total     6,188,067       7,592,889  
Less: Current portion     (5,937,576 )     (1,963,887 )
Long-term portion   $ 250,491     $ 5,629,002  

 

$950,000 June 26, 2015 Security Agreement:

 

On June 26, 2015, the Company issued a 0% promissory note in a principal amount of $950,000 in connection with an Asset Purchase Agreement. The note requires $250,000 to be paid on or before June 30, 2016, and $700,000 to be paid in quarterly installments (beginning with the quarter ended September 30, 2015) equal to the greater of $12,500 or 5% of U.S. net sales, and 2% of U.S. net sales of Neuragen for 60 months thereafter. The payment of such amounts is secured by a security interest in certain assets, undertakings and property (“Collateral”) pursuant to the Security Agreement, which will be released upon receipt of total payments of $1.2 million.

 

The Company recorded present value of future payments of $263,546 and $272,151 as of September 30, 2019 and December 31, 2018, respectively. The Company recorded imputed interest expense of $9,526 for the three months ended September 30, 2019 and $28,896 for the nine months ended September 30, 2019.

 

During the three and nine months ended September 30, 2019, the Company made payments of $12,500 and $37,500, respectively, in connection with this Security Agreement.

 

$10,000,000 August 9, 2017 Loan:

 

On August 9, 2017, we entered into a Second Amendment to Loan Agreement (“Second Amendment”) with Knight, pursuant to which Knight agreed to loan us an additional $10 million, and an ongoing credit facility of up to $20 million, and which amount was borrowed at closing (the “Financing”) for working capital purposes. At closing, we paid Knight an origination fee of $200,000 and a work fee of $100,000 and also paid $100,000 of Knight’s expenses associated with the Loan.

 

Additional Tranches under the Loan Agreement are available to the Company until August 9, 2022 provided that no event of default exists. Each Additional Tranche must be for a minimum amount of $1.0 million, may only be used to finance qualified acquisitions (as defined in the Loan Agreement), and can be denied in Knight’s absolute discretion. If an Additional Tranche is denied, the Company can effect a qualified acquisition through a special purpose entity with such special purpose entity being entitled to obtain financing from third parties so long as such financing does not adversely affect Knight or Knight’s rights under the Loan Agreement. Upon the closing of any Additional Tranche, the Company will pay Knight an origination fee equal to 2% of the Additional Tranche, a work fee equal to 1% of the amount of the Additional Tranche, and reimburse Knight for its expenses incurred in connection with its consideration of any Additional Tranche (whether or not advanced).

 

The Loan bears interest at 10.5% per annum. The amended Loan Agreement matures on August 8, 2020 and (b) the date that Knight, in its discretion, accelerates the Company’s obligations due to an event of default.

 

On the Maturity Date of the Third Tranche and every Additional Tranche (or upon the acceleration of each such loan), the Company must pay Knight a success fee (the “Success Fee”) of that number of Company common shares equal to 10% of the loan, divided by the lesser of (a) $1.50, (b) the lowest price at which any common shares were issued by the Company in any offering or equity financing or other transaction between the Closing Date and the date the Success Fee is due, and (c) the current market price on the date the Success Fee is due. The Company may also pay the Success Fee in cash pursuant to the terms of the Loan Agreement.

 

The Loan Agreement includes customary representations, warranties, and affirmative and restrictive covenants, including covenants to attain and maintain certain financial metrics, and to not merge or dispose of assets, acquire other businesses (except for businesses substantially similar or complementary to the Company’s business, and provided that the aggregate consideration to be paid does not exceed $100,000 and the acquired business guarantees the Company’s obligations under the Loan Agreement) or make capital expenditures in excess of $500,000. The Loan Agreement also includes customary events of default, including payment defaults, breaches of covenants, change of control and material adverse effect defaults. Upon the occurrence of an event of default and during the continuation thereof, the principal amount of all loans under the Loan Agreement will bear a default interest rate of an additional 5%.

 

The Company’s obligations and liabilities under the Loan Agreement are secured and unconditionally guaranteed by certain of the Company’s wholly owned subsidiaries as provided in the Loan Agreement.

 

We have met all the covenants except for the TTM EBITDA of $5 million during the period ending March 31, 2018. Default Interest rate of 5% (from 10.5% to 15.5%) applies in accordance to our current agreement and will be in effect starting April 1, 2018 and will be in effect until the $5 million TTM EDITDA covenant is achieved. When we entered into Loan Amendment Agreement on May 14, 2018, the interest rate was reduced to 13% due to reducing payroll expenses. Also, Synergy will maintain Focus Factor Net Sales as measured on a year-end basis of at least USD $15 million for each fiscal year starting with December 31, 2017.

 

We have amended our covenants under our loan agreement on March 27, 2019 and are currently in compliance with all covenants. The new covenants are as follows: we will maintain a minimum EBITDA of $1,900,000 for the twelve months ending on December 31, 2018, $2,500,000 for the twelve months ending March 31, 2019, $3,500,000 for the twelve months ending September 30, 2019 and $5,000,000 for the twelve months period ending on last day of each fiscal quarters thereafter. We shall maintain a net debt to TTM EBITDA ratio of no more than 8:1 for the twelve month period ending on December 31, 2018 until March 31, 2019 and shall maintain a net debt to TTM EBITDA ratio of no more than 6:1 thereafter. We shall maintain at all times a positive cash balance of $575,000 for the three month period ending December 31, 2018, $750,000 for the three month period ending March 31, 2019 and $1,000,000 thereafter. The default interest rate of 2.5% applies (from 13% to 15.5%) in accordance to our current agreement and will be in effect from October 1, 2018 to June 30, 2019. Effective June 30, 2019 the interest rate referred back to 10.5%.

 

The Company also recorded deferred financing costs of $452,869 with respect to the above loan. The Company recognized amortization of deferred financing costs of $30,820 and $103,782 during the three and nine months ended September 30, 2019, respectively. Unamortized debt issuance cost as of September 30, 2019 amounted to $75,478.

 

The Company recognized interest expense of $166,833 and paid $166,833 during the three months ended September 30, 2019 and $759,069 and paid $709,763 during the nine months ended September 30, 2019. Accrued interest was $49,306 as of September 30, 2019. The loan balance at September 30, 2019 was $6,000,000.
XML 37 R35.htm IDEA: XBRL DOCUMENT v3.19.3
Summary of Significant Accounting Policies - Schedule of Number of Shares Used in Calculation of Earnings Per Share Basic and Diluted (Details) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Sep. 30, 2019
Sep. 30, 2018
Accounting Policies [Abstract]                
Net income (loss) after tax $ 107,864 $ 318,462 $ 1,467,287 $ 345,590 $ (783,393) $ (55,493) $ 1,893,613 $ (493,296)
Weighted average common shares outstanding 89,889,044     89,862,683     89,881,223 89,862,683
Incremental shares from the assumed exercise of dilutive stock options        
Incremental shares from the assumed exercise of dilutive stock warrants        
Dilutive potential common shares 89,889,044     89,862,683     89,881,223 89,862,683
Net earnings (loss) per share - Basic $ 0.00     $ 0.00     $ 0.02 $ (0.01)
Net earnings (loss) per share - Diluted $ 0.00     $ 0.00     $ 0.02 $ (0.01)
XML 38 R31.htm IDEA: XBRL DOCUMENT v3.19.3
Stock Options (Tables)
 9 Months Ended
Sep. 30, 2019
Share-based Payment Arrangement [Abstract]  
Summary of Options Outstanding by Price Range

The following table summarizes the options outstanding, option exercisability and the related prices for the shares of the Company’s common stock issued to employees and consultants under the Plan at September 30, 2019:

 

      Options Outstanding     Options Exercisable  
Exercise
Prices ($)		     Number
Outstanding		     Weighted
Average
Remaining
Contractual
Life
(Years)		     Weighted
Average
Exercise
Price ($)		     Number
Exercisable		     Weighted
Average
Exercise
Price ($)		  
$ 0.25 - $0.70       6,166,667       5.8     $ 0.54       5,750,000     $ 0.53  
Schedule of Stock Options Activity

The stock option activity for the nine months ended September 30, 2019 is as follows:

 

    Options
Outstanding		     Weighted
Average
Exercise Price		  
Outstanding at December 31, 2018     7,166,667     $ 0.50  
Granted     -       -  
Exercised     -       -  
Expired or canceled     (1,000,000 )     0.25  
Outstanding at September 30, 2019     6,166,667     $ 0.54  
XML 39 R39.htm IDEA: XBRL DOCUMENT v3.19.3
Accounts Receivable - Accounts Receivable, Net of Allowances for Sales Returns and Doubtful Accounts (Details) - USD ($)
Sep. 30, 2019
Dec. 31, 2018
Receivables [Abstract]    
Trade accounts receivable $ 1,902,130 $ 4,458,225
Less allowances
Total accounts receivable, net $ 1,902,130 $ 4,458,225
XML 40 R58.htm IDEA: XBRL DOCUMENT v3.19.3
Income Taxes (Details Narrative) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Income Tax Disclosure [Abstract]        
Income tax (benefit) $ (57,421) $ (126,190) $ (22,873) $ 256,812
Income tax examination description     On December 22, 2017, the Tax Cuts and Jobs Act (the TCJA), which significantly modified U.S. corporate income tax law, was signed into law by President Trump. The TCJA contains significant changes to corporate income taxation, including but not limited to the reduction of the corporate income tax rate from a top marginal rate of 35% to a flat rate of 21%, limitation of the tax deduction for interest expense to 30% of earnings (except for certain small businesses), limitation of the deduction for net operating losses to 80% of current year taxable income and generally eliminating net operating loss carrybacks, allowing net operating losses to carryforward without expiration, one-time taxation of offshore earnings at reduced rates regardless of whether they are repatriated, elimination of U.S. tax on foreign earnings (subject to certain important exceptions), immediate deductions for certain new investments instead of deductions for depreciation expense over time, and modifying or repealing many business deductions and credits (including changes to the orphan drug tax credit and changes to the deductibility of research and experimental expenditures that will be effective in the future).  
Effective corporate income tax rate     21.00%  
Percentage of marginal tax rate used for calculation of deferred tax asset     21.00%  
Operating loss carryforwards expiration year     2035  
Valuation allowance percentage     100.00%  
XML 41 R50.htm IDEA: XBRL DOCUMENT v3.19.3
Stock Options (Details Narrative)
 3 Months Ended 9 Months Ended
Sep. 30, 2019
USD ($)
$ / shares
Sep. 30, 2019
USD ($)
$ / shares
Stock-based compensation expense $ 38,679 $ 122,891
Expected lives   10 years
Dividend yield   0.00%
Unamortized stock-based compensation 167,608 $ 167,608
Recognized, period for recognition   1 year
Stock Option [Member]    
Stock option outstanding intrinsic value $ 0 $ 0
Minimum [Member]    
Estimated fair value of company's common stock | $ / shares $ 0.48 $ 0.48
Risk-free interest rate   1.95%
Volatility rate   116.00%
Maximum [Member]    
Estimated fair value of company's common stock | $ / shares $ 0.50 $ 0.50
Risk-free interest rate   1.99%
Volatility rate   117.00%
XML 42 R54.htm IDEA: XBRL DOCUMENT v3.19.3
Segments - Summary of Net Sales Attributed to Customers Geographical Segment (Details) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Revenue $ 7,364,546 $ 9,190,377 $ 23,170,222 $ 28,619,950
United States [Member]        
Revenue 6,785,123 8,944,970 21,377,182 27,215,818
Foreign Countries [Member]        
Revenue $ 579,423 $ 245,407 $ 1,793,040 $ 1,404,132
XML 43 R8.htm IDEA: XBRL DOCUMENT v3.19.3
Summary of Significant Accounting Policies
 9 Months Ended
Sep. 30, 2019
Accounting Policies [Abstract]  
Summary of Significant Accounting Policies

Note 2 – Summary of Significant Accounting Policies

 

General

 

The accompanying condensed consolidated financial statements as of September 30, 2019 and December 31, 2018 and for the three and nine months ended September 30, 2019 and 2018 are unaudited. These unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information and are presented in accordance with the requirements of Rule S-X of the Securities and Exchange Commission (the “SEC”) and with the instructions to Form 10-Q. Accordingly, they do not include all the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three and nine months ended September 30, 2019 are not necessarily indicative of the results that may be expected for the fiscal year ending December 31, 2019. The unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements as of and for the year ended December 31, 2018 and footnotes thereto included in the Company’s Annual Report on Form 10-K filed with the SEC on March 29, 2019.

 

Basis of Presentation

 

The unaudited condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.

 

Use of Estimates

 

The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosure of contingent liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates. Significant estimates are assumptions about collection of accounts receivable, useful life of fixed and intangible assets, goodwill and assumptions used in Black-Scholes-Merton, or BSM, valuation methods, such as expected volatility, risk-free interest rate, and expected dividend rate.

 

Cash and Cash Equivalents

 

The Company considers all cash on hand and in banks, including accounts in book overdraft positions, certificates of deposit and other highly-liquid investments with maturities of three months or less, when purchased, to be cash and cash equivalents. As of September 30, 2019, the Company had no cash equivalents. The Company maintains its cash and cash equivalents in banks insured by the Federal Deposit Insurance Corporation (FDIC) in accounts that at times may be in excess of the federally insured limit of $250,000 per bank. The Company minimizes this risk by placing its cash deposits with major financial institutions. At September 30, 2019, the uninsured balance amounted to $981,699.

 

Restricted Cash

 

The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the statement of financial position that sum to the total of the same such amounts shown in the statement of cash flows.

 

    September 30, 2019     December 31, 2018     September 30, 2018  
                   
Cash and cash equivalents   $ 1,389,311     $ 459,736     $ 1,605,381  
Restricted cash     100,000       136,180       137,096  
Total cash, cash equivalents, and restricted cash shown in the statement of cash flows   $ 1,489,311     $ 595,916     $ 1,742,477  

 

Amounts included in restricted cash represent amounts held for credit card collateral.

 

Capitalization of Fixed Assets

 

The Company capitalizes expenditures related to property and equipment, subject to a minimum rule, that have a useful life greater than one year for: (1) assets purchased; (2) existing assets that are replaced, improved or the useful lives have been extended; or (3) all land, regardless of cost. Acquisitions of new assets, additions, replacements and improvements (other than land) costing less than the minimum rule in addition to maintenance and repair costs, including any planned major maintenance activities, are expensed as incurred.

 

Intangible Assets

 

We evaluate the recoverability of intangible assets periodically and take into account events or circumstances that warrant revised estimates of useful lives or that indicate that impairment exists. All of our intangible assets are subject to amortization except intellectual property of $1,450,000 acquired as part of an Asset Purchase Agreement entered into with Factor Nutrition Labs LLC on January 22, 2015, $10,000 acquired as part of an Asset Purchase Agreement entered into with Perfekt Beauty Holdings LLC and CDG Holdings, LLC on June 21, 2017 and $50,000 acquired as part of an Asset Purchase Agreement entered into with Cocowhite on May 22, 2018. Intangible assets are amortized on a straight line basis over the useful lives. During the year ended December 31, 2018, the Company fully impaired intangible assets related to Perfekt and Cocowhite and charged to operations impairment loss of $60,000. As of September 30, 2019, our qualitative analysis of intangible assets with indefinite lives did not indicate any impairment.

 

Long-lived Assets

 

Long-lived assets include equipment and intangible assets other than those with indefinite lives. We assess the carrying value of our long-lived asset groups when indicators of impairment exist and recognize an impairment loss when the carrying amount of a long-lived asset is not recoverable when compared to undiscounted cash flows expected to result from the use and eventual disposition of the asset.

 

Indicators of impairment include significant underperformance relative to historical or projected future operating results, significant changes in our use of the assets or in our business strategy, loss of or changes in customer relationships and significant negative industry or economic trends. When indications of impairment arise for a particular asset or group of assets, we assess the future recoverability of the carrying value of the asset (or asset group) based on an undiscounted cash flow analysis. If carrying value exceeds projected, net, undiscounted cash flows, an additional analysis is performed to determine the fair value of the asset (or asset group), typically a discounted cash flow analysis, and an impairment charge is recorded for the excess of carrying value over fair value. However, as of December 31, 2018 our review of intangible assets related to two of our subsidiaries did indicate that the carrying amount of the asset may not be recoverable. During the year ended December 31, 2018, the Company fully impaired related intangible assets and charged to operations impairment loss of $864,067. As of September 30, 2019, our qualitative analysis of long-lived assets did not indicate any impairment.

 

Goodwill

 

An asset purchase is accounted for under the purchase method of accounting. Under that method, assets and liabilities of the business acquired are recorded at their estimated fair values as of the date of the acquisition, with any excess of the cost of the acquisition over the estimated fair value of the net tangible and intangible assets acquired recorded as goodwill. As of September 30, 2019, our qualitative analysis of goodwill did not indicate any impairment.

 

Revenue Recognition

 

The Company recognizes revenue in accordance with the Financial Accounting Standards Board’s (“FASB”), Accounting Standards Codification (“ASC”) ASC 606, Revenue from Contracts with Customers (“ASC 606”). Revenues are recognized when control is transferred to customers in amounts that reflect the consideration the Company expects to be entitled to receive in exchange for those goods. Revenue recognition is evaluated through the following five steps: (i) identification of the contract, or contracts, with a customer; (ii) identification of the performance obligations in the contract; (iii) determination of the transaction price; (iv) allocation of the transaction price to the performance obligations in the contract; and (v) recognition of revenue when or as a performance obligation is satisfied.

 

The Company recognizes revenue upon shipment from its fulfillment centers. Certain of our distributors may also perform a separate function as a co-packer on our behalf. In such cases, ownership of and title to our products that are co-packed on our behalf by those co-packers who are also distributors, passes to such distributors when we are notified by them that they have taken transfer or possession of the relevant portion of our finished goods. Freight billed to customers is presented as revenues, and the related freight costs are presented as cost of goods sold. Cancelled orders are refunded if not already dispatched, refunds are only paid if stock is damaged in transit, discounts are only offered with specific promotions and orders will be refilled if lost in transit.

 

Contract Assets

 

The Company does not have any contract assets such as work-in-process. All trade receivables on the Company’s condensed consolidated balance sheet are from contracts with customers.

 

Contract Costs

 

Costs incurred to obtain a contract are capitalized unless short term in nature. As a practical expedient, costs to obtain a contract that are short term in nature are expensed as incurred. The Company does not have any contract costs capitalized as of September 30, 2019.

 

Contract Liabilities - Deferred Revenue

 

The Company’s contract liabilities consist of advance customer payments and deferred revenue. Deferred revenue results from transactions in which the Company has been paid for products by customers, but for which all revenue recognition criteria have not yet been met. Once all revenue recognition criteria have been met, the deferred revenues are recognized.

 

Accounts receivable

 

Accounts receivable are generally unsecured. The Company establishes an allowance for doubtful accounts receivable based on the age of outstanding invoices and management’s evaluation of collectability. Accounts are written off after all reasonable collection efforts have been exhausted and management concludes that likelihood of collection is remote. Any future recoveries are applied against the allowance for doubtful accounts. As of both September 30, 2019 and December 31, 2018, allowance for doubtful accounts was $0.

 

Advertising Expense

 

The Company expenses marketing, promotions and advertising costs as incurred. Such costs are included in selling expense in the accompanying unaudited condensed consolidated statements of operations.

 

Research and Development

 

Costs incurred in connection with the development of new products and processing methods are charged to general and administrative expenses as incurred.

 

Income Taxes

 

The Company utilizes FASB ASC 740, “Income Taxes,” which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns. Under this method, deferred tax assets and liabilities are determined based on the difference between the tax basis of assets and liabilities and their financial reporting amounts based on enacted tax laws and statutory tax rates applicable to the periods in which the differences are expected to affect taxable income. A valuation allowance is recorded when it is “more likely-than-not” that a deferred tax asset will not be realized.

 

The Company generated a deferred tax asset through net operating loss carry-forward. However, a valuation allowance of 100% has been established due to the uncertainty of the Company’s realization of the net operating loss carry forward prior to its expiration.

 

NomadChoice Pty Ltd, the Company’s wholly-owned foreign subsidiary, is subject to income taxes in the jurisdictions in which it operates. Significant judgment is required in determining the provision for income tax. There are many transactions and calculations undertaken during the ordinary course of business for which the ultimate tax determination is uncertain. The company recognizes liabilities for anticipated tax audit issues based on the Company’s current understanding of the tax law. Where the final tax outcome of these matters is different from the carrying amounts, such differences will impact the current and deferred tax provisions in the period in which such determination is made.

 

Synergy CHC Inc. is a wholly-owned foreign subsidiary, is subject to income taxes in the jurisdictions in which it operates. Significant judgment is required in determining the provision for income tax. There are many transactions and calculations undertaken during the ordinary course of business for which the ultimate tax determination is uncertain. The company recognizes liabilities for anticipated tax audit issues based on the Company’s current understanding of the tax law. Where the final tax outcome of these matters is different from the carrying amounts, such differences will impact the current and deferred tax provisions in the period in which such determination is made.

 

Net Earnings (Loss) Per Common Share

 

The Company computes earnings per share under ASC subtopic 260-10, Earnings Per Share. Basic earnings (loss) per share is computed by dividing the net income (loss) attributable to the common stockholders (the numerator) by the weighted average number of shares of common stock outstanding (the denominator) during the reporting periods. Diluted earnings per share is computed by increasing the denominator by the weighted average number of additional shares that could have been outstanding from securities convertible into common stock (using the “treasury stock” method), unless their effect on net loss per share is anti-dilutive. As of September 30, 2019, and 2018, options to purchase 6,166,667 and 7,166,667 shares of common stock, respectively, were outstanding. As of September 30, 2018, warrants to purchase 1,000,000 shares of common stock were outstanding.

 

The following is a reconciliation of the number of shares used in the calculation of basic earnings per share and diluted earnings per share for the three and nine months ended September 30, 2019, and 2018:

 

    For the three months ended     For the nine months ended  
    September 30, 2019     September 30, 2018     September 30, 2019     September 30, 2018  
                         
Net income (loss) after tax   $ 107,864     $ 345,590     $ 1,893,613     $ (493,296 )
                                 
Weighted average common shares outstanding     89,889,044       89,862,683       89,881,223       89,862,683  
Incremental shares from the assumed exercise of dilutive stock options     -       -       -       -  
Incremental shares from the assumed exercise of dilutive stock warrants     -       -       -       -  
Dilutive potential common shares     89,889,044       89,862,683       89,881,223       89,862,683  
                                 
Net earnings (loss) per share:                                
Basic   $ 0.00     $ 0.00     $ 0.02     $ (0.01 )
Diluted   $ 0.00     $ 0.00     $ 0.02     $ (0.01 )

 

The following securities were not included in the computation of diluted net earnings per share as their effect would have been antidilutive:

 

    2019     2018  
             
Options to purchase common stock     6,166,667       7,166,667  
Warrants to purchase common stock     -       1,000,000  
      6,166,667       8,166,667  

 

Fair Value Measurements

 

The Company measures and discloses the fair value of assets and liabilities required to be carried at fair value in accordance with ASC 820, Fair Value Measurements and Disclosures. ASC 820 defines fair value, establishes a framework for measuring fair value, and enhances fair value measurement disclosure.

 

ASC 825 defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required or permitted to be recorded at fair value, the Company considers the principal or most advantageous market in which it would transact and considers assumptions that market participants would use when pricing the asset or liability, such as inherent risk, transfer restrictions, and risk of nonperformance. ASC 825 establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 825 establishes three levels of inputs that may be used to measure fair value:

 

Level 1 - Quoted prices for identical assets or liabilities in active markets to which we have access at the measurement date.

 

Level 2 - Inputs other than quoted prices within Level 1 that are observable for the asset or liability, either directly or indirectly.

 

Level 3 - Unobservable inputs for the asset or liability.

 

The determination of where assets and liabilities fall within this hierarchy is based upon the lowest level of input that is significant to the fair value measurement.

 

As of September 30, 2019, the Company has determined that there were no assets or liabilities measured at fair value.

 

Inventory

 

Inventory consists of raw materials, components and finished goods. The Company’s inventory is stated at the lower of cost (FIFO cost basis) or net realizable value. Finished goods include the cost of labor to assemble the items.

 

Stock-Based Compensation

 

ASC 718, “Compensation – Stock Compensation,” prescribes accounting and reporting standards for all share-based payment transactions in which employee services are acquired. Transactions include incurring liabilities, or issuing or offering to issue shares, options, and other equity instruments such as employee stock ownership plans and stock appreciation rights. Share-based payments to employees, including grants of employee stock options, are recognized as compensation expense in the financial statements based on their fair values. That expense is recognized over the period during which an employee is required to provide services in exchange for the award, known as the requisite service period (usually the vesting period).

 

The Company accounts for stock-based compensation issued to non-employees and consultants in accordance with the provisions of ASC 505-50, “Equity – Based Payments to Non-Employees.” Measurement of share-based payment transactions with non-employees is based on the fair value of whichever is more reliably measurable: (a) the goods or services received; or (b) the equity instruments issued. The fair value of the share-based payment transaction is determined at the earlier of performance commitment date or performance completion date.

 

Foreign Currency Translation

 

The functional currency of one of the Company’s foreign subsidiaries (Nomadchoice Pty Ltd.) is the U.S. Dollar. The Company’s foreign subsidiary maintains its records using local currency (Australian Dollar). All monetary assets and liabilities of the foreign subsidiary were translated into U.S. Dollars at quarter end exchange rates, non-monetary assets and liabilities of the foreign subsidiary were translated into U.S. Dollars at transaction day exchange rates. Income and expense items related to non-monetary items were translated at exchange rates prevailing during the transaction date and other incomes and expenses were translated using average exchange rate for the period. The resulting translation adjustments, net of income taxes, were recorded in statements of operations as Remeasurement gain or loss on translation of foreign subsidiary.

 

The functional currency of the Company’s other foreign subsidiary (Synergy CHC Inc.) is the Canadian Dollar (CAD). The Company’s foreign subsidiary maintains its records using local currency (CAD). All assets and liabilities of the foreign subsidiary were translated into U.S. Dollars at period end exchange rates and stockholders’ equity is translated at the historical rates. Income and expense items were translated using average exchange rate for the period. The resulting translation adjustments, net of income taxes, are reported as other comprehensive income and accumulated other comprehensive income in the stockholder’s equity in accordance with ASC 220 – Comprehensive Income.

 

The exchange rates used to translate amounts in AUD and CAD into USD for the purposes of preparing the consolidated financial statements were as follows:

 

Balance sheet:

 

    September 30, 2019     December 31, 2018  
Period-end AUD: USD exchange rate   $ 0.6746     $ 0.7046  
Period-end CAD: USD exchange rate   $ 0.7551     $ 0.7330  

 

Income statement:

 

    September 30, 2019     September 30, 2018  
Average Quarterly AUD: USD exchange rate   $ 0.6994     $ 0.7579  
Average Quarterly CAD: USD exchange rate   $ 0.7524     $ 0.7768  

 

Translation gains and losses that arise from exchange rate fluctuations from transactions denominated in a currency other than the functional currency are translated into either Australian Dollars or Canadian Dollars, as the case may be, at the rate on the date of the transaction and included in the results of operations as incurred.

 

Concentrations of Credit Risk

 

In the normal course of business, the Company provides credit terms to its customers; however, collateral is not required. Accordingly, the Company performs credit evaluations of its customers and maintains allowances for possible losses which, when realized, were within the range of management’s expectations. From time to time, a higher concentration of credit risk exists on outstanding accounts receivable for a select number of customers due to individual buying patterns.

 

Warehousing costs

 

Warehouse costs include all third party warehouse rent fees and are charged to selling and marketing expenses as incurred. Any additional costs relating to assembly or special pack-outs of the Company’s products are charged to cost of sales.

 

Product display costs

 

All displays manufactured and purchased by the Company are for placement of product in retail stores. This also includes all costs for display execution and setup and retail services are charged to cost of sales and expensed as incurred.

 

Cost of Sales

 

Cost of sales includes the purchase cost of products sold and all costs associated with getting the products into the retail stores including buying and transportation costs.

 

Debt Issuance Costs

 

Debt issuance costs consist primarily of arrangement fees, professional fees and legal fees. These costs are netted off with the related loan and are being amortized to interest expense over the term of the related debt facilities.

 

Shipping Costs

 

Shipping and handling costs billed to customers are recorded in sales. Shipping costs incurred by the company are recorded in selling and marketing expenses.

 

Related parties

 

Parties are considered to be related to the Company if the parties, directly or indirectly, through one or more intermediaries, control, are controlled by, or are under common control with the Company. Related parties also include principal owners of the Company, its management, members of the immediate families of principal owners of the Company and its management and other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests. All transactions with related parties are recorded at fair value of the goods or services exchanged.

 

Segment Reporting

 

Segment identification and selection is consistent with the management structure used by the Company’s chief operating decision maker to evaluate performance and make decisions regarding resource allocation, as well as the materiality of financial results consistent with that structure. Based on the Company’s management structure and method of internal reporting, the Company has one operating segment. The Company’s chief operating decision maker does not review operating results on a disaggregated basis; rather, the chief operating decision maker reviews operating results on an aggregate basis.

 

Presentation of Financial Statements – Going Concern

 

Going Concern Evaluation

 

In connection with preparing unaudited condensed consolidated financial statements for the three and nine months ended September 30, 2019, management evaluated whether there were conditions and events, considered in the aggregate, that raised substantial doubt about the Company’s ability to continue as a going concern within one year from the date that the financial statements are issued.

 

The Company considered the following:

 

● At September 30, 2019, the Company had an accumulated deficit of $13,133,509.

● At September 30, 2019, the Company had working capital deficit of $3,980,990.

● Revenue decline in 2019 as compared to 2018 of $5,449,728.

 

Ordinarily, conditions or events that raise substantial doubt about an entity’s ability to continue as a going concern relate to the entity’s ability to meet its obligations as they become due.

 

The Company evaluated its ability to meet its obligations as they become due within one year from the date that the financial statements are issued by considering the following:

 

● The Company raised $10.0 million via debt financing during the year ended December 31, 2017.

● In 2019, the Company repaid $1,537,500 of loans.

● The Company generated net income of $107,864 for the three months ended September 30, 2019 and $1,893,613 for the nine months ended September 30, 2019.

● In 2019, the Company has generated $2,529,885 of cash from operating activities.

● Working capital deficit of $3,980,990 at September 30, 2019, includes loans payable to related party of $5,937,576, payables to related party of $370,939 and deferred revenue of $9,947.

● The Company has line of credit facility of $20 million available from its current lender for future mergers and acquisition.

 

Management concluded that above factors alleviate doubts about the Company’s ability to generate enough cash from operations and other available sources to satisfy its obligations for the next twelve months from the issuance date.

 

The Company will take the following actions if it starts to trend unfavorably to its internal profitability and cash flow projections, in order to mitigate conditions or events that would raise substantial doubt about its ability to continue as a going concern:

 

● Raise additional capital through line of credit and/or loan financing for future mergers and acquisition.

● Implement additional restructuring and cost reductions.

● Raise additional capital through a private placement.

 

As of November 14, 2019 and September 30, 2019, the Company had $684,916 and $1,489,311, respectively, in cash and cash equivalents.

 

Recent Accounting Pronouncements

 

ASU 2018-13

 

In August 2018, the FASB issued ASU 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework – Changes in Disclosure Requirements for Fair Value Measurement, which removes, modifies and adds certain disclosure requirements in Topic 820 “Fair Value Measurement”. ASU 2018-13 is effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. Early adoption is permitted. The adoption of ASU 2018-13 is not expected to have any impact on the Company’s unaudited condensed consolidated financial statements.

 

ASU 2018-07

 

In June 2018, the FASB issued ASU 2018-07, Compensation – Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting, which simplifies the accounting for share-based payments to nonemployees by aligning it with the accounting for share-based payments to employees, with certain exceptions. ASU 2018-07 is effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. Early adoption is permitted. The adoption of ASU 2018-07 did not have any impact on the Company’s unaudited condensed consolidated financial statements.

 

ASU 2018-05

 

This Accounting Standards Update adds SEC paragraphs pursuant to the SEC Staff Accounting Bulletin No. 118, which expresses the view of the staff regarding application of Topic 740, Income Taxes, in the reporting period that includes December 22, 2017 - the date on which the Tax Cuts and Jobs Act (H.R.1, An Act to Provide for Reconciliation Pursuant to Titles II and V of the Concurrent Resolution on the Budget for Fiscal Year 2018) was signed into law. We are currently evaluating the impact of adopting ASU 2017-13 on our consolidated financial statements.

 

ASU 2018-02

 

On December 22, 2017, the U.S. federal government enacted a tax bill, H.R.1, An Act to Provide for Reconciliation Pursuant to Titles II and V of the Concurrent Resolution on the Budget for Fiscal Year 2018 (Tax Cuts and Jobs Act of 2017). Stakeholders raised a narrow-scope financial reporting issue that arose as a consequence of the Tax Cuts and Jobs Act of 2017. The amendments in this Update allow a reclassification from accumulated other comprehensive income to retained earnings for stranded tax effects resulting from the Tax Cuts and Jobs Act of 2017. The amendments in this Update affect any entity that is required to apply the provisions of Topic 220, Income Statement-Reporting Comprehensive Income, and has items of other comprehensive income for which the related tax effects are presented in other comprehensive income as required by GAAP. The amendments in this update is effective for all entities for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. Early adoption of the amendments in this Update is permitted, including adoption in any interim period, (1) for public business entities for reporting periods for which financial statements have not yet been issued and (2) for all other entities for reporting periods for which financial statements have not yet been made available for issuance. The amendments in this Update should be applied either in the period of adoption or retrospectively to each period (or periods) in which the effect of the change in the U.S. federal corporate income tax rate in the Tax Cuts and Jobs Act is recognized.

 

This Accounting Standards Update is the final version of Proposed Accounting Standards Update 2018-210—Income Statement—Reporting Comprehensive Income (Topic 220), which has been deleted. We are currently evaluating the impact of adopting ASU 2017-13 on our consolidated financial statements.

 

ASU 2018-01

 

The amendments in this Update provide an optional transition practical expedient to not evaluate under Topic 842 existing or expired land easements that were not previously accounted for as leases under Topic 840, Leases. An entity that elects this practical expedient should evaluate new or modified land easements under Topic 842 beginning at the date that the entity adopts Topic 842. An entity that does not elect this practical expedient should evaluate all existing or expired land easements in connection with the adoption of the new lease requirements in Topic 842 to assess whether they meet the definition of a lease. We are currently evaluating the impact of adopting ASU 2017-13 on our consolidated financial statements.
XML 45 R4.htm IDEA: XBRL DOCUMENT v3.19.3
Condensed Consolidated Statements of Operations and Comprehensive (Loss) Income (Unaudited) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Income Statement [Abstract]        
Revenue $ 7,364,546 $ 9,190,377 $ 23,170,222 $ 28,619,950
Cost of sales 2,490,444 2,945,389 6,638,481 8,500,057
Gross profit 4,874,102 6,244,988 16,531,741 20,119,893
Operating expenses        
Selling and marketing 2,771,884 3,960,131 8,731,129 13,361,490
General and administrative 1,437,624 1,189,681 3,997,437 4,425,826
Depreciation and amortization 301,388 455,579 911,259 1,363,016
Total operating expenses 4,510,896 5,605,391 13,639,825 19,150,332
Income from operations 363,206 639,597 2,891,916 969,561
Other (income) expenses        
Interest income (105) (50) (329) (121)
Interest expense 180,759 288,479 805,172 864,342
Other income (27,674) (27,674)
Remeasurement loss on translation of foreign subsidiary 101,289 66,353 112,551 197,674
Amortization of debt issuance cost 30,820 93,089 103,782 171,824
Total other expenses 312,763 420,197 1,021,176 1,206,045
Net income (loss) before income taxes 50,443 219,400 1,870,740 (236,484)
Income tax (benefit) expense (57,421) (126,190) (22,873) 256,812
Net income (loss) after tax $ 107,864 $ 345,590 $ 1,893,613 $ (493,296)
Net income (loss) per share - basic $ 0.00 $ 0.00 $ 0.02 $ (0.01)
Net income (loss) per share - diluted $ 0.00 $ 0.00 $ 0.02 $ (0.01)
Weighted average common shares outstanding        
Basic 89,889,044 89,862,683 89,881,223 89,862,683
Diluted 89,889,044 89,862,683 89,881,223 89,862,683
Comprehensive (loss) income:        
Net income (loss) $ 107,864 $ 345,590 $ 1,893,613 $ (493,296)
Foreign currency translation adjustment 47,011 (17,578) (98,990) 85,826
Comprehensive income (loss) $ 154,875 $ 328,012 $ 1,794,623 $ (407,470)
XML 46 R47.htm IDEA: XBRL DOCUMENT v3.19.3
Notes Payable - Schedule of Loans Payable (Details) - USD ($)
Sep. 30, 2019
Dec. 31, 2018
Debt Disclosure [Abstract]    
Loans payable $ 6,263,545 $ 7,772,150
Unamortized debt issuance cost (75,478) (179,261)
Total 6,188,067 7,592,889
Less: Current portion (5,937,576) (1,963,887)
Long-term portion $ 250,491 $ 5,629,002
XML 47 R43.htm IDEA: XBRL DOCUMENT v3.19.3
Fixed Assets and Intangible Assets - Summary of Fixed and Intangible Assets (Details) - USD ($)
Sep. 30, 2019
Dec. 31, 2018
Property and equipment $ 566,445 $ 566,445
Less accumulated depreciation (400,163) (296,674)
Fixed assets, net 166,282 269,771
Intangible assets subject to amortization 5,388,230 7,150,165
Less accumulated amortization (4,638,479) (4,728,576)
Less accumulated impairment (924,068)
Intangible assets, net 2,199,751 3,007,521
Focus Factor [Member]    
Intellectual property 1,450,000 1,450,000
Perfekt [Member]    
Intellectual property 10,000
Cocowhite [Member]    
Intellectual property $ 50,000
XML 48 R22.htm IDEA: XBRL DOCUMENT v3.19.3
Subsequent Events
 9 Months Ended
Sep. 30, 2019
Subsequent Events [Abstract]  
Subsequent Events

Note 16 – Subsequent Events

 

Management evaluated all activities of the Company through the issuance date of the Company’s unaudited condensed consolidated financial statements and concluded that no subsequent events have occurred that would require adjustments or disclosure into the unaudited condensed consolidated financial statements.
XML 49 R26.htm IDEA: XBRL DOCUMENT v3.19.3
Accounts Receivable (Tables)
 9 Months Ended
Sep. 30, 2019
Receivables [Abstract]  
Accounts Receivable, Net of Allowances for Sales Returns and Doubtful Accounts

Accounts receivable, net of allowances for sales returns and doubtful accounts, consisted of the following:

 

    September 30, 2019     December 31, 2018  
Trade accounts receivable   $ 1,902,130     $ 4,458,225  
Less allowances     -       -  
Total accounts receivable, net   $ 1,902,130     $ 4,458,225  
XML 50 R37.htm IDEA: XBRL DOCUMENT v3.19.3
Summary of Significant Accounting Policies - Schedule of Foreign Currencies Translation Exchange Rate (Details)
Sep. 30, 2019
Dec. 31, 2018
Sep. 30, 2018
Period-End AUD: USD Exchange Rate [Member]      
Foreign currency translation exchange rate 0.6746 0.7046  
Period-End CAD: USD Exchange Rate [Member]      
Foreign currency translation exchange rate 0.7551 0.7330  
Average Quarterly AUD: USD Exchange Rate [Member]      
Foreign currency translation exchange rate 0.6994   0.7579
Average Quarterly CAD: USD Exchange Rate [Member]      
Foreign currency translation exchange rate 0.7524   0.7768
XML 51 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 52 R33.htm IDEA: XBRL DOCUMENT v3.19.3
Summary of Significant Accounting Policies (Details Narrative)
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2019
USD ($)
Jun. 30, 2019
USD ($)
Mar. 31, 2019
USD ($)
Sep. 30, 2018
USD ($)
shares
Jun. 30, 2018
USD ($)
Mar. 31, 2018
USD ($)
Sep. 30, 2019
USD ($)
Segment
shares
Sep. 30, 2018
USD ($)
shares
Dec. 31, 2018
USD ($)
Nov. 14, 2019
USD ($)
May 22, 2018
USD ($)
Dec. 31, 2017
USD ($)
Jun. 21, 2017
USD ($)
Jan. 22, 2015
USD ($)
Cash equivalents                        
Cash federally insured limit per bank 250,000           250,000              
Cash uninsured amount 981,699           981,699   $ 162,729          
Intangible assets and charged to operations impairment loss                 60,000          
Goodwill and charged to operations impairment loss                 864,067          
Allowance for doubtful accounts 0           $ 0   0          
Percentage of valuation allowance             100.00%              
Anti-dilutive securities | shares             6,166,667 8,166,667            
Warrant to purchase common stock | shares       1,000,000       1,000,000            
Number of operating segment | Segment             1              
Accumulated deficit (13,133,509)           $ (13,133,509)   (15,027,122)          
Working capital deficit (3,980,990)           (3,980,990)              
Revenue decline             5,449,728              
Debt financing                       $ 10,000,000    
Repayment of loans payable             1,537,500              
Net income loss 107,864 $ 318,462 $ 1,467,287 $ 345,590 $ (783,393) $ (55,493) 1,893,613 $ (493,296)            
Cash from operating activities             2,529,885 2,043,765            
Due to related party 370,939           370,939              
Deferred revenue                 9,947          
Available line of credit 20,000,000           20,000,000              
Cash and cash equivalents 1,389,311     $ 1,605,381     1,389,311 $ 1,605,381 $ 459,736          
Subsequent Event [Member]                            
Cash and cash equivalents                   $ 684,916        
Loans Payable [Member]                            
Due to related party $ 5,937,576           $ 5,937,576              
Options to Purchase of Common Stock [Member]                            
Anti-dilutive securities | shares             6,166,667 7,166,667            
Factor Nutrition Labs LLC [Member]                            
Value of intellectual property acquired                           $ 1,450,000
Perfekt Beauty Holdings LLC [Member]                            
Value of intellectual property acquired                         $ 10,000  
CDG Holdings, LLC [Member]                            
Value of intellectual property acquired                         $ 10,000  
Cocowhite [Member]                            
Value of intellectual property acquired                     $ 50,000      
XML 53 FilingSummary.xml IDEA: XBRL DOCUMENT 3.19.3 html 231 384 1 false 80 0 false 7 false false R1.htm 00000001 - Document - Document and Entity Information Sheet http://synergystripscorp.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00000002 - Statement - Condensed Consolidated Balance Sheets Sheet http://synergystripscorp.com/role/BalanceSheets Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://synergystripscorp.com/role/BalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Condensed Consolidated Statements of Operations and Comprehensive (Loss) Income (Unaudited) Sheet http://synergystripscorp.com/role/StatementsOfOperationsAndComprehensiveLossIncome Condensed Consolidated Statements of Operations and Comprehensive (Loss) Income (Unaudited) Statements 4 false false R5.htm 00000005 - Statement - Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) Sheet http://synergystripscorp.com/role/StatementsOfChangesInStockholdersEquity Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) Statements 5 false false R6.htm 00000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://synergystripscorp.com/role/StatementsOfCashFlows Condensed Consolidated Statements of Cash Flows (Unaudited) Statements 6 false false R7.htm 00000007 - Disclosure - Nature of the Business Sheet http://synergystripscorp.com/role/NatureOfBusiness Nature of the Business Notes 7 false false R8.htm 00000008 - Disclosure - Summary of Significant Accounting Policies Sheet http://synergystripscorp.com/role/SummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 8 false false R9.htm 00000009 - Disclosure - Inventory Sheet http://synergystripscorp.com/role/Inventory Inventory Notes 9 false false R10.htm 00000010 - Disclosure - Accounts Receivable Sheet http://synergystripscorp.com/role/AccountsReceivable Accounts Receivable Notes 10 false false R11.htm 00000011 - Disclosure - Prepaid Expenses and Other Current Assets Sheet http://synergystripscorp.com/role/PrepaidExpensesAndOtherCurrentAssets Prepaid Expenses and Other Current Assets Notes 11 false false R12.htm 00000012 - Disclosure - Concentration of Credit Risk Sheet http://synergystripscorp.com/role/ConcentrationOfCreditRisk Concentration of Credit Risk Notes 12 false false R13.htm 00000013 - Disclosure - Fixed Assets and Intangible Assets Sheet http://synergystripscorp.com/role/FixedAssetsAndIntangibleAssets Fixed Assets and Intangible Assets Notes 13 false false R14.htm 00000014 - Disclosure - Related Party Transactions Sheet http://synergystripscorp.com/role/RelatedPartyTransactions Related Party Transactions Notes 14 false false R15.htm 00000015 - Disclosure - Accounts Payable and Accrued Liabilities Sheet http://synergystripscorp.com/role/AccountsPayableAndAccruedLiabilities Accounts Payable and Accrued Liabilities Notes 15 false false R16.htm 00000016 - Disclosure - Notes Payable Notes http://synergystripscorp.com/role/NotesPayable Notes Payable Notes 16 false false R17.htm 00000017 - Disclosure - Stockholders' Equity Sheet http://synergystripscorp.com/role/StockholdersEquity Stockholders' Equity Notes 17 false false R18.htm 00000018 - Disclosure - Commitments & Contingencies Sheet http://synergystripscorp.com/role/CommitmentsContingencies Commitments & Contingencies Notes 18 false false R19.htm 00000019 - Disclosure - Stock Options Sheet http://synergystripscorp.com/role/StockOptions Stock Options Notes 19 false false R20.htm 00000020 - Disclosure - Segments Sheet http://synergystripscorp.com/role/Segments Segments Notes 20 false false R21.htm 00000021 - Disclosure - Income Taxes Sheet http://synergystripscorp.com/role/IncomeTaxes Income Taxes Notes 21 false false R22.htm 00000022 - Disclosure - Subsequent Events Sheet http://synergystripscorp.com/role/SubsequentEvents Subsequent Events Notes 22 false false R23.htm 00000023 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://synergystripscorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://synergystripscorp.com/role/SummaryOfSignificantAccountingPolicies 23 false false R24.htm 00000024 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://synergystripscorp.com/role/SummaryOfSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://synergystripscorp.com/role/SummaryOfSignificantAccountingPolicies 24 false false R25.htm 00000025 - Disclosure - Inventory (Tables) Sheet http://synergystripscorp.com/role/InventoryTables Inventory (Tables) Tables http://synergystripscorp.com/role/Inventory 25 false false R26.htm 00000026 - Disclosure - Accounts Receivable (Tables) Sheet http://synergystripscorp.com/role/AccountsReceivableTables Accounts Receivable (Tables) Tables http://synergystripscorp.com/role/AccountsReceivable 26 false false R27.htm 00000027 - Disclosure - Prepaid Expenses and Other Current Assets (Tables) Sheet http://synergystripscorp.com/role/PrepaidExpensesAndOtherCurrentAssetsTables Prepaid Expenses and Other Current Assets (Tables) Tables http://synergystripscorp.com/role/PrepaidExpensesAndOtherCurrentAssets 27 false false R28.htm 00000028 - Disclosure - Fixed Assets and Intangible Assets (Tables) Sheet http://synergystripscorp.com/role/FixedAssetsAndIntangibleAssetsTables Fixed Assets and Intangible Assets (Tables) Tables http://synergystripscorp.com/role/FixedAssetsAndIntangibleAssets 28 false false R29.htm 00000029 - Disclosure - Accounts Payable and Accrued Liabilities (Tables) Sheet http://synergystripscorp.com/role/AccountsPayableAndAccruedLiabilitiesTables Accounts Payable and Accrued Liabilities (Tables) Tables http://synergystripscorp.com/role/AccountsPayableAndAccruedLiabilities 29 false false R30.htm 00000030 - Disclosure - Notes Payable (Tables) Notes http://synergystripscorp.com/role/NotesPayableTables Notes Payable (Tables) Tables http://synergystripscorp.com/role/NotesPayable 30 false false R31.htm 00000031 - Disclosure - Stock Options (Tables) Sheet http://synergystripscorp.com/role/StockOptionsTables Stock Options (Tables) Tables http://synergystripscorp.com/role/StockOptions 31 false false R32.htm 00000032 - Disclosure - Segments (Tables) Sheet http://synergystripscorp.com/role/SegmentsTables Segments (Tables) Tables http://synergystripscorp.com/role/Segments 32 false false R33.htm 00000033 - Disclosure - Summary of Significant Accounting Policies (Details Narrative) Sheet http://synergystripscorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative Summary of Significant Accounting Policies (Details Narrative) Details http://synergystripscorp.com/role/SummaryOfSignificantAccountingPoliciesTables 33 false false R34.htm 00000034 - Disclosure - Summary of Significant Accounting Policies - Schedule of Cash, Cash Equivalents, and Restricted Cash (Details) Sheet http://synergystripscorp.com/role/SummaryOfSignificantAccountingPolicies-ScheduleOfCashCashEquivalentsAndRestrictedCashDetails Summary of Significant Accounting Policies - Schedule of Cash, Cash Equivalents, and Restricted Cash (Details) Details 34 false false R35.htm 00000035 - Disclosure - Summary of Significant Accounting Policies - Schedule of Number of Shares Used in Calculation of Earnings Per Share Basic and Diluted (Details) Sheet http://synergystripscorp.com/role/SummaryOfSignificantAccountingPolicies-ScheduleOfNumberOfSharesUsedInCalculationOfEarningsPerShareBasicAndDilutedDetails Summary of Significant Accounting Policies - Schedule of Number of Shares Used in Calculation of Earnings Per Share Basic and Diluted (Details) Details 35 false false R36.htm 00000036 - Disclosure - Summary of Significant Accounting Policies - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) Sheet http://synergystripscorp.com/role/SummaryOfSignificantAccountingPolicies-ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails Summary of Significant Accounting Policies - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) Details 36 false false R37.htm 00000037 - Disclosure - Summary of Significant Accounting Policies - Schedule of Foreign Currencies Translation Exchange Rate (Details) Sheet http://synergystripscorp.com/role/SummaryOfSignificantAccountingPolicies-ScheduleOfForeignCurrenciesTranslationExchangeRateDetails Summary of Significant Accounting Policies - Schedule of Foreign Currencies Translation Exchange Rate (Details) Details 37 false false R38.htm 00000038 - Disclosure - Inventory - Schedule of Carrying Value of Inventory (Details) Sheet http://synergystripscorp.com/role/Inventory-ScheduleOfCarryingValueOfInventoryDetails Inventory - Schedule of Carrying Value of Inventory (Details) Details 38 false false R39.htm 00000039 - Disclosure - Accounts Receivable - Accounts Receivable, Net of Allowances for Sales Returns and Doubtful Accounts (Details) Sheet http://synergystripscorp.com/role/AccountsReceivable-AccountsReceivableNetOfAllowancesForSalesReturnsAndDoubtfulAccountsDetails Accounts Receivable - Accounts Receivable, Net of Allowances for Sales Returns and Doubtful Accounts (Details) Details 39 false false R40.htm 00000040 - Disclosure - Prepaid Expenses and Other Current Assets - Schedule of Prepaid Expenses and Other Current Assets (Details) Sheet http://synergystripscorp.com/role/PrepaidExpensesAndOtherCurrentAssets-ScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails Prepaid Expenses and Other Current Assets - Schedule of Prepaid Expenses and Other Current Assets (Details) Details 40 false false R41.htm 00000041 - Disclosure - Concentration of Credit Risk (Details Narrative) Sheet http://synergystripscorp.com/role/ConcentrationOfCreditRiskDetailsNarrative Concentration of Credit Risk (Details Narrative) Details http://synergystripscorp.com/role/ConcentrationOfCreditRisk 41 false false R42.htm 00000042 - Disclosure - Fixed Assets and Intangible Assets (Details Narrative) Sheet http://synergystripscorp.com/role/FixedAssetsAndIntangibleAssetsDetailsNarrative Fixed Assets and Intangible Assets (Details Narrative) Details http://synergystripscorp.com/role/FixedAssetsAndIntangibleAssetsTables 42 false false R43.htm 00000043 - Disclosure - Fixed Assets and Intangible Assets - Summary of Fixed and Intangible Assets (Details) Sheet http://synergystripscorp.com/role/FixedAssetsAndIntangibleAssets-SummaryOfFixedAndIntangibleAssetsDetails Fixed Assets and Intangible Assets - Summary of Fixed and Intangible Assets (Details) Details 43 false false R44.htm 00000044 - Disclosure - Related Party Transactions (Details Narrative) Sheet http://synergystripscorp.com/role/RelatedPartyTransactionsDetailsNarrative Related Party Transactions (Details Narrative) Details http://synergystripscorp.com/role/RelatedPartyTransactions 44 false false R45.htm 00000045 - Disclosure - Accounts Payable and Accrued Liabilities - Schedule of Accounts Payable and Accrued Liabilities (Details) Sheet http://synergystripscorp.com/role/AccountsPayableAndAccruedLiabilities-ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails Accounts Payable and Accrued Liabilities - Schedule of Accounts Payable and Accrued Liabilities (Details) Details 45 false false R46.htm 00000046 - Disclosure - Notes Payable (Details Narrative) Notes http://synergystripscorp.com/role/NotesPayableDetailsNarrative Notes Payable (Details Narrative) Details http://synergystripscorp.com/role/NotesPayableTables 46 false false R47.htm 00000047 - Disclosure - Notes Payable - Schedule of Loans Payable (Details) Notes http://synergystripscorp.com/role/NotesPayable-ScheduleOfLoansPayableDetails Notes Payable - Schedule of Loans Payable (Details) Details 47 false false R48.htm 00000048 - Disclosure - Stockholders' Equity (Details Narrative) Sheet http://synergystripscorp.com/role/StockholdersEquityDetailsNarrative Stockholders' Equity (Details Narrative) Details http://synergystripscorp.com/role/StockholdersEquity 48 false false R49.htm 00000049 - Disclosure - Commitments & Contingencies (Details Narrative) Sheet http://synergystripscorp.com/role/CommitmentsContingenciesDetailsNarrative Commitments & Contingencies (Details Narrative) Details http://synergystripscorp.com/role/CommitmentsContingencies 49 false false R50.htm 00000050 - Disclosure - Stock Options (Details Narrative) Sheet http://synergystripscorp.com/role/StockOptionsDetailsNarrative Stock Options (Details Narrative) Details http://synergystripscorp.com/role/StockOptionsTables 50 false false R51.htm 00000051 - Disclosure - Stock Options - Summary of Options Outstanding by Price Range (Details) Sheet http://synergystripscorp.com/role/StockOptions-SummaryOfOptionsOutstandingByPriceRangeDetails Stock Options - Summary of Options Outstanding by Price Range (Details) Details 51 false false R52.htm 00000052 - Disclosure - Stock Options - Schedule of Stock Options Activity (Details) Sheet http://synergystripscorp.com/role/StockOptions-ScheduleOfStockOptionsActivityDetails Stock Options - Schedule of Stock Options Activity (Details) Details 52 false false R53.htm 00000053 - Disclosure - Segments (Details Narrative) Sheet http://synergystripscorp.com/role/SegmentsDetailsNarrative Segments (Details Narrative) Details http://synergystripscorp.com/role/SegmentsTables 53 false false R54.htm 00000054 - Disclosure - Segments - Summary of Net Sales Attributed to Customers Geographical Segment (Details) Sheet http://synergystripscorp.com/role/Segments-SummaryOfNetSalesAttributedToCustomersGeographicalSegmentDetails Segments - Summary of Net Sales Attributed to Customers Geographical Segment (Details) Details 54 false false R55.htm 00000055 - Disclosure - Segments - Summary of Net Sales Attributed to Customers Product Group (Details) Sheet http://synergystripscorp.com/role/Segments-SummaryOfNetSalesAttributedToCustomersProductGroupDetails Segments - Summary of Net Sales Attributed to Customers Product Group (Details) Details 55 false false R56.htm 00000056 - Disclosure - Segments - Summary of Net Sales Attributed to Major Sales Channel (Details) Sheet http://synergystripscorp.com/role/Segments-SummaryOfNetSalesAttributedToMajorSalesChannelDetails Segments - Summary of Net Sales Attributed to Major Sales Channel (Details) Details 56 false false R57.htm 00000057 - Disclosure - Segments - Summary of Long-lived Assets (Net) Attributable to Operations Geographical Segment (Details) Sheet http://synergystripscorp.com/role/Segments-SummaryOfLong-livedAssetsNetAttributableToOperationsGeographicalSegmentDetails Segments - Summary of Long-lived Assets (Net) Attributable to Operations Geographical Segment (Details) Details 57 false false R58.htm 00000058 - Disclosure - Income Taxes (Details Narrative) Sheet http://synergystripscorp.com/role/IncomeTaxesDetailsNarrative Income Taxes (Details Narrative) Details http://synergystripscorp.com/role/IncomeTaxes 58 false false All Reports Book All Reports snyr-20190930.xml snyr-20190930.xsd snyr-20190930_cal.xml snyr-20190930_def.xml snyr-20190930_lab.xml snyr-20190930_pre.xml http://xbrl.sec.gov/dei/2019-01-31 http://fasb.org/us-gaap/2019-01-31 http://xbrl.sec.gov/country/2017-01-31 http://fasb.org/srt/2019-01-31 true true XML 54 R10.htm IDEA: XBRL DOCUMENT v3.19.3
Accounts Receivable
 9 Months Ended
Sep. 30, 2019
Receivables [Abstract]  
Accounts Receivable

Note 4 – Accounts Receivable

 

Accounts receivable, net of allowances for sales returns and doubtful accounts, consisted of the following:

 

    September 30, 2019     December 31, 2018  
Trade accounts receivable   $ 1,902,130     $ 4,458,225  
Less allowances     -       -  
Total accounts receivable, net   $ 1,902,130     $ 4,458,225  
XML 55 R14.htm IDEA: XBRL DOCUMENT v3.19.3
Related Party Transactions
 9 Months Ended
Sep. 30, 2019
Related Party Transactions [Abstract]  
Related Party Transactions

Note 8 – Related Party Transactions

 

The Company accrued and paid consulting fees of $57,917 per month and management fees of $129,478 to a company owned by Mr. Jack Ross, Chief Executive Officer of the Company. The Company expensed $226,515 during the three months ended September 30, 2019 and $650,728 during the nine months ended September 30, 2019. As of September 30, 2019, the total outstanding balance was $0 for consulting fees and reimbursements.

 

On June 26, 2015, the Company entered into a Security Agreement with Knight Therapeutics, Inc., through its wholly owned subsidiary Neuragen Corp., for the purchase of Knight Therapeutics, Inc.’s assets. At September 30, 2019, the Company owed Knight $487,500 in relation to this agreement (see Note 10). The Company recorded present value of future payments of $263,546 and $272,151 as of September 30, 2019 and December 31, 2018, respectively.

 

On August 18, 2015, the Company entered into a Consulting Agreement with Kara Harshbarger, the co-founder of Hand MD, LLC, pursuant to which she will provide marketing and sales related service. The Company pays Ms. Harshbarger $10,000 a month for one year unless the Consulting Agreement is terminated earlier by either party. The Company has extended this agreement on a month to month basis. Hand MD, LLC is a 50% owner in Hand MD Corp. The Company expensed $30,000 through payroll for the three months ended September 30, 2019 and $90,000 for the nine months ended September 30, 2019. As of September 30, 2019, the total outstanding balance was $0.

  

On August 9, 2017, the Company entered into a Loan Agreement with Knight Therapeutics (Barbados) Inc., a related party, for a working capital loan. At September 30, 2019, the Company owed Knight $5,924,522 on this loan, net of debt issuance cost (see Note 10).

 

On December 23, 2016, we entered into an agreement with Knight Therapeutics for the distribution rights of FOCUSFactor in Canada. In conjunction with this agreement, we are required to pay Knight a distribution fee equal to 30% of gross sales for sales achieved through a direct sales channel and 5% of gross sales for sales achieved through retail sales. The minimum due to Knight under this agreement is $100,000 Canadian dollars. As of September 30, 2019, the total outstanding balance was $200,000 Canadian dollars (approximately $152,834 USD).

 

On December 23, 2016, we entered into an agreement with Knight Therapeutics for the distribution rights of Hand MD into Canada. In conjunction with this agreement, we are required to pay Knight a distribution fee equal to 60% of gross sales for sales achieved through a direct sales channel until the sales in the calendar year equal the threshold amount and then 40% of all such gross sales in such calendar year in excess of the threshold amount and 5% of gross sales for sales achieved through retail sales. The minimum due to Knight under this agreement is $25,000 Canadian dollars. As of September 30, 2019, the total outstanding balance was $25,000 Canadian dollars (approximately $18,325 USD).

 

The Company expensed royalty of $36,082 during the three months ended September 30, 2019 and $175,391 during the nine months ended September 30, 2019. At September 30, 2019 NomadChoice Pty Ltd., a subsidiary of the Company, owed Knight Therapeutics $36,082 in connection with a royalty distribution agreement.

 

The Company expensed royalty of $1,067 during the three months ended September 30, 2019 and $4,252 for the nine months ended September 30, 2019. At September 30, 2019 the Company owed Knight Therapeutics $1,067 in connection with a royalty distribution agreement for Sneaky Vaunt.

 

The Company expensed commissions of $0 during the three months ended September 30, 2019 and $9,065 for the nine months ended September 30, 2019. At September 30, 2019, the Company owed Founded Ventures, owned by a shareholder in the Company, $0 in connection with a commission agreement for Sneaky Vaunt.

 

The Company expensed commissions of $0 during the three months ended September 30, 2019 and $644 for the nine months ended September 30, 2019. At September 30, 2019, the Company owed Founded Ventures $0 in connection with a commission agreement for The Queen Pegasus.

 

The Company paid $6,180 during the three months ended September 30, 2019 and $14,801 for the nine months ended September 30, 2019 to Hand MD, Corp, related to a royalty agreement. At September 30, 2019, the Company owed Hand MD Corp. $0 in minimum future royalties.
XML 56 R18.htm IDEA: XBRL DOCUMENT v3.19.3
Commitments & Contingencies
 9 Months Ended
Sep. 30, 2019
Commitments and Contingencies Disclosure [Abstract]  
Commitments & Contingencies

Note 12 – Commitments & Contingencies

 

Litigation:

 

From time to time the Company may become a party to litigation in the normal course of business. Management believes that there are no current legal matters that would have a material effect on the Company’s financial position or results of operations.

 

Employee Commitments

 

The Company and Mr. McCullough entered into an employment agreement on October 17, 2017 (the “Employment Agreement”) with an initial term of 3 years. In exchange for his service as President, Mr. McCullough will receive an annual base salary of $340,000. He received a cash signing bonus of $37,500 paid on January 1, 2018, and an additional cash signing bonus of $37,500 paid on July 1, 2018. Mr. McCullough will be eligible for an annual bonus of up to twenty-five percent (25%) of his base salary. The annual bonus will be determined at the discretion of our Board or compensation committee based upon the achievement of financial goals established by the Company’s Chief Executive Officer. Mr. McCullough will also be eligible for additional bonus compensation based on the Company’s achievement of certain annual earnings and retail sales goals established each year by the Company’s Chief Executive Officer. Subject to the Company’s achievement of an annual overall earnings goal and certain adjustments in the event of future acquisitions by the Company, Mr. McCullough will be eligible to receive five percent (5%) of all retail sales by the Company in excess of the annual retail sales goal set by the Chief Executive Officer.

 

The Company granted Mr. McCullough an option to purchase 1,000,000 shares of the Company’s common stock (the “Option Grant”). The Option Grant vests in three (3) equal annual installments on the first three anniversaries of Mr. McCullough’s start date with the Company, provided that Mr. McCullough remains employed by the Company on each such date. The Option Grant was granted under the Company’s 2014 Stock Incentive Plan pursuant to a stock grant agreement between the Company and Mr. McCullough.

 

Other Commitments

 

During the nine months ended September 30, 2019 the Company received a 60 day Proposition 65 letter that one of its products did not have California’s Proposition 65 label. The Company has settled the matter and made a one-time payment of $85,000 in full satisfaction of the matter.
XML 57 R6.htm IDEA: XBRL DOCUMENT v3.19.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Cash Flows from Operating Activities    
Net income (loss) $ 1,893,613 $ (493,296)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation and amortization 911,259 1,363,016
Amortization of debt issuance cost 103,782 171,824
Stock based compensation expense 162,476 148,990
Remeasurement loss on translation of foreign subsidiary 112,551 197,674
Foreign currency transaction gain (4,878) (47,887)
Non cash implied interest 28,895 58,014
Changes in operating assets and liabilities:    
Accounts receivable 2,556,095 2,309,350
Inventory 437,155 (539,438)
Other current assets 393,683 375,795
Accounts payable and accrued liabilities (4,024,983) (1,545,260)
Deferred revenue (39,763) 44,983
Net cash provided by operating activities 2,529,885 2,043,765
Cash Flows from Investing Activities    
Payments for acquisition of fixed assets (129,087)
Payment for acquisition of domain name (15,213)
Purchase of intangible assets (50,000)
Net cash used in investing activities (194,300)
Cash Flows from Financing Activities    
Repayment of notes payable (1,537,500) (2,287,500)
Net cash used in financing activities (1,537,500) (2,287,500)
Effect of exchange rate on cash, cash equivalents and restricted cash (98,990) 85,827
Net increase (decrease) in cash, cash equivalents and restricted cash 893,395 (352,208)
Cash, Cash Equivalents and restricted cash, beginning of period 595,916 2,094,685
Cash, Cash Equivalents and restricted cash, end of period $ 1,489,311 $ 1,742,477
Supplemental Disclosure of Cash Flow Information:    
Cash paid during the period for:
Interest $ 723,892 $ 983,130
Income taxes 38,919 224,114
Supplemental Disclosure of Non-cash Investing and Financing Activities:
XML 58 R2.htm IDEA: XBRL DOCUMENT v3.19.3
Condensed Consolidated Balance Sheets - USD ($)
Sep. 30, 2019
Dec. 31, 2018
Current Assets:    
Cash and cash equivalents $ 1,389,311 $ 459,736
Restricted cash 100,000 136,180
Accounts receivable, net 1,902,130 4,458,225
Prepaid expenses and other current assets 435,165 828,847
Income taxes receivable 404,391 386,686
Inventory, net 2,233,152 2,670,305
Total Current Assets 6,464,149 8,939,979
Fixed assets, net 166,282 269,771
Goodwill 7,793,240 7,793,240
Intangible assets, net 2,199,751 3,007,521
Total Assets 16,623,422 20,010,511
Current Liabilities:    
Accounts payable and accrued liabilities 4,497,616 8,397,220
Deferred revenue 9,947 49,709
Current portion of long-term debt, net of debt discount and debt issuance cost, related party 5,937,576 1,963,887
Total Current Liabilities 10,445,139 10,410,816
Long-term Liabilities:    
Note payable, net of debt discount and debt issuance cost, related party 250,491 5,629,002
Total Long-term Liabilities 250,491 5,629,002
Total Liabilities 10,695,630 16,039,818
Commitments and contingencies
Stockholders' Equity:    
Common stock, $0.00001 par value; 300,000,000 shares authorized; 89,889,074 and 89,862,683 shares issued and outstanding, respectively 899 899
Additional paid in capital 18,980,276 18,817,800
Accumulated other comprehensive income 80,126 179,116
Accumulated deficit (13,133,509) (15,027,122)
Total stockholders' equity 5,927,792 3,970,693
Total Liabilities and Stockholders' Equity $ 16,623,422 $ 20,010,511
XML 59 R52.htm IDEA: XBRL DOCUMENT v3.19.3
Stock Options - Schedule of Stock Options Activity (Details) - Stock Option Plan [Member]
 9 Months Ended
Sep. 30, 2019
$ / shares
shares
Options Outstanding, at Beginning balance | shares 7,166,667
Options Outstanding, Granted | shares
Options Outstanding, Exercised | shares
Options Outstanding, Expired or canceled | shares (1,000,000)
Options Outstanding, at Ending balance | shares 6,166,667
Weighted Average Exercise Price, at Beginning balance | $ / shares $ 0.50
Weighted Average Exercise Price, Granted | $ / shares
Weighted Average Exercise Price, Exercised | $ / shares
Weighted Average Exercise Price, Expired or canceled | $ / shares 0.25
Weighted Average Exercise Price, at Ending balance | $ / shares $ 0.54
XML 60 R56.htm IDEA: XBRL DOCUMENT v3.19.3
Segments - Summary of Net Sales Attributed to Major Sales Channel (Details) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Revenue $ 7,364,546 $ 9,190,377 $ 23,170,222 $ 28,619,950
Online [Member]        
Revenue 2,318,455 4,902,161 8,841,272 13,926,758
Retail [Member]        
Revenue $ 5,046,091 $ 4,288,216 $ 14,328,950 $ 14,693,192
XML 61 R36.htm IDEA: XBRL DOCUMENT v3.19.3
Summary of Significant Accounting Policies - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) - shares
 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Anti-dilutive securities 6,166,667 8,166,667
Options to Purchase of Common Stock [Member]    
Anti-dilutive securities 6,166,667 7,166,667
Warrants to Purchase of Common Stock [Member]    
Anti-dilutive securities 1,000,000
XML 62 R32.htm IDEA: XBRL DOCUMENT v3.19.3
Segments (Tables)
 9 Months Ended
Sep. 30, 2019
Segment Reporting [Abstract]  
Summary of Net Sales Attributed to Customers Geographical Segment

Net sales attributed to customers in the United States and foreign countries for the three months ended September 30, 2019 and 2018 were as follows:

 

    September 30, 2019     September 30, 2018  
United States   $ 6,785,123     $ 8,944,970  
Foreign countries     579,423       245,407  
    $ 7,364,546     $ 9,190,377  

 

Net sales attributed to customers in the United States and foreign countries for the nine months ended September 30, 2019 and 2018 were as follows:

 

    September 30, 2019     September 30, 2018  
United States   $ 21,377,182     $ 27,215,818  
Foreign countries     1,793,040       1,404,132  
    $ 23,170,222     $ 28,619,950  
Summary of Net Sales Attributed to Customers Product Group

The Company’s net sales by product group for the three months ended September 30, 2019 and 2018 were as follows:

 

    September 30, 2019     September 30, 2018  
Nutraceuticals   $ 7,094,211     $ 8,540,044  
Over the Counter (OTC)     9,055       125,878  
Consumer Goods     224,724       260,027  
Cosmeceuticals     36,556       264,428  
    $ 7,364,546     $ 9,190,377  

 

The Company’s net sales by product group for the nine months ended September 30, 2019 and 2018 were as follows:

 

    September 30, 2019     September 30, 2018  
Nutraceuticals   $ 22,151,047     $ 26,450,312  
Over the Counter (OTC)     38,121       459,980  
Consumer Goods     576,754       822,959  
Cosmeceuticals     404,300       886,699  
    $ 23,170,222     $ 28,619,950  
Summary of Net Sales Attributed to Major Sales Channel

The Company’s net sales by major sales channel for the three months ended September 30, 2019 and 2018 were as follows:

 

    September 30, 2019     September 30, 2018  
Online   $ 2,318,455     $ 4,902,161  
Retail     5,046,091       4,288,216  
    $ 7,364,546     $ 9,190,377  

 

The Company’s net sales by major sales channel for the nine months ended September 30, 2019 and 2018 were as follows:

 

    September 30, 2019     September 30, 2018  
Online   $ 8,841,272     $ 13,926,758  
Retail     14,328,950       14,693,192  
    $ 23,170,222     $ 28,619,950  
Summary of Long-lived Assets (Net) Attributable to Operations Geographical Segment

Long-lived assets (net) attributable to operations in the United States and foreign countries as of September 30, 2019 and December 31, 2018 were as follows:

 

    September 30, 2019     December 31, 2018  
United States   $ 10,150,670     $ 11,058,528  
Foreign countries     8,603       12,004  
    $ 10,159,273     $ 11,070,532  
XML 63 R19.htm IDEA: XBRL DOCUMENT v3.19.3
Stock Options
 9 Months Ended
Sep. 30, 2019
Share-based Payment Arrangement [Abstract]  
Stock Options

Note 13 – Stock Options

 

The following table summarizes the options outstanding, option exercisability and the related prices for the shares of the Company’s common stock issued to employees and consultants under the Plan at September 30, 2019:

 

      Options Outstanding     Options Exercisable  
Exercise
Prices ($)		     Number
Outstanding		     Weighted
Average
Remaining
Contractual
Life
(Years)		     Weighted
Average
Exercise
Price ($)		     Number
Exercisable		     Weighted
Average
Exercise
Price ($)		  
$ 0.25 - $0.70       6,166,667       5.8     $ 0.54       5,750,000     $ 0.53  

 

The stock option activity for the nine months ended September 30, 2019 is as follows:

 

    Options
Outstanding		     Weighted
Average
Exercise Price		  
Outstanding at December 31, 2018     7,166,667     $ 0.50  
Granted     -       -  
Exercised     -       -  
Expired or canceled     (1,000,000 )     0.25  
Outstanding at September 30, 2019     6,166,667     $ 0.54  

 

Stock-based compensation expense related to vested options was $38,679 and $122,891 during the three and nine months ended September 30, 2019, respectively, which is a component of general and administrative expense in the statement of income. The Company determined the value of share-based compensation for options vesting during the period using the Black-Scholes fair value option-pricing model with the following weighted average assumptions: estimated fair value of Company’s common stock of $0.48-0.50, risk-free interest rate of 1.95-1.99%, volatility of 116-117%, expected lives of 10 years, and dividend yield of 0%. Stock options outstanding as of September 30, 2019, as disclosed in the above table, have an intrinsic value of $0. As of September 30, 2019, unamortized stock-based compensation costs related to options was $167,608, and will be recognized over a period of 1 year.
XML 64 R11.htm IDEA: XBRL DOCUMENT v3.19.3
Prepaid Expenses and Other Current Assets
 9 Months Ended
Sep. 30, 2019
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]  
Prepaid Expenses and Other Current Assets

Note 5 – Prepaid Expenses and Other Current Assets

 

Prepaid expenses and other current assets consisted of the following:

 

    September 30, 2019     December 31, 2018  
Advances for inventory   $ 14,571     $ 25,170  
Media production     -       20,791  
Insurance     29,183       13,302  
Deposits     10,257       45,144  
Trademarks     19,707       78,826  
Rent     86,354       103,912  
Promotion     114,018       342,220  
License agreement     -       58,333  
Software subscriptions     48,962       34,440  
Rebranding     7,415       40,783  
Clinical research     23,745       35,617  
Miscellaneous     33,286       30,309  
Related party receivables     9,467       -  
Capital asset deposit     38,200       -  
Total   $ 435,165     $ 828,847  
XML 65 R15.htm IDEA: XBRL DOCUMENT v3.19.3
Accounts Payable and Accrued Liabilities
 9 Months Ended
Sep. 30, 2019
Payables and Accruals [Abstract]  
Accounts Payable and Accrued Liabilities

Note 9 – Accounts Payable and Accrued Liabilities

 

As of September 30, 2019, and December 31, 2018, accounts payable and accrued liabilities consisted of the following:

 

    September 30, 2019     December 31, 2018  
Accrued payroll   $ 243,730     $ 217,069  
Legal fees     116,769       71,236  
Commissions     255,170       134,784  
Manufacturers     2,529,037       3,898,896  
Promotions     140,359       1,262,503  
Returns allowance     -       850,627  
Accounting fees     97,714       104,198  
Rent     -       61,738  
Customers     1,800       76,617  
Interest     49,306       -  
Royalties, related party     191,211       304,434  
Warehousing     11,106       64,289  
Sales taxes     302,870       180,222  
Taxes     -       178,069  
Severance Accrual     270,333       506,250  
Related Party Reimbursements     131,650       178,825  
Others     156,561       307,463  
Total   $ 4,497,616     $ 8,397,220  
XML 66 R7.htm IDEA: XBRL DOCUMENT v3.19.3
Nature of the Business
 9 Months Ended
Sep. 30, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Nature of the Business

Note 1 – Nature of the Business

 

Synergy CHC Corp. (“Synergy”, “we”, “us”, “our” or the “Company”) (formerly Synergy Strips Corp.) was incorporated on December 29, 2010 in Nevada under the name “Oro Capital Corporation.” On April 21, 2014, the Company changed its fiscal year end from July 31 to December 31. On April 28, 2014, the Company changed its name to “Synergy Strips Corp.”. On August 5, 2015, the Company changed its name to “Synergy CHC Corp.”

 

The Company is a consumer health care company that is in the process of building a portfolio of best-in-class consumer product brands. Synergy’s strategy is to grow its portfolio both organically and by further acquisition.

 

Effective January 1, 2019 the Company has merged its U.S. subsidiaries (Neuragen Corp., Breakthrough Products, Inc., Sneaky Vaunt Corp., and The Queen Pegasus Corp.) into the parent company.

 

Synergy is the sole owner of two subsidiaries: NomadChoice Pty Ltd., and Synergy CHC Inc. and the results have been consolidated in these statements.
XML 67 R3.htm IDEA: XBRL DOCUMENT v3.19.3
Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares
Sep. 30, 2019
Dec. 31, 2018
Statement of Financial Position [Abstract]    
Common stock, par value $ 0.00001 $ 0.00001
Common stock, shares authorized 300,000,000 300,000,000
Common stock, shares issued 89,889,074 89,862,683
Common stock, shares outstanding 89,889,074 89,862,683
XML 68 R53.htm IDEA: XBRL DOCUMENT v3.19.3
Segments (Details Narrative) - Segment
 3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2019
Number of operating segments   1
Sales Revenue, Net [Member]    
Concentration risk percentage 10.00% 10.00%
XML 69 R57.htm IDEA: XBRL DOCUMENT v3.19.3
Segments - Summary of Long-lived Assets (Net) Attributable to Operations Geographical Segment (Details) - USD ($)
Sep. 30, 2019
Dec. 31, 2018
Long-lived assets net $ 10,159,273 $ 11,070,532
United States [Member]    
Long-lived assets net 10,150,670 11,058,528
Foreign Countries [Member]    
Long-lived assets net $ 8,603 $ 12,004
XML 70 R46.htm IDEA: XBRL DOCUMENT v3.19.3
Notes Payable (Details Narrative) - USD ($)
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2018
Aug. 09, 2017
Jun. 26, 2015
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Dec. 31, 2018
Dec. 31, 2017
Jun. 30, 2019
Debt instrument interest rate percentage                   10.50%
Present value of future payments       $ 263,546   $ 263,546   $ 272,151    
Payments of debt           1,537,500        
Deferred financing costs                 $ 10,000,000  
Recognized amortization of deferred financing costs       30,820 $ 93,089 103,782 $ 171,824      
Unamortized debt issuance costs       75,478   75,478   179,261    
June 26, 2015 Security Agreement [Member]                    
Debt instrument interest rate percentage     0.00%              
Note principal amount     $ 950,000              
Present value of future payments       263,546   263,546   $ 272,151    
Interest expense       9,526   28,896        
Payments of debt       $ 12,500   $ 37,500        
June 26, 2015 Security Agreement [Member] | United States [Member]                    
Percentage of sale revenue net     5.00%              
June 26, 2015 Security Agreement [Member] | June 30, 2016 [Member]                    
Note payable     $ 250,000              
June 26, 2015 Security Agreement [Member] | June 30, 2016 [Member] | Minimum [Member]                    
Note payable     12,500              
June 26, 2015 Security Agreement [Member] | Quarter Ending September 30, 2015 [Member]                    
Note payable     700,000              
Neuragen Corp [Member] | June 26, 2015 Security Agreement [Member]                    
Total payments of acquire assets     $ 1,200,000              
Neuragen Corp [Member] | June 26, 2015 Security Agreement [Member] | United States [Member]                    
Percentage of sale revenue net     2.00%              
Focus Factor [Member] | Minimum [Member]                    
Net sales                 $ 15,000,000  
Loan Agreement [Member]                    
Debt instrument interest rate percentage 5.00% 5.00%   2.50% 5.00% 2.50% 5.00%      
Capital expenditures   $ 500,000                
Debt EBITDA $ 5,000,000                  
Debt covenants, net debt to TTM EBITDA ratio               8:1    
Loan Agreement [Member] | After March 31, 2019 [Member]                    
Debt covenants, net debt to TTM EBITDA ratio               6:1    
Loan Agreement [Member] | Additional Tranche [Member]                    
Percentage of loan, description   Additional Tranches under the Loan Agreement are available to the Company until August 9, 2022 provided that no event of default exists. Each Additional Tranche must be for a minimum amount of $1.0 million, may only be used to finance qualified acquisitions (as defined in the Loan Agreement), and can be denied in Knight's absolute discretion. If an Additional Tranche is denied, the Company can effect a qualified acquisition through a special purpose entity with such special purpose entity being entitled to obtain financing from third parties so long as such financing does not adversely affect Knight or Knight's rights under the Loan Agreement. Upon the closing of any Additional Tranche, the Company will pay Knight an origination fee equal to 2% of the Additional Tranche, a work fee equal to 1% of the amount of the Additional Tranche, and reimburse Knight for its expenses incurred in connection with its consideration of any Additional Tranche (whether or not advanced).                
Loan agreement, description   On the Maturity Date of the Third Tranche and every Additional Tranche (or upon the acceleration of each such loan), the Company must pay Knight a success fee (the "Success Fee") of that number of Company common shares equal to 10% of the loan, divided by the lesser of (a) $1.50, (b) the lowest price at which any common shares were issued by the Company in any offering or equity financing or other transaction between the Closing Date and the date the Success Fee is due, and (c) the current market price on the date the Success Fee is due. The Company may also pay the Success Fee in cash pursuant to the terms of the Loan Agreement.                
Loan Agreement [Member] | Minimum [Member]                    
Debt instrument interest rate percentage 10.50%     13.00% 10.50% 13.00% 10.50%      
Debt covenants, minimum EBITDA               $ 1,900,000    
Debt covenants, minimum cash balance       $ 750,000   $ 750,000   575,000    
Loan Agreement [Member] | Minimum [Member] | Twelve Months Ending March 31, 2019 [Member]                    
Debt covenants, minimum EBITDA           2,500,000        
Loan Agreement [Member] | Minimum [Member] | Twelve Months Ending June 30, 2019 [Member]                    
Debt covenants, minimum EBITDA           3,500,000        
Loan Agreement [Member] | Minimum [Member] | Thereafter [Member]                    
Debt covenants, minimum EBITDA           $ 5,000,000        
Loan Agreement [Member] | Minimum [Member] | Quarters Ending After March 31, 2019 [Member]                    
Debt covenants, minimum cash balance               $ 1,000,000    
Loan Agreement [Member] | Minimum [Member] | Additional Tranche [Member]                    
Loan amount   $ 1,000,000                
Loan Agreement [Member] | Maximum [Member]                    
Debt instrument interest rate percentage 15.50%     15.50% 15.50% 15.50% 15.50%      
Payment for business acquisition consideration   $ 100,000                
Loan Agreement [Member] | Knight Therapeutics Inc [Member]                    
Debt instrument interest rate percentage   10.50%                
Loan amount   $ 10,000,000                
Credit facility maximum borrowing amount   20,000,000                
Expenses associated with loan   $ 100,000                
Note maturity date   Aug. 08, 2020                
Loan Agreement [Member] | Knight Therapeutics Inc [Member] | Second Amendment [Member]                    
Note principal amount       $ 6,000,000   $ 6,000,000        
Interest expense       166,833   759,069        
Payments of debt       166,833   709,763        
Deferred financing costs       452,869   452,869        
Recognized amortization of deferred financing costs       30,820   103,782        
Unamortized debt issuance costs       75,478   75,478        
Accrued interest       $ 49,306   $ 49,306        
Loan Agreement [Member] | Knight Therapeutics Inc [Member] | Origination Fee [Member]                    
Expenses associated with loan   $ 200,000                
Loan Agreement [Member] | Knight Therapeutics Inc [Member] | Work Fee [Member]                    
Expenses associated with loan   $ 100,000                
Loan Amendment Agreement [Member]                    
Debt instrument interest rate percentage 13.00%       13.00%   13.00%      
XML 71 R42.htm IDEA: XBRL DOCUMENT v3.19.3
Fixed Assets and Intangible Assets (Details Narrative) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Assets        
Depreciation expense $ 31,166 $ 38,299 $ 103,489 $ 114,461
Amortization expense $ 270,222 $ 417,280 $ 807,770 $ 1,248,555
XML 72 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 73 R23.htm IDEA: XBRL DOCUMENT v3.19.3
Summary of Significant Accounting Policies (Policies)
 9 Months Ended
Sep. 30, 2019
Accounting Policies [Abstract]  
General

General

 

The accompanying condensed consolidated financial statements as of September 30, 2019 and December 31, 2018 and for the three and nine months ended September 30, 2019 and 2018 are unaudited. These unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information and are presented in accordance with the requirements of Rule S-X of the Securities and Exchange Commission (the “SEC”) and with the instructions to Form 10-Q. Accordingly, they do not include all the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three and nine months ended September 30, 2019 are not necessarily indicative of the results that may be expected for the fiscal year ending December 31, 2019. The unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements as of and for the year ended December 31, 2018 and footnotes thereto included in the Company’s Annual Report on Form 10-K filed with the SEC on March 29, 2019.
Basis of Presentation

Basis of Presentation

 

The unaudited condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.
Use of Estimates

Use of Estimates

 

The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosure of contingent liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates. Significant estimates are assumptions about collection of accounts receivable, useful life of fixed and intangible assets, goodwill and assumptions used in Black-Scholes-Merton, or BSM, valuation methods, such as expected volatility, risk-free interest rate, and expected dividend rate.
Cash and Cash Equivalents

Cash and Cash Equivalents

 

The Company considers all cash on hand and in banks, including accounts in book overdraft positions, certificates of deposit and other highly-liquid investments with maturities of three months or less, when purchased, to be cash and cash equivalents. As of September 30, 2019, the Company had no cash equivalents. The Company maintains its cash and cash equivalents in banks insured by the Federal Deposit Insurance Corporation (FDIC) in accounts that at times may be in excess of the federally insured limit of $250,000 per bank. The Company minimizes this risk by placing its cash deposits with major financial institutions. At September 30, 2019, the uninsured balance amounted to $981,699.
Restricted Cash

Restricted Cash

 

The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the statement of financial position that sum to the total of the same such amounts shown in the statement of cash flows.

 

    September 30, 2019     December 31, 2018     September 30, 2018  
                   
Cash and cash equivalents   $ 1,389,311     $ 459,736     $ 1,605,381  
Restricted cash     100,000       136,180       137,096  
Total cash, cash equivalents, and restricted cash shown in the statement of cash flows   $ 1,489,311     $ 595,916     $ 1,742,477  

 

Amounts included in restricted cash represent amounts held for credit card collateral.
Capitalization of Fixed Assets

Capitalization of Fixed Assets

 

The Company capitalizes expenditures related to property and equipment, subject to a minimum rule, that have a useful life greater than one year for: (1) assets purchased; (2) existing assets that are replaced, improved or the useful lives have been extended; or (3) all land, regardless of cost. Acquisitions of new assets, additions, replacements and improvements (other than land) costing less than the minimum rule in addition to maintenance and repair costs, including any planned major maintenance activities, are expensed as incurred.
Intangible Assets

Intangible Assets

 

We evaluate the recoverability of intangible assets periodically and take into account events or circumstances that warrant revised estimates of useful lives or that indicate that impairment exists. All of our intangible assets are subject to amortization except intellectual property of $1,450,000 acquired as part of an Asset Purchase Agreement entered into with Factor Nutrition Labs LLC on January 22, 2015, $10,000 acquired as part of an Asset Purchase Agreement entered into with Perfekt Beauty Holdings LLC and CDG Holdings, LLC on June 21, 2017 and $50,000 acquired as part of an Asset Purchase Agreement entered into with Cocowhite on May 22, 2018. Intangible assets are amortized on a straight line basis over the useful lives. During the year ended December 31, 2018, the Company fully impaired intangible assets related to Perfekt and Cocowhite and charged to operations impairment loss of $60,000. As of September 30, 2019, our qualitative analysis of intangible assets with indefinite lives did not indicate any impairment.
Long-lived Assets

Long-lived Assets

 

Long-lived assets include equipment and intangible assets other than those with indefinite lives. We assess the carrying value of our long-lived asset groups when indicators of impairment exist and recognize an impairment loss when the carrying amount of a long-lived asset is not recoverable when compared to undiscounted cash flows expected to result from the use and eventual disposition of the asset.

 

Indicators of impairment include significant underperformance relative to historical or projected future operating results, significant changes in our use of the assets or in our business strategy, loss of or changes in customer relationships and significant negative industry or economic trends. When indications of impairment arise for a particular asset or group of assets, we assess the future recoverability of the carrying value of the asset (or asset group) based on an undiscounted cash flow analysis. If carrying value exceeds projected, net, undiscounted cash flows, an additional analysis is performed to determine the fair value of the asset (or asset group), typically a discounted cash flow analysis, and an impairment charge is recorded for the excess of carrying value over fair value. However, as of December 31, 2018 our review of intangible assets related to two of our subsidiaries did indicate that the carrying amount of the asset may not be recoverable. During the year ended December 31, 2018, the Company fully impaired related intangible assets and charged to operations impairment loss of $864,067. As of September 30, 2019, our qualitative analysis of long-lived assets did not indicate any impairment.
Goodwill

Goodwill

 

An asset purchase is accounted for under the purchase method of accounting. Under that method, assets and liabilities of the business acquired are recorded at their estimated fair values as of the date of the acquisition, with any excess of the cost of the acquisition over the estimated fair value of the net tangible and intangible assets acquired recorded as goodwill. As of September 30, 2019, our qualitative analysis of goodwill did not indicate any impairment.
Revenue Recognition

Revenue Recognition

 

The Company recognizes revenue in accordance with the Financial Accounting Standards Board’s (“FASB”), Accounting Standards Codification (“ASC”) ASC 606, Revenue from Contracts with Customers (“ASC 606”). Revenues are recognized when control is transferred to customers in amounts that reflect the consideration the Company expects to be entitled to receive in exchange for those goods. Revenue recognition is evaluated through the following five steps: (i) identification of the contract, or contracts, with a customer; (ii) identification of the performance obligations in the contract; (iii) determination of the transaction price; (iv) allocation of the transaction price to the performance obligations in the contract; and (v) recognition of revenue when or as a performance obligation is satisfied.

 

The Company recognizes revenue upon shipment from its fulfillment centers. Certain of our distributors may also perform a separate function as a co-packer on our behalf. In such cases, ownership of and title to our products that are co-packed on our behalf by those co-packers who are also distributors, passes to such distributors when we are notified by them that they have taken transfer or possession of the relevant portion of our finished goods. Freight billed to customers is presented as revenues, and the related freight costs are presented as cost of goods sold. Cancelled orders are refunded if not already dispatched, refunds are only paid if stock is damaged in transit, discounts are only offered with specific promotions and orders will be refilled if lost in transit.
Contract Assets

Contract Assets

 

The Company does not have any contract assets such as work-in-process. All trade receivables on the Company’s condensed consolidated balance sheet are from contracts with customers.
Contract Costs

Contract Costs

 

Costs incurred to obtain a contract are capitalized unless short term in nature. As a practical expedient, costs to obtain a contract that are short term in nature are expensed as incurred. The Company does not have any contract costs capitalized as of September 30, 2019.
Contract Liabilities - Deferred Revenue

Contract Liabilities - Deferred Revenue

 

The Company’s contract liabilities consist of advance customer payments and deferred revenue. Deferred revenue results from transactions in which the Company has been paid for products by customers, but for which all revenue recognition criteria have not yet been met. Once all revenue recognition criteria have been met, the deferred revenues are recognized.
Accounts Receivable

Accounts receivable

 

Accounts receivable are generally unsecured. The Company establishes an allowance for doubtful accounts receivable based on the age of outstanding invoices and management’s evaluation of collectability. Accounts are written off after all reasonable collection efforts have been exhausted and management concludes that likelihood of collection is remote. Any future recoveries are applied against the allowance for doubtful accounts. As of both September 30, 2019 and December 31, 2018, allowance for doubtful accounts was $0.
Advertising Expense

Advertising Expense

 

The Company expenses marketing, promotions and advertising costs as incurred. Such costs are included in selling expense in the accompanying unaudited condensed consolidated statements of operations.
Research and Development

Research and Development

 

Costs incurred in connection with the development of new products and processing methods are charged to general and administrative expenses as incurred.
Income Taxes

Income Taxes

 

The Company utilizes FASB ASC 740, “Income Taxes,” which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns. Under this method, deferred tax assets and liabilities are determined based on the difference between the tax basis of assets and liabilities and their financial reporting amounts based on enacted tax laws and statutory tax rates applicable to the periods in which the differences are expected to affect taxable income. A valuation allowance is recorded when it is “more likely-than-not” that a deferred tax asset will not be realized.

 

The Company generated a deferred tax asset through net operating loss carry-forward. However, a valuation allowance of 100% has been established due to the uncertainty of the Company’s realization of the net operating loss carry forward prior to its expiration.

 

NomadChoice Pty Ltd, the Company’s wholly-owned foreign subsidiary, is subject to income taxes in the jurisdictions in which it operates. Significant judgment is required in determining the provision for income tax. There are many transactions and calculations undertaken during the ordinary course of business for which the ultimate tax determination is uncertain. The company recognizes liabilities for anticipated tax audit issues based on the Company’s current understanding of the tax law. Where the final tax outcome of these matters is different from the carrying amounts, such differences will impact the current and deferred tax provisions in the period in which such determination is made.

 

Synergy CHC Inc. is a wholly-owned foreign subsidiary, is subject to income taxes in the jurisdictions in which it operates. Significant judgment is required in determining the provision for income tax. There are many transactions and calculations undertaken during the ordinary course of business for which the ultimate tax determination is uncertain. The company recognizes liabilities for anticipated tax audit issues based on the Company’s current understanding of the tax law. Where the final tax outcome of these matters is different from the carrying amounts, such differences will impact the current and deferred tax provisions in the period in which such determination is made.
Net Earnings (Loss) Per Common Share

Net Earnings (Loss) Per Common Share

 

The Company computes earnings per share under ASC subtopic 260-10, Earnings Per Share. Basic earnings (loss) per share is computed by dividing the net income (loss) attributable to the common stockholders (the numerator) by the weighted average number of shares of common stock outstanding (the denominator) during the reporting periods. Diluted earnings per share is computed by increasing the denominator by the weighted average number of additional shares that could have been outstanding from securities convertible into common stock (using the “treasury stock” method), unless their effect on net loss per share is anti-dilutive. As of September 30, 2019, and 2018, options to purchase 6,166,667 and 7,166,667 shares of common stock, respectively, were outstanding. As of September 30, 2018, warrants to purchase 1,000,000 shares of common stock were outstanding.

 

The following is a reconciliation of the number of shares used in the calculation of basic earnings per share and diluted earnings per share for the three and nine months ended September 30, 2019, and 2018:

 

    For the three months ended     For the nine months ended  
    September 30, 2019     September 30, 2018     September 30, 2019     September 30, 2018  
                         
Net income (loss) after tax   $ 107,864     $ 345,590     $ 1,893,613     $ (493,296 )
                                 
Weighted average common shares outstanding     89,889,044       89,862,683       89,881,223       89,862,683  
Incremental shares from the assumed exercise of dilutive stock options     -       -       -       -  
Incremental shares from the assumed exercise of dilutive stock warrants     -       -       -       -  
Dilutive potential common shares     89,889,044       89,862,683       89,881,223       89,862,683  
                                 
Net earnings (loss) per share:                                
Basic   $ 0.00     $ 0.00     $ 0.02     $ (0.01 )
Diluted   $ 0.00     $ 0.00     $ 0.02     $ (0.01 )

 

The following securities were not included in the computation of diluted net earnings per share as their effect would have been antidilutive:

 

    2019     2018  
             
Options to purchase common stock     6,166,667       7,166,667  
Warrants to purchase common stock     -       1,000,000  
      6,166,667       8,166,667  
Fair Value Measurements

Fair Value Measurements

 

The Company measures and discloses the fair value of assets and liabilities required to be carried at fair value in accordance with ASC 820, Fair Value Measurements and Disclosures. ASC 820 defines fair value, establishes a framework for measuring fair value, and enhances fair value measurement disclosure.

 

ASC 825 defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required or permitted to be recorded at fair value, the Company considers the principal or most advantageous market in which it would transact and considers assumptions that market participants would use when pricing the asset or liability, such as inherent risk, transfer restrictions, and risk of nonperformance. ASC 825 establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 825 establishes three levels of inputs that may be used to measure fair value:

 

Level 1 - Quoted prices for identical assets or liabilities in active markets to which we have access at the measurement date.

 

Level 2 - Inputs other than quoted prices within Level 1 that are observable for the asset or liability, either directly or indirectly.

 

Level 3 - Unobservable inputs for the asset or liability.

 

The determination of where assets and liabilities fall within this hierarchy is based upon the lowest level of input that is significant to the fair value measurement.

 

As of September 30, 2019, the Company has determined that there were no assets or liabilities measured at fair value.
Inventory

Inventory

 

Inventory consists of raw materials, components and finished goods. The Company’s inventory is stated at the lower of cost (FIFO cost basis) or net realizable value. Finished goods include the cost of labor to assemble the items.
Stock-Based Compensation

Stock-Based Compensation

 

ASC 718, “Compensation – Stock Compensation,” prescribes accounting and reporting standards for all share-based payment transactions in which employee services are acquired. Transactions include incurring liabilities, or issuing or offering to issue shares, options, and other equity instruments such as employee stock ownership plans and stock appreciation rights. Share-based payments to employees, including grants of employee stock options, are recognized as compensation expense in the financial statements based on their fair values. That expense is recognized over the period during which an employee is required to provide services in exchange for the award, known as the requisite service period (usually the vesting period).

 

The Company accounts for stock-based compensation issued to non-employees and consultants in accordance with the provisions of ASC 505-50, “Equity – Based Payments to Non-Employees.” Measurement of share-based payment transactions with non-employees is based on the fair value of whichever is more reliably measurable: (a) the goods or services received; or (b) the equity instruments issued. The fair value of the share-based payment transaction is determined at the earlier of performance commitment date or performance completion date.
Foreign Currency Translation

Foreign Currency Translation

 

The functional currency of one of the Company’s foreign subsidiaries (Nomadchoice Pty Ltd.) is the U.S. Dollar. The Company’s foreign subsidiary maintains its records using local currency (Australian Dollar). All monetary assets and liabilities of the foreign subsidiary were translated into U.S. Dollars at quarter end exchange rates, non-monetary assets and liabilities of the foreign subsidiary were translated into U.S. Dollars at transaction day exchange rates. Income and expense items related to non-monetary items were translated at exchange rates prevailing during the transaction date and other incomes and expenses were translated using average exchange rate for the period. The resulting translation adjustments, net of income taxes, were recorded in statements of operations as Remeasurement gain or loss on translation of foreign subsidiary.

 

The functional currency of the Company’s other foreign subsidiary (Synergy CHC Inc.) is the Canadian Dollar (CAD). The Company’s foreign subsidiary maintains its records using local currency (CAD). All assets and liabilities of the foreign subsidiary were translated into U.S. Dollars at period end exchange rates and stockholders’ equity is translated at the historical rates. Income and expense items were translated using average exchange rate for the period. The resulting translation adjustments, net of income taxes, are reported as other comprehensive income and accumulated other comprehensive income in the stockholder’s equity in accordance with ASC 220 – Comprehensive Income.

 

The exchange rates used to translate amounts in AUD and CAD into USD for the purposes of preparing the consolidated financial statements were as follows:

 

Balance sheet:

 

    September 30, 2019     December 31, 2018  
Period-end AUD: USD exchange rate   $ 0.6746     $ 0.7046  
Period-end CAD: USD exchange rate   $ 0.7551     $ 0.7330  

 

Income statement:

 

    September 30, 2019     September 30, 2018  
Average Quarterly AUD: USD exchange rate   $ 0.6994     $ 0.7579  
Average Quarterly CAD: USD exchange rate   $ 0.7524     $ 0.7768  

 

Translation gains and losses that arise from exchange rate fluctuations from transactions denominated in a currency other than the functional currency are translated into either Australian Dollars or Canadian Dollars, as the case may be, at the rate on the date of the transaction and included in the results of operations as incurred.
Concentrations of Credit Risk

Concentrations of Credit Risk

 

In the normal course of business, the Company provides credit terms to its customers; however, collateral is not required. Accordingly, the Company performs credit evaluations of its customers and maintains allowances for possible losses which, when realized, were within the range of management’s expectations. From time to time, a higher concentration of credit risk exists on outstanding accounts receivable for a select number of customers due to individual buying patterns.
Warehousing Costs

Warehousing costs

 

Warehouse costs include all third party warehouse rent fees and are charged to selling and marketing expenses as incurred. Any additional costs relating to assembly or special pack-outs of the Company’s products are charged to cost of sales.
Product Display Costs

Product display costs

 

All displays manufactured and purchased by the Company are for placement of product in retail stores. This also includes all costs for display execution and setup and retail services are charged to cost of sales and expensed as incurred.
Cost of Sales

Cost of Sales

 

Cost of sales includes the purchase cost of products sold and all costs associated with getting the products into the retail stores including buying and transportation costs.
Debt Issuance Costs

Debt Issuance Costs

 

Debt issuance costs consist primarily of arrangement fees, professional fees and legal fees. These costs are netted off with the related loan and are being amortized to interest expense over the term of the related debt facilities.
Shipping Costs

Shipping Costs

 

Shipping and handling costs billed to customers are recorded in sales. Shipping costs incurred by the company are recorded in selling and marketing expenses.
Related Parties

Related parties

 

Parties are considered to be related to the Company if the parties, directly or indirectly, through one or more intermediaries, control, are controlled by, or are under common control with the Company. Related parties also include principal owners of the Company, its management, members of the immediate families of principal owners of the Company and its management and other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests. All transactions with related parties are recorded at fair value of the goods or services exchanged.
Segment Reporting

Segment Reporting

 

Segment identification and selection is consistent with the management structure used by the Company’s chief operating decision maker to evaluate performance and make decisions regarding resource allocation, as well as the materiality of financial results consistent with that structure. Based on the Company’s management structure and method of internal reporting, the Company has one operating segment. The Company’s chief operating decision maker does not review operating results on a disaggregated basis; rather, the chief operating decision maker reviews operating results on an aggregate basis.
Presentation of Financial Statements - Going Concern

Presentation of Financial Statements – Going Concern

 

Going Concern Evaluation

 

In connection with preparing unaudited condensed consolidated financial statements for the three and nine months ended September 30, 2019, management evaluated whether there were conditions and events, considered in the aggregate, that raised substantial doubt about the Company’s ability to continue as a going concern within one year from the date that the financial statements are issued.

 

The Company considered the following:

 

● At September 30, 2019, the Company had an accumulated deficit of $13,133,509.

● At September 30, 2019, the Company had working capital deficit of $3,980,990.

● Revenue decline in 2019 as compared to 2018 of $5,449,728.

 

Ordinarily, conditions or events that raise substantial doubt about an entity’s ability to continue as a going concern relate to the entity’s ability to meet its obligations as they become due.

 

The Company evaluated its ability to meet its obligations as they become due within one year from the date that the financial statements are issued by considering the following:

 

● The Company raised $10.0 million via debt financing during the year ended December 31, 2017.

● In 2019, the Company repaid $1,537,500 of loans.

● The Company generated net income of $107,864 for the three months ended September 30, 2019 and $1,893,613 for the nine months ended September 30, 2019.

● In 2019, the Company has generated $2,529,885 of cash from operating activities.

● Working capital deficit of $3,980,990 at September 30, 2019, includes loans payable to related party of $5,937,576, payables to related party of $370,939 and deferred revenue of $9,947.

● The Company has line of credit facility of $20 million available from its current lender for future mergers and acquisition.

 

Management concluded that above factors alleviate doubts about the Company’s ability to generate enough cash from operations and other available sources to satisfy its obligations for the next twelve months from the issuance date.

 

The Company will take the following actions if it starts to trend unfavorably to its internal profitability and cash flow projections, in order to mitigate conditions or events that would raise substantial doubt about its ability to continue as a going concern:

 

● Raise additional capital through line of credit and/or loan financing for future mergers and acquisition.

● Implement additional restructuring and cost reductions.

● Raise additional capital through a private placement.

 

As of November 14, 2019 and September 30, 2019, the Company had $684,916 and $1,489,311, respectively, in cash and cash equivalents.
Recent Accounting Pronouncements

Recent Accounting Pronouncements

 

ASU 2018-13

 

In August 2018, the FASB issued ASU 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework – Changes in Disclosure Requirements for Fair Value Measurement, which removes, modifies and adds certain disclosure requirements in Topic 820 “Fair Value Measurement”. ASU 2018-13 is effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. Early adoption is permitted. The adoption of ASU 2018-13 is not expected to have any impact on the Company’s unaudited condensed consolidated financial statements.

 

ASU 2018-07

 

In June 2018, the FASB issued ASU 2018-07, Compensation – Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting, which simplifies the accounting for share-based payments to nonemployees by aligning it with the accounting for share-based payments to employees, with certain exceptions. ASU 2018-07 is effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. Early adoption is permitted. The adoption of ASU 2018-07 did not have any impact on the Company’s unaudited condensed consolidated financial statements.

 

ASU 2018-05

 

This Accounting Standards Update adds SEC paragraphs pursuant to the SEC Staff Accounting Bulletin No. 118, which expresses the view of the staff regarding application of Topic 740, Income Taxes, in the reporting period that includes December 22, 2017 - the date on which the Tax Cuts and Jobs Act (H.R.1, An Act to Provide for Reconciliation Pursuant to Titles II and V of the Concurrent Resolution on the Budget for Fiscal Year 2018) was signed into law. We are currently evaluating the impact of adopting ASU 2017-13 on our consolidated financial statements.

 

ASU 2018-02

 

On December 22, 2017, the U.S. federal government enacted a tax bill, H.R.1, An Act to Provide for Reconciliation Pursuant to Titles II and V of the Concurrent Resolution on the Budget for Fiscal Year 2018 (Tax Cuts and Jobs Act of 2017). Stakeholders raised a narrow-scope financial reporting issue that arose as a consequence of the Tax Cuts and Jobs Act of 2017. The amendments in this Update allow a reclassification from accumulated other comprehensive income to retained earnings for stranded tax effects resulting from the Tax Cuts and Jobs Act of 2017. The amendments in this Update affect any entity that is required to apply the provisions of Topic 220, Income Statement-Reporting Comprehensive Income, and has items of other comprehensive income for which the related tax effects are presented in other comprehensive income as required by GAAP. The amendments in this update is effective for all entities for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. Early adoption of the amendments in this Update is permitted, including adoption in any interim period, (1) for public business entities for reporting periods for which financial statements have not yet been issued and (2) for all other entities for reporting periods for which financial statements have not yet been made available for issuance. The amendments in this Update should be applied either in the period of adoption or retrospectively to each period (or periods) in which the effect of the change in the U.S. federal corporate income tax rate in the Tax Cuts and Jobs Act is recognized.

 

This Accounting Standards Update is the final version of Proposed Accounting Standards Update 2018-210—Income Statement—Reporting Comprehensive Income (Topic 220), which has been deleted. We are currently evaluating the impact of adopting ASU 2017-13 on our consolidated financial statements.

 

ASU 2018-01

 

The amendments in this Update provide an optional transition practical expedient to not evaluate under Topic 842 existing or expired land easements that were not previously accounted for as leases under Topic 840, Leases. An entity that elects this practical expedient should evaluate new or modified land easements under Topic 842 beginning at the date that the entity adopts Topic 842. An entity that does not elect this practical expedient should evaluate all existing or expired land easements in connection with the adoption of the new lease requirements in Topic 842 to assess whether they meet the definition of a lease. We are currently evaluating the impact of adopting ASU 2017-13 on our consolidated financial statements.
ZIP 74 0001493152-19-017372-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-19-017372-xbrl.zip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

^+MR\ZRC]#^7@&7"S/2S:0LW4(C!HOU 9]\$&^ MU&E:X##&(T2XY 3G3--DW]Q_8$DA1_S5)@%P-$NT\ ;]Y9(^5C!-JT& U,:Y M"5U\E0*,!AH%A%4GDEHD$]C3D;\X;V:9A]UZO[ V[-4S&W@#,9?H! MP+%K22RFO"/?76J2M.;8M[J/<3[&@&F_==C7"J&S5G%JL( MO,^0, HY( IAYH2F+/MR?OBC>Y<^(]8T4[O0_F^1(".10.$,&"*0J/4+5N2D ME-:XD9X8*MG@%$[&,.>3)\;#'O $8>MPGT]16! ,9RS>.?(M0/XG3K()CJ!% MPHVU_]2N ]_ND(_/D#?&!X%AY_&*?V0'[";QP4):/ F'N8@U&D B?RINP4; M;N&/!EE40^D\!YPUWKZ-V=Q,$Y"]3WR.S?)!@2.<5LW)F4\:K-Z94 Z**:9B MYVR/QKDVK:W@Q4FL..0R24_*6BX/U=G'"C*X(IWQ<=6I_X2S MG& 5/X+E,!,CBLOX5<51^7O3_%4C1!) ZD=J MHXRG8.D-T_ >[;WA$">DDX]#[">BTDI7*2U74'*.RT]Q6#CC\.I-D6V M$L.%\2_^%) V%)-OR'^.@P(7,4(6DEP5(.$G0V@?>#011(;\,X=$;?&DD\I? MSN$+$,2A>M%B(/K*N<_J=&857"0RQ^YLB M*X#P^'RM1U 5J^%=;\]H"I-4XP2K60MU7RA0"LGRBLD[MJ(9"Y G2+PYP%5C0:OYTR%"Z1]-3CF_^+]L9_2POP MAQX1+$E9^EI_Q=^^N>I@X%?4 ['27SQ@#3/LE+1A?["_#0* MN0:C>/@H$2',2S^+<)>J?YY&C%:=<\-4FL@&&L9"X(O/8;VFV9F@S"BW!2O0 MCV*JZ2FI]N+4FCRVIART4U=$(G81#\6\PZ%$$WJ/XY(C&O1X[D*8G\2-9N@; MFNX]K$WWOGR+'(-+_7%Y=ZF]QSSC=+F-L#CA&\X2QC@&-Z,IZCR\@+/KY/18 MH%05_C=7<,@4#@PO(=_M[:5V!9K1!(Z5XX)+@AKBQ T0D/&="_*AD7D@,97C M9#+6\9_"3W&&!_Y,:!II!*'#] MO'J/2E#Y7^?W)P5%71G5U4<_C.2M*#,]ZR#E3%'\^ "03 5G<2\^,U-V(JYM M6ZHM7.'@= 5:)DY6EC.?*[;7_ Y@%X"G0Q*\F=5\Z?%M$H9PL*G5U'9D#-H M_#2?")UI7YGJ27\ &B7'#,[BQ)=.D32EYKOW8#RIYH+VYOGK_=G,91Y) V+X/X!BAU=L_IR'NG70O6#:EL M@Z7W;"B09![#C,HM*[",'0PMNB7EX0(U'G@5?J&7H/::^KF!@[.4*=L3U^VLWHS XJ'N;,_A:K\-+ M4LY^J,5QUFIFT34#F4>@;>^E=NLEJF..R<9;"HMP(Y3&USYMC,Z^KH<"7\E_^7QW*B66=K[-'6\+Q7-5_\%&T-9^"]0EMCKUTE%F5 M9XZL05#600>IO'X$#OKN:S5'#AM>4L*(#Q2MI;!KDO'2;JK5PG%V6(_+8Z?U M&&54#/-"A/?Y,#PUL0W,BH3*;'AB@*]$K*N2L7Q)4-M?#.IR"'A%V$+."F6W MS<6M,?3) ]I#['+#RRIU&;RE(X@$.YYL-EK(OD!TR/:*FJAER\M(;$.& T_U M94%S*67S"6K7"66Q\7V_AMGW:]@RS/%?KSH%K78NPBX_F(8G(YC./ ?M M$R?7&!,B<E45YR,\HF& G M0"WH(N@V6Q>93+SW-JRN-7'5@:P+4$0%V12XH(E,H*"(,#*5KBK C!_7\PH M*]S/X2;BYI*;%4) RHN[+__\^LN?($K'">6:7"< ]BGEK"IGH]*EKFV+@A1> MS565H6"U"W!+&E!'AQF.I.6?$_E9H'^-9#X]/K_PU*%:YD>LSB]MF*#&,+=\B_=A-HW\V=JO!\W5\4]:C 7\( MI& #E;@8@7+&JX2![&6SQ$"[GY5Z8%G$DG)1#]\=EI4?@E11]TT9/'283)6D MO%XIQ$Y&;6PK[*,6'0DW"I5JEC$'L2/E 5>JG4H[V-& MC<22T:BJELF@G2CU, MKAC@\>!1%#GYC>S5P#0UY>IN'$ZG4@O[.X"'>N59<)D\><=@FR.SQ"$RQEA0 MCV QY(G[,(J$^E.Y&N8+E,A"T,JE2B.)%"+0[LH!*E*SJWV[R1(J?0MH#2VJ M5&UHOL8D7SG#W6+CO=>N5+7D#G%DWFSP:/2M5\8>@F"X*2!Z.U8]!.^96K.H MFB\AE_,"]_J2?FOH\H.-'\:\WC7E=>?TA$R8*&G5B3K3)-(E$/A#)("XGU'7 M"_P+P,^+BB:DK=''JC=, ':IS9%%S6A2>V!2AXLYOX%./L?*&Z@3#!/*Z2@_ M&TX(=HQF^!-XV&1IS,J5>5R@MKA2HREAI=/P)A/S7ED,100,7:R\>)@[9 0: M*)0QA,=;Z1468175*"I8/.2M>)2=L7D(#T*@RQ"%A5(P)T(M"?6Y^)%3<;YL MO*J4+9=!#_(Z#=2"\1:.3=1Y%ERRIF[KA!_[]HAB&, ?QX*>\4;L;6&^1V MXI5^0AUI%V&8LOU,V4B#:R_?6?D=]- ^^!3; MP>!F O8\.8P3?A(*I#XQ*L\5 /,&9UC>B77:9;V@C(S.G5)XS'SE?)>BLXH( MP3:=L!$M!#O+QTG *UTQ0D(;"PI>Z!+(GRN))N$TH_M:7M+\#&Z#A,G8V&,( M!%5]L(P,8\ ["#/_X0$QB\*36K/]BG%G$,EZZ4-\9BN^0[9D"_A_N0%?O[DG M2AL!-^<#!T,SYLZ4F]%'>;UW937H;PDIM$!,:?RZ)>6\=[PZ.-)7>72M.KM: MM4QP$3(T@8T#2-"#N@5QY1#_4<."]J$, 1,XX?D@Y!,IM+&0^"3CJU+K(O:+ M(,RIOQ4^>+)STO/EU[*$FW<.1RD8AR#80'_.QQEV4($O-O5,582H? \"C*6+ M'!S9+%5"P0-W(F+PR+L*5+:$K/@OI8XN.JW[(/?=T?$FZ>F#@,(MA2.&/ MGTU;-VU;=PSO(-2T]E%PL@EQDC\-%*24 M1BC:@-WQ5+)=I*_X,K <@R[#T7L]3Q]8[IEP]@WJZ!1#(+$LI36\#5Q8*^*8 M:[I+)'(Y$>,Y>:PUR&)NP$LOTNIU)@SGD,A!#/=PHBI;$KZ-*9E4ZQ84+]CH MY6B$<_4BHQME,[3MZ&E$4U.^%>6HFS-^+-1K$NK-SZ9Q:6B3,(I0LWL,?0*' MA\4XWWYA3E9_1CTG/AT*YGZWW3+K_<1K<^MBM$ M7T>)(8X32W M[O4.R2F7^V*OGE8_M)GJ6,-,$3M%/* XT8A6>0&48% M>=TF+'V0B=O4[CPCS>-,GNS?*QL:=2!>#\(+9.Z31XP=#?,DI2P^]AA*CROI M6UE[$UCR+@@<"K,M\*NTRWE0I[H_[J\E,L9VQ]EHQJ,RE=I \)2R#4ZIY4]8 M@B]%7*DRE-DK+SOGZF@4LJ<00U;H&J_I/YH(8!$D(58SH!*5\L;X>8H-6(IX MY#\F*?7@%O45I7,:,WM LHFKIH;E=+>P./[MWTQ.P O% $-2 8'#R+';I.=7 M#G4^D8\TE*7^ESGE7S_#8 ?F95+MS!% W^JV? SE/R(3 ME:G99R+4^!"M+_ ZH:Y406'V].J'4@,NE2J":MG K4!Q&/7=GNZ9_>HW0I'N MN9YNFV#D "%AL57XR-!7 8*-1%XI^["H#(Q?E&5-2>B;AY_FH_N Q*MR',QM MFL#;&G-*R$XAT#^?1H4U85IU8*U^XG,+3EW=_4&^P@O3/H\#@V%X53S +^C8 MG($_7MV]DTX>!2$\!-T\4UM[\RV9AD,3@T>D7Y M[%=>.%J%KYKWXG#P1"GX#4@L./$D"<)1**O1@@!L$Y9BM:@R95M6IHI));%6 MPJR.=&G>5)G8!08S\ M3P&*[C-"Q!APYET]MJTV^4Y*EH'I@F0!%31%%47.&/N2Q.4T+CZ'K#9^27G8 M=)%:F0%U1R0JRHP:9?H;#95:,L\LKO;*T/E-:. 9C55F5LNUJMEH7)CAUZ7 M8C^&;"I*SA7,:=M)&7>%E"EA:"5IM)92!D .PH#$3'O10J \)UX:0Q-G)UJ< M\S@P%;\J"NI=.9+QCRF?=H.O_=V':W3%^@^I/QUS*J*,8V5N,GX$OCP:J:N] M*R*<$!:#)+G43.02,;SQ!XZ'S$2](D_:$S/,:(DJ_=&?@CP9E@E@0EKU#,[9 MHC/G-SY90[:>*.=+BAE_?-JS=$J7K&M9//:C72A=9V(E1QR6U:X+,?[D?Y)[ M1!3H8G^__'H)%M455PKP5X""6S&=$"4'J/U@"X61F.1XJV#J6YBCA_O3)UKS M'U4F>RR=O5\9,"*O,A9\_*X('EC.538N./Z)D2PDT[=#4(; ML8":TCQ@B6),*CS"PV*?]%T?A]U0_9>NE>RB[9U5"(85[ +:3B-+P])XOK>7 M*,&^,S%W2,:9?2WVTS1YNLB&R935LJNEH.$C8LM2#C_%5Y[KJ]NE-U]P="THJ%B_3X@+1:>FUAHK@<"U5MY3;4.K M6%+T\CM6E5E51:[;U3'77FM@Z-H;\RUOXU'<@PI0=M6JGWG^L<^4RVI,L2%E M&;7F&<-R*E:;9HO8>&.]+=$KYCOO=D,0O]C_IXKW)FD) P;[GA,!V9AB3/>, M*T?(OZ$81Z@,*:M>]H3F^@&S@U0J?:^'F%U*A-B3X3E>)9S5N,_T.BXLUEX*G-!-?! M&XJ3PX*5"Y#"8IE&:0%:O\Z+2N5/2X2FE*YO2H'[5G41H@@EH@X8:/IHL7:* MYWX43_,\#KQ:]LDA\'XLQMD+UJ"R5@H]PDY8AJ+OQ,NL,HNH_U&;@2%N&&29%%Y MD(XJH"&6S*JO+4!:UMH1R$LA)A#FH2:%Y7E,AXL5._F<%XSGS3QQ-#<''@@" M/+CH<9=E:IG-C*?T$AX8B)=0KNSS-715!V&_=<,ZNV&=W;#.;KI.-UVG M&]:Y/FJZ89TO,D"G&]9Y\ $ZW;#.;CI.-ZRS&];YNGH@=\,Z.W.B,R=>"Y9> MNSW1#>L\ 5NC&]9Y<%NC&];90@9TYD@WK+,;UKE&K=U"@\T=AK[FPVK./B M&T,@HW*K(.@9/=LS6T+ V^<74U&G[$=5==G-Z$L28R7II_B148#W*@X^R@KL MJ[*M2=M(XAS,/[+PESB,@ G2@OVD_77/$+D*1.X&$,'.U[CSA-*S/LFQ'IN= MO79?ENMZCBC+;=YE0T!:'+D&B.,:9J\5(-4LDFF*X^60Q^ JKOCD$U\,"-H: M,YYI6HZGCCY9NMV6D&'MS3JHZCD.Z#TO!-E:EVC:?=LP^R\!FJ<@K_2J_]M,41U/QLM/VDG(9CZL;?7S_Z?I3C ('82KB?%-);#D& M_)\R&:MI\28(_HC#Y_9O\Q:9?6M@>?7]YY;>R"\T&43($4ILKXAN>OU>'HR]G"\?IF'_Y/H>:=@/=B M9UZMB"XYL_NZS]QPS_+IN.$-![XEMV(RZ\WHFF9M44.&A??D;&ABM_@9G"Q^ M_J3II/DR!-T4.?89Q&>W+:Y(G5(EZ.O"U0I>VP&N5OIV1'?<:][>[KWHC;OA M WQA>Z[A>5)5;%Q['JE?F6QU:'_*@'*&H&(.ZQ^YPW<=K$)1)-1"'Q\8WJ!OO]CQ ML%G/MR?X^NPN_/'M*?DV3HK,1_?C*&)^&0W>:SS^$$ M^_CI MK@4$^K0_Q;=I,F39QICH]4S+;4)$;?7-86AE#WJ&X33A824,%&LN/_HI_L8; M56V*",OI&^J;L&3Y+:!H11/P,=5L;PE%^8FO_M/O/C9[A 5!GZ0$WOE4W+52 MUPQ5FWENFUV U0I+VX&UF'WQ6SJ?*K,6"SFN93E*Q*]Y_2W :(44S[!,%2UM MP6B5GW(M.@.WQ]%SELC6^VZ86TJ6$DU;4,_#3 M 2N42U_#[/O'E#&9YO]5S$1LX_-?15Y+U#+XLK,GG#6= MY+A1MX3FEJ/..Q74?1"3E/Z1H.:-;NR]TIUYJ59%O,!)CAUYZU >(&]P>LA[ M'V+CV3A8 W4M6'1_[\$BU.W0)-R_13Y.4NS&_0?VD>6I4[3T;>3//3=?$<#/ MR1-+^;\P6KI14M**A]-Z]A'8#=Q[Q=$?T^D^<31XEIAV W2GR<" M#G\RS.AA@7#V?&43/XSYO%$*[Z;[?@Y;AS_!SN28 MV%>!Y$M![5B>#R[,G6_CW-N=PWX0Y,SG7&R&G(7$[?TC!P']1#,MWM/H:-[M MCL.GG*(DWZ"M-K F)O9FY@KXP2H?L1!'>Z,KY0,V%*<5LD\Q/_*>SO5<.O7> MS[5'=I@35\^:Q6M*D!>PD-<[TQ&A-'9?;,OK]1HH$D^M;HW)[1 M:ZC=6HH]=TQYDM=_TFWEVJ$.OH'%\4*G;E=SB;ID&!>D=#*Q^L[,5$N).+7? MOE8V(WX=/V 1+C5D&"4IHBBKT$%S^MIJ\99ART8H;==>U<)B)U4TAMUSES3Z M6'?O=9N,V*[E[6[K];J(F+U>W]S-WFNW"3%!MVZWM=HR9+&.?1?W[QJ#@6J$ MK]YQ>_C6;D1C#BSW9>%;CY"LGNLXSLL!N"ZU60/#LJQ-X9-='_ QRO$=^$\1 M3O&IV"JNZ_3[O9Z"L]6[; ]3&SQM!]-5-<14Y6?X-\Z27FC_LW3QC7,L/##6 M>[4(]4[@>2^SOF1VH-\QO8@M[ X:,//$7S9G^?F^H^[$37I M6:RK*['(1M]^,&&U$+D9C0*AZT>6F?@80["\P#,X^]W/_:Y2P<^=>O/GNFN MM160IN7U!DK:7-/>-536C[ +B[7O&"".!*+JRZ^_\WJFE-5W3&?ESJ517[!O MR5=&DN363[&%C,BW!*T3F_PN3[[L(\=9=JTP^7V]4/[ZZOW"7<'OFKIS*GZ& M=B#M\"2MG"$#P[.](X!2Z;2!/7]FZ_?J6/T*N?7N*"]_3N?" &'N5NJ:I-\E M)_T]^[N?9N-[/WW8Q% X^$6NU7#EG9_>^T'2\C(=>, =U:GR\H>=DQ(M6LA< M@Z@.0C]^CV.5%B]T47Z8QK'%R@-W6071+)4,/+:X"R$(.93*-DQI@XO^RM M4.%@8]^3.3#ZB@A_=J.=0-;JP>[9 ]7"6ALR;)3T/ S/W^S*-J;*)MOMOP\A M8,T+@1< ]IFV;Y9K]_8 T.X4K7U ]$R]HZV&?AL ()55;:Q$'H4[/V*5X'C/ MLF$:3I>%N?B+P[7E]J_/3W_C?]1\+5"VUT:,:>P_A1_A<'O;^ M.J'\@=TH& M0&4TP9[_RQ^"K0)&FY:/TZ1X&--**1OFXN]8Y1JS2 -D:!RB+. 3'YF(G?AS'],,3A!(&?:C,,>HLMX?>P&LO& M211H/N]^B5L;7?1 MV&XDS#*9KKY^[[!J@5(WO8G;*#.>T:],SWD@]@[C7#?"M?MX&8<&?;5+H==[ M(?C^;\%8?,L>_*S(#H"V9=W/-J;* P*X.^A$F95HY"9RH?;8$U""U;AODR/R M,Q!,A&ZF+37U@6G9_?^_O6O];A-)]O]*G\QD;W*.[.$I(-F=IN$$@@-0_9EJPOB25!UZ^JJZM?]2@?,:XVW9:\ ME*^1.K1PHR!#OW#!BX^A=4Z6W=A1#JIN6';YMKR>2&=$4CL5TU0MI2$BKD1N M.,C%:F(R>)@PKRG(,4SRM '9T.Q-F6Q3&6I9UTE3 MZP]CP]NRHGT2>1/$,7]7E5$,U;'+!K"20""D\&R(I.7<-/'64Q M5"W=7E/60L/M2+?IZBS=:-*[XEO#87ZGMYU*#Z#DLB/E=9[D,66]D!T\BE/8 M_I.7R!.0NOQW=*64_ZBJ\=71!I.*QQ=E/I84S8^+%UWG5,4P],*HVT:G#UQR M^6U4357;XT+-^:\;4\S C_-,1\-@:/;*(G&]\?80Y!:JJC*4A9 '7.!:C85* M8!C$K?NC]1!9':TE_]TM9'I )75MJVAV*79;#A63**O4VU4JEJWD6XEB@XTH MM9DL;BC&NV0K$#=HRP$NBXCA4A-E(L796Q'&DK]V6!"UN1 MB4^][CUHEPZM90GVBE3*&NCJT%R]!VV#-,O!)<8&#!?62N^K#EVQC!4GZ49T M=X%;2M#FT"P&Y73%C?<@G\,$1C$>K!3S_K!:ZM[RN+<*L877MHK3RIV@ZBJK MYG97559N;N00]\OK=M<)B;PPJU=0SY.1-EFI5/,9L+9='R7ZZ!GP8?>A:WO! M1YO<<<_"',BRMH>CJ(JUK*I68S54]:=GR&1%JH<90U)ET;*'+^D<0[?#Y;V% MKMFJHEAVLS1@S]W:-QR"SZ!7'>Q5F3#WGNS%99329(/O>!T]E+M@;LBT MNW8_8LKR5M;;3^ZXJHSJ8]F[BL-R<]T'K@IN%[:Z."_W4"URN)H,2I9'<6N= MW$9GX_^;^S'%E.%)RKZKND+GW6>R*_1^NW*+,J[PMPGW*H^BMNWO%$NC?9KC MI:,8!EDK7\'.PO\LH^75Y)*F*[^W=JVU-+48P]0=R:/R)AE3T;V4Z[[*2>K8 M;JB;Q2I!>\;;X^G SN7T>Q3>8=)+M(UY MO'.#JJ";8I%WJL O<(')QYGH]N MDFZ %33&]U1BX5W+3T-V6/T2ZB4XMV#F2#S/KB_.S'FRV-332P]ECUS%_IT? MLDCA3U3&:VYM,JKEXYERC.5CY%A=#2+:&U9WQ%5Y7?7%39E1_%"3H+M_KD#W M-(6U9-1-$C>FQ,W*^6(< #Z#B?_<<"'< M^<_F=T"1. ,"*J"161QAFG5TDW=3$D:$XKX5W>H].G'G04KH#S])DU/RT1W? MDW4T9(K-C2ASO7?)E-OZS$L?VOE9/57@ZR" UP9DZBY(% 8+?&..R7L!Y 2L M)HP4@I$$[.*,N+@83WR>"O"-FR 8Z#XO"T$HL_UVP*(!QO =M.K1T.=/:!$04MY!\"+IQHE+K "Y<1_C@!-0-*?NR1 M&;]Q)$E$ I@H"0B*-;Y\V(O@YS "R-YW&B<4!.]R'D00"71:+J88_Z_7KE/R M;1:)$) @0A<(%M0!HED78EET#]#[ ':1$856H^5D68Y:< M\AMJ_L92Z6K?!SV)J3\=S4$8&1S47!\8I]PI'&-26 @H4R(8X2%FC02C8C$#9/ M"2G?,DW,.$;YHDM!M3A #/-,A=SQF 8%$5(T+TQ[ T#XMJQ S,84%0B?9.%! MJ EO\-%7-^(;6)"\>LO1H47C"=+A8SZ.6:E@DK!TV 4M4G(U0@ #L!7<,(X6 M_$MHFS?TQGV+1LU4!N3-Z*UXXX$B0I;J%:@^W/O R#JU!QJC?<'DYEF[&2Q0 M-?PO@M$9LZ'%0JM0VLO1#-]%3)]2K%+G)\"OBX0?\ MHR A9N3F8D"\&7,NLA#L*7,5%MR([MK0R"GH0*&KH)=@$HY8=ZV] -KJ)O=H M]7!UE&935 I+_#S4:\7JU*U/-HR5A-[]Z,9872(YIV"3\Q)-S'^KF-=O)9U?30)/YT1SB@D\NW&7^6BUA[G& M[44$:RU,$BXVR!]'?NJYV].1E@[5FMYV5=8U7.&O&E@'_!LBIJ3P9P_?/M#@ M.V7ICQ)^ _/%CI>/8:QW'W\?GJ5_N=6@6LAN(30,Q^XCG>SYC,)4?: MK\-6S"WGCJ0RMUKO9L^TS)5)*UG+J=8GF)4+9#%\&XFVT=%I$WXZ>E!47&F; MV\%\"UT^.V+27EC9B0.SJLC@1@[%CE;T'MU,I3LFF;L;RRQERWLD2$]UB=R) MV_(:GU5$P%%2>V$N%7YEX;U@[:UVF4A70%*Y"]DE5:W'SF9 Q>Q7K25B.II= MK/=0;+0I02F.5=M6BG7$9 EV#2]PAKIMU]"M\1>7)"^5W'7[EU4<_ MFT,-%O?:^GW:9O'+ 9 +UU8,1VU&?V,%N$OZP'Z2S2%:6,A@3NQSZL[3Q3^C M .?>I"I'5TV9-!BQ13[D,$IRQBXU=\Y8Q=+?,6US*T]E=&LK"G:^Q5[ES!?* M;H*:UV7ZV'9CE*LL= $UB81\Z\_1?$-C;_[8RE% MT'$1FOGD+4]<\6SE=78KTZ4N2+;=;TZQ M+OY<+%/K_ T:'FWL=MGME/)O5G#0/Y,]^&OQ_#([05V71JH[:L?4'AOT8^N3 M.H395V_$)*9E&6.$0775P6:YTK8X\FIVT3#*4>X5;[-B;_:P6'NB'=SJ6M_K MM1Q'J[4<<\^Y,Y@BIEG=SAD= P)@E66+ORJ*G]L*S[>!Z"ZW,!B:JL6 MVV7$G+>IQV@DMQ&L?HJ_8^8C?OET#:/A+L0CB=9!RD-K6/2=VAG 1Y,$7TK M\D%\A<\U48P_'D$8E1@KA\D:.;Y&.ING]U&,37U#+Y>;0U1 M=%3\@FBHN7J(_TB@=ZJCZ^0V]6,_.JGO2"<;\E+KU/K%C=$7+Q %D;\E M;!=YX09CK('%"H1^H-P#!1YAM9*:K^$VU&?N U").5Q:\*5(EB>P)LRV/7+U M-+];WD2M!.LW&D*W!%^CP!\O;@'#.:P"_Y*>8O\6I.]G)$D7 ?W'JRD3T3NB MS-)7?[M+W^./O\S87S^INOBG^,($J+PC*CQ/;OTI3<@E?2#7T11=W=@7 P+3 MM3]Y3_*FWQ/$=>(&_AU\_!,V$OYDD5.;XQ^")49]_J@XQ)<^#!5L$(:9'W)L M[G3V_B=UJ#RR3&ZY4R-W@Q/'C!XNX]D:,X%.1Q\Z+W/G Z$AG@0CLGGPE,L\ MX/*08J(KZ*.M.LQ'[P,=BV]5]JW-OD7/U2P[.G?X"_%P9\K\0PCL]8!>38/8 M!D. /N/ST)U[/J!COGQ)X8NM7) "!_?N=TI&Z(PXB^G,%1ZT*)388Q[>S(/6 MS3-,HHLA-#(+:,*@W'%M0B?E\1AAYP[?WT(&AL6O)^0-[V-;TY3WOYV=?W*OZTP)*/X3OI]Q=#-E'KF<\\&L5)8/"D"+EF+*X4,X@],_U/*#D MYN1_,V]%$="&;MC8[L1" M22,"QF\*:GKRGU-RQF""[((%UQ3CR$)*;J4NO%"1!U,8#^9=2=G>:F*0C"@ MVE^X=G1%BOLCH&CNBS,U\ MS,:0H#[QDS'PS'N<"?;?%@R"$V&9G(?S0,/R^X'$\RM_DJ9:X9MB.^58212BF/Y&*1/AF69*GC MXRQ=[[I.;U382M5FZ< /4K,99R]-L1G3RP"F90"96]#J&(OXL,MAW&TR1/,0 M UQPF@ #B^$8:(Y##/BAH.)@[F%ZQ8 3G*AP O-\-J./&;E**FS*0U)5;;(? M1+R5E\TE&>IR0,F&X<6V_+"X=%GH I+ M/']<&W._6NVP< [0K*#L2__D&3O_^RK;5UJNSJ M#$?/=_K!3=TJI[(&5*M;6Z=ZS\+I."5E.S%,G;*4HD0RJ_T;-@.M%M*IJ5,^&M-%=!\MR][*5^C2./'_UT%81B.1F"ZI9;$F]CLC^'R9SEF.] M=E1;ER'80QT<5=$=5')QLB#+61^]\>X+E^F%6GK?6XO"PVL MMMF88*LB#=$DA04MO9F/\ECQUI94-PPC+]10U7 [TE+E:VQGJ$F3OJ:CF"_; M.^JDH5BY_J\UVIRD5*24H9I2%"\"V"/ 9O2:)I2=\[7M5;-0FFFES<8$I8R* M;AFF#,%BQ9WK_&2IOTI+[8A(514SALLJ;QO:7UW8QU$0M*NGVJ3DNE/8+Y:) M-L=3YZO9!(^^%<]R+<7OO#_Q?$GLY.*25G:3)37EK&=[K230 <<3^[ :)BS MG<8,5M<'.PN]RR@<;QT;3\:L3)&S$A/K?(]CS)/Y@?+_/X=LRY*]VF7O6D)Z MHCMZ*;1'AG!?8)MN>$\PA,\QVX$MG!4UCDA251C$32*2Y(A5R#&:8JTN877. M:4@G?@L/GPK1:9IME;NYBE0'1';!!DMUIJH-54?9,:1&^J690UO5=HFHJ;/Z MB6D9FMH84>%XHVNA6,VV#:ORX&3[ 4[74I&ZJ0[-QK2_HL.+[PD)[8+_2@K= ML+26QT8L?"53>B+)BG:UFDJ>VS7C"/_ 0@;$S-UZ5/4]$3R3C&GF\,#89J"R MCBCMLM<)C!:%!C/<):280.ES"EO=L'$:8\CIX& M08))9L,['%[L\\SUO.QS&:\*>"\ P2CV!^2?F/H);V !JQLF)P+P@^^E]\B; M\OH]&46Q1^.3,4C&G27T'K4$A%CBC-!W&K-+W8S/493"ZG/Y-(YH]H:7 MO5&4"GJYPJJT0@"I5]&$['.(&H04_N.5EDM$<,;Q <[ '?]%U%,3),1\*,K= M500&3:(XFZH">[G"^0M18QOYT.W$ZOZ)9,VOJ[-$V)]Q(P4%30=F[^)H'GJH M[5'\COQT5AZ>_FC-0 M;?WE*K&J#W1%>RY*O#M++#Q'DL/38%49:*;U'=V&+V$#D][[>% -[O;H+WE7U7T@:,^FV7$ M+HWPUSB:1H>YEU-58]#'"=S>"D WM(&FR9Y4[+$5%BZ2Q,T<2@Y/F5_PP81I M#W2]^YYV#XQQYKY*DJ+_ZN$ILV$/G&'WZ75O^=>-@6&\ +N\]%(^/!VV!H9J MOEP5-I2!U<-!XQX8Y

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end XML 75 R27.htm IDEA: XBRL DOCUMENT v3.19.3
Prepaid Expenses and Other Current Assets (Tables)
 9 Months Ended
Sep. 30, 2019
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]  
Schedule of Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets consisted of the following:

 

    September 30, 2019     December 31, 2018  
Advances for inventory   $ 14,571     $ 25,170  
Media production     -       20,791  
Insurance     29,183       13,302  
Deposits     10,257       45,144  
Trademarks     19,707       78,826  
Rent     86,354       103,912  
Promotion     114,018       342,220  
License agreement     -       58,333  
Software subscriptions     48,962       34,440  
Rebranding     7,415       40,783  
Clinical research     23,745       35,617  
Miscellaneous     33,286       30,309  
Related party receivables     9,467       -  
Capital asset deposit     38,200       -  
Total   $ 435,165     $ 828,847